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Abstract 
Background overall Quality of Life (QoL) is fundamental for both well and ill people. For 
the cancer patients it is a vital issue in the presence of this devastating condition that 
depletes all the resources on both the individual and community level. This study looked 
into the cancer patients QoL at the most difficult times of their lives. Cancer is the second 
leading cause of death in Palestine; 12.4% of all deaths (MOH, 2012). Most of the cases are 
diagnosed in late stage (Husseini et al, 2009), and very low levels of pain control and 
palliative care are available (AL-Sadeel Society website, 2012).  
Methods The aim of this study is to assess QoL domains scores and symptoms experience 
within the Palestinian culture. The study was carried out in the only three main settings 
available for treatment of cancer in the West Bank of Palestine.  
In-depth interviews with 10 cancer patients were done to reveal the uniqueness and any 
special concerns for Palestinian patients. And a cross sectional design studied 323 patients 
to reveal associated factors with QoL. The data collection tools were structured in-depth-
interview questions and the QoL assessment tool of the European Organization for 
Research and Treatment of Cancer (EORTC QLQ C-30) to which socio demographic data 
were added.  
Findings Both qualitative and quantitative parts of this research were in harmony in 
representing the poor health related QoL (41.8%) of the cancer patients. The predictors of 
poor QoL were advanced stage of cancer (β= -0.3, p<0.001), poor economical condition 
(β= 0.19, p=0.001), low educational level (β= 0.12, p=0.04), and long duration of treatment 
(β= -0.11, p=0.04). As well, the generated qualitative themes supported these results; the 
main expressed needs of the cancer patients were financial aid, pain management, fully 
equipped healthcare facilities in their vicinity, availability of medications and qualified 
staff, eradication of stigmatization, communication and psychosocial support, health 
education, home nursing care, and palliative care.  
QoL functions were low and below half of the full function in most cases; physical 
(48.5%), role (48.8%), emotional (46%), cognitive (60.5%), and social (50%). Moreover, 
severe symptoms were experienced by cancer patients; fatigue (66.6%), pain (63%), 
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insomnia (56.4%), appetite loss (45.3%), and financial difficulties (64.6%). These results 
were lower than other studies in the region, denoting difficult conditions of Palestinian 
patients with cancer.  
Conclusion Palestinian cancer patients are suffering from quite difficult conditions. These 
can be divided to two main streams; socio-economic factors of the patients, and inability of 
the healthcare system to early detect, diagnose, treat, and provide professional support, 
especially to advanced stages cancer patients.  
So, and for better QoL, there is desperate need for integrating palliative care services into 
the health care system in Palestine as quality improvement, cost-effective and economically 
efficient measure, and develops social welfare system. As well as, there is a need for early 
detection, and awareness and education for cancer patients and health care providers. 
 
 
 ﺔﻋﺎﻳﺔ اﻟﺗﻠطﻳﻔﻳ ّﻳن ﻓﻲ ظﻝ ﻏﻳﺎب اﻟر ّﻳ ّﻔﻠﺳطﻳﻧرطﺎن اﻟﻣرﺿﻰ اﻟﺳ ّﺟودة ﺣﻳﺎة 
  ﻣﺣﻣد ﺣﺳﻳن ﺧﻠﻳف: اﻋداد
  أﺳﻣﻰ اﻻﻣﺎم. د: فااﺷر 
  :ﻣﻠﺧص
 ، وﻋﻠﻰ ﺣد اﻟﺳواء ﻫﻲ ﺷﻲء اﺳﺎﺳﻲ ﻟﻸﺻﺣﺎء و اﻟﻣرﺿﻰ اﻟﺣﻳﺎة و ﺟودة ﻧوﻋﻳﺔ ان :اﻟﺧﻠﻔﻳﺔ
ﻫﻳب اﻟذي ﻳﺳﺗﻧزف ﻛﻝ اﻟﻣوارد ر اﻟ ﻫذا اﻟﻣرضﺗﺣت وطﺄة  اﻟذﻳن ﻳﻌﻳﺷون ﺑﺎﻟﻧﺳﺑﺔ ﻟﻣرﺿﻰ اﻟﺳرطﺎن
  .ﻓﻬذﻩ ﻣﺳﺄﻟﺔ ﺣﻳوﻳﺔ ﺟدا ﻲو اﻟﻣﺟﺗﻣﻌ ﻲاﻟﺷﺧﺻ اﻟﻣﺳﺗوﻳﻳنﻋﻠﻰ 
ﻓﺎﻟﺳرطﺎن ﻫو . اﺣﻠك ظروﻓﻬم اﻟﻣﻌﻳﺷﻳﺔﺟودة ﺣﻳﺎة ﻣرض اﻟﺳرطﺎن ﺧﻼﻝ ﻓﻲ  ﺗﺑﺣث ﻫذﻩ اﻟدراﺳﺔ ان
، و (2102 ,HOM)ﻣن ﻣﺟﻣوع اﻟوﻓﻳﺎت % 4.21ﺣﻳث ﻳﺷﻛﻝ  ﺛﺎﻧﻲ ﻣﺳﺑﺑﺎت اﻟوﻓﺎة ﻓﻲ ﻓﻠﺳطﻳن
ﺑﺎﻷﺿﺎﻓﺔ اﻟﻰ ، (9002 ,la te iniessuH) ﻟﻠﻣرض ﻝ اﻟﻣﺗﺄﺧرةاﺣﻣر اﻟﻣﻌظم ﺣﺎﻻﺗﻪ ﺗﺷﺧص ﻓﻲ 
   .(2102ﻣؤﺳﺳﺔ اﻟّﺳدﻳﻝ، ) اﻟرﻋﺎﻳﺔ اﻟﺗﻠطﻳﻔﻳﺔﺧدﻣﺎت ﺗوﻓر  ﻋدم اﻟﺗﺣﻛم ﺑﺎﻷﻟم و ﻣﺣدودﻳﺔ
و اﻷﻋراض ﺣﻳﺎة اﻟ و ﺟودة ﻣﺟﺎﻻت ﻧوﻋﻳﺔﻣﻘﺎﻳﻳس ﺗﻬدف ﻫذﻩ اﻟدراﺳﺔ اﻟﻰ ﺗﻘﻳﻳم : اﻟﻣﻧﻬﺟﻳﺔ
اﻟﺛﻼث اﻟرﺋﻳﺳﻳﺔ ﻟﻌﻼج  اﻟﻣراﻛزﺣﻳث أﺟرﻳت اﻟدراﺳﺔ ﻓﻲ . ﻓﻠﺳطﻳنﻔﻲ ﺿﻣاﻟﻣﺻﺎﺣﺑﺔ ﻟﻠﺳرطﺎن 
و  اﻟدﻳﻣﻐراﻓﻳﺔاﻟﻌواﻣﻝ اﻷﺟﺗﻣﺎﻋﻳﺔ و  اﻟﻌﻼﻗﺔ ﻣﺎ ﺑﻳن ﺑﺣﺛت ﻓﻲو ، اﻟﺳرطﺎن ﻓﻲ اﻟﺿﻔﺔ اﻟﻐرﺑﻳﺔ
  . و ﻣﻘﺎﻳﻳس ﻣﺟﺎﻻت ﻧوﻋﻳﺔ و ﺟودة اﻟﺣﻳﺎة و اﻷﻋراض اﻟﻣﺻﺎﺣﺑﺔ ﻟﻠﺳرطﺎن اﻷﻗﺗﺻﺎدﻳﺔ اﻟﻣﺻﺎﺣﺑﺔ
اي ﺗﻣّﻳز أو ﺳرطﺎن ﻷﺳﺗﻘﺻﺎء  ﻣرﺿﻰﻊ ﻋﺷرة اﻋﺗﻣدت اﻟﻣﻧﻬﺟﻳﺔ ﻋﻠﻰ ﻋﻣﻝ ﻣﻘﺎﺑﻼت ﻣﻌّﻣﻘﺔ ﻣ
 323ِﻝ دراﺳﺔ ﻣﺳﺣﻳﺔ ﻣﻘطﻌﻳﺔ ﻛﻣﺎ اﻋﺗﻣدت ﻋﻠﻰ ﻋﻣﻝ  ،رﺿﻰ ﻓﻲ ﻓﻠﺳطﻳنﻣﻠﻟاﻫﺗﻣﺎﻣﺎت ﺧﺎﺻﺔ 
ﻣﺟﻣوﻋﺔ أﺳﺋﻠﺔ ﺣﻳث ﺗم ﺟﻣﻊ اﻟﻣﻌﻠوﻣﺎت ﺑواﺳطﺔ . ﻷﺳﺗﻘﺻﺎء اﻟﻌواﻣﻝ اﻟﻣرﺗﺑطﺔ ﺑﻧوﻋﻳﺔ ﺣﻳﺎﺗﻬم ﻣرﻳﺿﺎ ً
ﻟﻠﻣﻧظﻣﺔ اﻷوروﺑﻳﺔ ﻟﻠﺑﺣث و اﻟﻣﻌﺎﻟﺟﺔ ﻣن أداة ﻓﺣص ﻧوﻋﻳﺔ اﻟﺣﻳﺎة ﻟﻣﻘﺎﺑﻼت اﻟﻣﻌّﻣﻘﺔ و ﻓﻲ اﻣﻣﻧﻬﺟﺔ 
  . (03-C QLQ CTROE) اﻟﺳرطﺎن
اﻟﺣﻳﺎة  و ﺟودة ﻧوﻋﻳﺔ ﺗدّﻧﻲﻓﻲ اﺑراز ﻣدى  ﻣﺗواﻓﻘﺔاﻟﺑﺣث اﻟﻛّﻣﻲ و اﻟﻧوﻋﻲ  ﻛﺎﻧت ﻧﺗﺎﺋﺞ: اﻟﻧﺗﺎﺋﺞ
 اﻟﺗﻲ أﺛرت ﺑﺷﻛﻝ ﻧوﻋﻳﺔ اﻟﺣﻳﺎةﻟ اﻟﻛّﻣﻳﺔ ﺋﺎتﻣﺗﻧﺑ ّاﻟ، ﺣﻳث ﻛﺎﻧت %(8.14)ﻟﻣرﺿﻰ اﻟﺳرطﺎن اﻟﺻﺣﻳﺔ 
 =β)اﻟوﺿﻊ اﻷﻗﺗﺻﺎدي اﻟﻣﺗدّﻧﻲ و ( 100.0<p ,3.0- =β)اﻟﻣرﺣﻠﺔ اﻟﻣﺗﻘدﻣﺔ ﻟﻠﺳرطﺎن ﺳّﻳﺊ ﻫﻲ 
- =β)اﻟﻣّدة اﻟطوﻳﻠﺔ ﻟﻠﻌﻼج و ( 40.0=p ,21.0 =β)و اﻟﻣﺳﺗوى اﻟﺗﻌﻠﻳﻣﻲ اﻟﻣﺗدّﻧﻲ ( 100.0=p ,91.0
v  
iv  
ﺣﻳث ﺳﺟﻠت اﻗﻝ ﻣن اﻟﻧﺻف ﻓﻲ ﻣﻌظم اﻷﺣﻳﺎن،  ،ﻣﺗدﻧﻳﺔس اﻟوظﺎﺋف اﻟﺣﻳﺎﺗﻳﺔ ﻳﻳﺎﻣﻘ تﻛﻣﺎ ﺟﺎء
و ( %5.06)و اﻷدراك ( %64)و اﻟﻌﺎطﻔﺔ ( %8.84)اﻟدور و %( 8.84)اﻟوظﺎﺋف اﻟﺟﺳدﻳﺔ 
، ﺣﻳث ﺳﺟﻝ ﺑﺎﻷﺿﺎﻓﺔ اﻟﻰ ﺷّدة وﺟود اﻷﻋراض ﻟدى ﻣرض اﻟﺳرطﺎن%(. 05)اﻟوظﺎﺋف اﻷﺟﺗﻣﺎﻋﻳﺔ 
و ( %3.54)اﻟﺷﻬﻳﺔ و ﻓﻘدان ( %4.65)و اﻷرق ( %36)و اﻷﻟم ( %6.66)ﻣﻘﻳﺎس اﻟﺗﻌب 
  . ﻛﺎﻧت ﻫذﻩ اﻟﻧﺗﺎﺋﺞ أﺳوأ ﻣن ﻣﺛﻳﻼﺗﻬﺎ ﻓﻲ اﻟﻣﻧطﻘﺔ (.%6.46)اﻟﺻﻌوﺑﺎت اﻟﻣﺎﻟﻳﺔ 
ﻣﺷﻛﻠﺔ ﻛﺑﻳرة ﺗﻣﺎﻣًﺎ ﺗﺗﻣّﺛﻝ ﻓﻲ ﻣﺣورﻳن ﻳﺗﺑّﻳن ﻟﻧﺎ أّن ﻣرﺿﻰ اﻟﺳرطﺎن اﻟﻔﻠﺳطﻳﻧﻳﻳن ﻳﻌﺎﻧون ﻣن : اﻟﺧﺎﺗﻣﺔ
ﻋﻠﻰ و ﻗدرة ﻧظﺎم اﻟرﻋﺎﻳﺔ اﻟﺻﺣﻳﺔ  ،اﻟﻌواﻣﻝ اﻷﺟﺗﻣﺎﻋﻳﺔ اﻷﻗﺗﺻﺎدﻳﺔ ﻟﺣﻳﺎة اﻟﻣرﺿﻰ: رﺋﻳﺳﻳﻳن ﻫﻣﺎ
ﺧﺎّﺻًﺔ ﻟﻣرﺿﻰ اﻟﺳرطﺎن ﻓﻲ  و ﺗوﻓﻳر اﻟدﻋم اﻟﻣﻬﻧﻲ ّ ،و اﻟﻣﻌﺎﻟﺟﺔ ،و اﻟﺗﺷﺧﻳص ،اﻟﻛﺷف اﻟﻣﺑﻛر
  . ﻣن ﻣﺟﻣوع اﻟﻌّﻳﻧﺔ% 4.17اﻟذﻳن ﻳﺷﻛﻠون  ﻣﺔاﻟﻣراﺣﻝ اﻟﻣﺗﻘد ّ
اﻟرﻋﺎﻳﺔ اﻟﺻﺣﻳﺔ ﻓﻲ ﻓﻠﺳطﻳن ﻛﺄداة  ﻧظﺎم ﻟﻰااﻟرﻋﺎﻳﺔ اﻟﺗﻠطﻳﻔﻳﺔ  أدراج ﺧدﻣﺎتﻫﻧﺎﻟك ﺣﺎﺟﺔ ﻣﺎّﺳﺔ اﻟﻰ 
و أﻳﺿًﺎ اﻟﺣﺎﺟﺔ اﻟﻰ ﺟﺗﻣﺎﻋﻲ، او ﺗطوﻳر ﻧظﺎم ﺿﻣﺎن  ،ﻣﺎدﻳﺎ ً و ﻣوﻓرة ٍ ،ﻓّﻌﺎﻟﺔ أﻗﺗﺻﺎدﻳﺎ ً ﺿﺑط ﺟودة ٍ
  . ﻟﻛٍﻝ ﻣن ﻣرﺿﻰ اﻟﺳرطﺎن و ﻣزودي اﻟرﻋﺎﻳﺔ اﻟﺻﺣﻳﺔ اﻟﻛﺷف اﻟﻣﺑﻛر و اﻟﺗوﻋﻳﺔ و اﻟﺗﺛﻘﻳف
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Chapter One  
Introduction  
 
1.1 Background   
Quality of life (QoL) is the up to date attracting issue in the world nowadays. The term 
quality of life is used to evaluate the general well-being of individuals and societies. The 
term is used in a wide range of contexts, including the fields of healthcare. Quality of life is 
a wide term that can include multi diverse aspects from wealth, employment and built 
environment, to physical and mental health, education, recreation and leisure time, and 
social belonging (Wikipedia, 2011). Quality of life for the cancer patients is a vital issue in 
the presence of this devastating condition that depletes all the resources on both the 
individual and community level.  
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Cancer is one of the first leading causes of death globally, according to WHO it caused 7.6 
million deaths in 2008, approximately 70% of cancer deaths occur in low- and middle-
income countries (WHO, 2012). Cancer is the second leading cause of death in Palestine, 
accounting for 12.4% of all deaths (MOH, 2012). According to the Palestinian health 
information center (PHIC) report (MOH, 2012), the reported new cases of cancer in 
Palestine were 1,498 in the West Bank, with an incidence rate of 64.2 per 100,000 
populations, where the cases of mortality from cancer were 897 persons. National statistics 
showed that most of the cancer cases are diagnosed at the end stage of the disease 
(Husseini, et al, 2009); this late diagnosis makes it difficult to treat and control symptoms 
and results in low survival rates and poor QoL of the cancer patients.  
According to WHO 30% of cancer deaths can be prevented by implementation of evidence-
based strategies for cancer prevention, early detection and management (WHO, 2012). 
Furthermore, it has been stated in the literature that at least 100 million people would have 
improved quality of life (QoL) if today’s knowledge of palliative care was accessible to 
everyone of the public (Stjernsward et al, 2007 a).  
Moreover, QoL assessment is a vital instrumental tool to adopt, especially at the primary 
steps, in developing data bases for future use in formulation of country wide programs to 
support the efforts for better QoL. Guner et al (2006) cited in their study that QoL 
assessment considered the most important indicators of the outcome of medical service; 
provides understanding of nature of disease and experiences of patient, and works as index 
of efficiency for treatment. There is need for QoL assessment in different places, as it was 
cited that there is differences between cultural groups in their QoL aspects (Alawadi and 
Ohaeri, 2009). 
Palliative care for those patients is the advanced and most up to date choice that should be 
provided for them. To our best knowledge, palliative care service is not yet integrated 
within the Palestinian health care system. So, this study will consider the QoL of the cancer 
patients in Palestine in the absence of palliative care services that are supposed to provide 
them with comfort and better QoL. 
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1.2 Study Problem  
It is evident, after searching the literature, that there is no comprehensive assessment of the 
QoL of Palestinian cancer patients. Despite the fact that some regional studies done in the 
neighboring Arab countries with their different contexts and circumstances, Palestine has 
its own special entity and cultural considerations, due to its unique situation under the 
Israeli occupation with its strict regulations and control over all aspects of life of the 
Palestinians. So, the researcher went toward studying the QoL of cancer patients in the 
Palestinian hospitals and how it has been affected by the level of pain and other symptoms 
management that is provided to them. In addition to that is the fact that, till the time of this 
study, palliative care service is not yet integrated within the national health care services.  
It has been stated in the literature that at least 100 million people would have improved 
QoL if today’s knowledge of palliative care was accessible to everyone of the public. This 
can be best achieved through taking up a Public Health Strategy approach for translating 
new knowledge and skills into evidence-based, cost-effective interventions that can reach 
everyone in the population (Stjernsward et al, 2007 a). This strategy should be included 
within the national health policy as Stjernsward et al (2007 b) stated. They add that this will 
facilitate the implementation of palliative care programs in the community and aim for 
providing care for all people in need of that, and ensures equitable access to affordable 
medications and therapies (Stjernsward et al, 2007 b).   
 
1.3 Study justification 
The quality of life (QoL) is the issue of today’s interest; especially the health-related QoL 
which increased since the 1990s. This is increasing not only because life span of patients is 
increasing, but also as people are more aware and interested in the quality of life they are 
living (Guner et al, 2006). Theofilou (2011) discussed the issue of under estimating the 
need, by many recent policies, for using health related quality of life (HRQoL) 
measurement as a supplement of the traditional public health’s measures of morbidity and 
mortality. It has been considered a measure of outcome of health care and took the attention 
of clinicians, researchers, economists and managers (Schwartz and Sprangers, 2002; 
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Theofilou, 2011). Even though, healthy people 2010 and the Center for Disease Control 
and Prevention identified it as central goal for public health and an important health 
outcome (CDC, 2012).  
QoL research is either led by researchers looking for medical outcomes focusing on 
HRQoL, or by medical sociologists with the intention to study economic and social 
determinants (Schwartz and Sprangers, 2002). So, we are going to study the QoL of our 
Palestinian cancer patients and measure the effects of the surrounding factors on that life. 
Cancer is the second leading cause of death in Palestine, accounting for 12.4% of all deaths 
(MOH, 2012). Moreover, national statistics showed that most of the cancer cases are 
diagnosed at the end stage of the disease (Husseini, et al, 2009); this late diagnosis makes it 
difficult to treat and control symptoms and results in low survival rates of the cancer 
patients. According to the Palestinian health information center (PHIC) report (MOH, 
2012), the reported new cases of cancer in Palestine were 1,498 in the West Bank, with an 
incidence rate of 64.2 per 100,000 populations, where the cases of mortality from cancer 
were 897 persons. This also confirms that those newly diagnosed cases of cancer are at an 
advanced stage and terminally ill, and in need for palliative care service. 
Moreover, very low level of pain control and palliative care, low level of staff training, and 
also low number and level of health facilities that care for cancer patients in Palestine (only 
three main centers in West Bank) are available. This is based on a need assessment survey 
in the West Bank of Palestine that was done by a local non-governmental organization for 
palliative care (AL-Sadeel Society, 2012). Unfortunately, there is scarcity of studies of QoL 
of cancer patients (Alawadi and Ohaeri, 2009); only one small-scale study was done in 
2010 to measure the Quality of Life (QoL) of 70 Palestinian cancer patients in two of the 
three available centers (Thweib, 2011). Results found that the QoL of Palestinian cancer 
patients is low in all QoL domains. More intense symptoms were found when compared 
with regional countries. Thweib’s study stressed the importance of palliative care service 
for Palestinian cancer patients. But on the other hand, it did not focus on all cancer patients 
in Palestine. The sample size of the study was not representative to generalize study 
findings.  
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While pain is considered one of the most important symptoms when talking about cancer; it 
is also considered one of the main factors that have an apparent effect on the QoL of 
patients with cancer. Thienthong et al (2006) found a high correlation between the average 
change of pain intensity and QoL scores; a change of scores of pain of at least 3 points out 
of 10 had a significant statistical and clinical effect on the QoL of 520 cancer patients. The 
conclusion of this study suggests the high importance of pain management for better QoL 
of cancer patients. It provided deeper look into the way those patients see and deal with 
their disease within their social context. 
This study provides information regarding patients’ perceived satisfaction with their global 
health status and their evaluation of their QoL, and adds to the baseline data of the QoL of 
cancer patients in Palestine. It is further expected that this study will improve national 
understanding of the need of integrating palliative care and symptom management service 
within the health care system policies and plans, and encourage stakeholders in Palestine to 
pay attention to this issue; the thing that might result in decreased patients' and families 
suffering. In other words, this might positively affects the national concept and 
methodology of dealing with ill cancer patients, and aligns with the universally approved 
and accepted concepts of palliative care for cancer patients. 
This study feasibility was clear as it was based on the researcher surveying and 
interviewing of the candidates of the three available settings for cancer care in Palestine. 
This was followed by the necessary data analysis and processing.  
 
1.4 Research Objectives, Hypothesis and Questions  
Purpose of the study 
The purpose of this triangulated study (qualitative, quantitative) is to assess the QoL 
domains scores within the unique Palestinian culture. This will be done in the three settings 
available for treatment of cancer in the West Bank of Palestine.  
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Objectives  
The objectives of this study were:  
Qualitative part:  
The objective of using this method is to have an in-depth understanding of any unique or 
specific factors (cultural, social, ideological or political) that are related to the quality of life 
of the cancer patients in Palestine, especially, in the absence of supportive palliative care 
services from the national health care system.  
 
Quantitative part:   
1. Assess the GQoL of cancer patients in the West Bank. 
2. Assess the QoL domains (functions and symptoms) scores of cancer patients. 
3. Assess the relationship between socio-demographic factors and global QoL and 
domains (functions, and symptoms). 
4. Identify determinants (predictors) of GQoL.  
 
Hypothesis  
1. H0: There is no significant relationship (at P<0.05) between GQoL of cancer 
patients and the independent variables (gender, age, education, place of residence, 
income, marital status, living condition, and house ownership, place of treatment of 
treatment, department, stage, duration of treatment, and region).  
 
2. H0: There is no significant relationship between functions and symptoms of cancer 
patients with the independent variables (gender, age, education, place of residence, 
income, marital status, living condition, and house ownership, place of treatment of 
treatment, department, stage, duration of treatment, and region).  
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Research Questions 
1. What are the factors that affect the QoL of the Palestinian cancer patients?  
2. Is there statistically significant relationship between QoL of Palestinian cancer 
patients and their sociodemographic characteristics?  
3. What are the needs of the Palestinian cancer patients?  
 
1.5 Potential difficulties and limitations:  
• Accessibility to the three settings and difficulty to reach them under the current 
imposed restrictions by the Israeli occupation of Palestine. Alternative approaches 
were used when needed such as filling the questionnaires by patients themselves 
with the help of their caregivers in case patient was illiterate.  
 
• Difficulty in collecting the data and completing the questionnaire tools assessments, 
when some participants were in exacerbation stage and not able to respond 
adequately; due to effects of medication and side effects. In this case, the researcher 
returned later to assess them or selected randomly another cancer patient.  
 
• Scarcity of literature and research studies related to cancer in Palestine, and 
unavailability of accurate cancer registry.  
  
 
 
 
 
 
 
 
 
Chapter Two  
Literature Review  
 
2.1 Introduction  
This chapter presents an overview about cancer, burden of cancer, the most common 
four types of cancer, cancer brief treatment modalities, and stages of cancer. Then, some 
main figures and statistics regarding cancer in Palestine are presented.  
Moreover, the theoretical background includes definitions and aspects of quality of life, 
palliative care, pain, and some of the quality of life domains are presented according to 
main international categorizations and definitions.  
In addition, previous studies that are related to palliative care as a way to better QoL, 
the factors that influence QoL; including pain and fatigue, demographic factors, and 
clinical factors, were discussed.  
The literature related to the study assessment tool including its validity and reliability 
and its effectiveness were presented.  
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At the end, the economic perspective and public health view of palliative care were 
discussed. This is a validating part of the need and efficiency of adopting a monitoring 
system of the QoL of cancer patients, and providing a cost-effective and valid scope of 
service, that is through palliative care integration into the health care system as a whole. 
Table (2.1) summarizes some studies that conducted in the contexts of QoL of cancer 
patients.  
2.2 Cancer Overview 
Cancer is defined by the WHO as  
“A generic term for a large group of diseases that can affect any part of the body”, and it is 
“the rapid creation of abnormal cells that grow beyond their usual boundaries, and which 
can then invade adjoining parts of the body and spread to other organs. This process is 
referred to as metastasis, and is the major cause of death from cancer” (WHO, 2012).  
Tobacco use, alcohol use, unhealthy diet and physical inactivity are the main cancer risk 
factors worldwide (WHO, 2012).  
 
2.2.1. Burden of cancer: 
Cancer is one of the first leading causes of death globally, according to WHO it 
accounts for 7.6 million deaths in 2008, approximately 70% of cancer deaths occur in 
low- and middle-income countries, and 30% of cancer deaths can be prevented by 
implementation of evidence-based strategies for cancer prevention, early detection and 
management (WHO, 2012). 
 
2.2.2. Types of cancer:  
The following are the first four types of cancer in Palestine:  
Breast cancer: is “Cancer that forms in tissues of the breast, usually the lobules (glands 
that make milk). It occurs in both men and women, although male breast cancer is rare” 
(NCI, 2012). The incidence rate of breast cancer in Palestine was 7.6 per 100,000 
(MOH, 2011).  
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Colon cancer: is “Cancer that forms in the tissues of the colon. Most colon cancers are 
adenocarcinomas (cancers that begin in cells that make and release mucus and other 
fluids)” (NCI, 2012). The incidence rate of colon cancer in Palestine was 6.2 per 
100,000 (MOH, 2011). 
Stomach cancer: is “cancer arising from any part of the stomach. Stomach cancer causes 
about 800,000 deaths worldwide per year” (Wikipedia, 2012). The incidence rate of 
stomach cancer in Palestine was 5.8 per 100,000 (MOH, 2011). 
Lung cancer: is “a disease characterized by uncontrolled cell growth in tissues of the 
lung. This growth can spread beyond the lung in a process called metastasis into nearby 
tissue and, eventually, into other parts of the body. Most cancers that start in lung, 
known as primary lung cancers, are carcinomas that derive from epithelial cells” 
(Wikipedia, 2012). The incidence rate of lung cancer in Palestine was 3.6 per 100,000 
(MOH, 2011). 
 
2.2.3. Treatment Modalities:   
Cancer treatment requires a careful selection of one or more intervention, such as 
surgery, radiotherapy, and chemotherapy. The goal is to cure the disease or considerably 
prolong life while improving the patient's quality of life. Cancer diagnosis and treatment 
is complemented by psychological support. Some of the most common cancer types, 
such as breast cancer, cervical cancer, oral cancer and colorectal cancer have higher 
cure rates when detected early and treated according to best practices (WHO, 2012). 
Chemotherapy: is “Chemotherapy is the treatment of cancer with an antineoplastic drug 
or with a combination of such drugs into a standardized treatment regimen” (Wikipedia, 
2012). It is “Treatment with drugs that kill cancer cells” (NCI, 2012).  
Radiotherapy: is “The use of high-energy radiation from x-rays, gamma rays, neutrons, 
protons, and other sources to kill cancer cells and shrink tumors. Radiation may come 
from a machine outside the body, or it may come from radioactive material placed in the 
body near cancer cells. Systemic radiotherapy uses a radioactive substance, such as a 
radiolabeled monoclonal antibody, that travels in the blood to tissues throughout the 
body. Also called irradiation and radiation therapy” (NCI, 2012). 
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Surgery: is “A procedure to remove or repair a part of the body or to find out whether 
disease is present; an operation to remove tissue or part or all of an organ. For example, 
mastectomy is Surgery to remove part or all of the breast. There are different types of 
mastectomy that differ in the amount of tissue and lymph nodes removed” (NCI, 2012).  
 
2.2.4. Stages of cancer: 
Staging system: is “A system that is used to describe the extent of cancer in the body. 
Staging is usually based on the size of the tumor and whether the cancer has spread 
from where it started to nearby areas, lymph nodes, or other parts of the body” (NCI, 
2012).  
The roman numbers I to IV usually used for staging cancer, with IV having more 
progression.  
Stage I: cancers are localized to one part of the body. 
Stage II: cancers are locally advanced. 
Stage III: cancers are also locally advanced. The specific criteria for Stages II and III 
therefore differ according to diagnosis. 
Stage IV: cancers have often metastasized, or spread to other organs or throughout the 
body. 
(Wikipedia, 2012). 
 
2.2.5. Cancer in Palestine:   
Cancer is the second leading cause of death in Palestine, accounting for 12.4% of all 
deaths. 1,498 new cancer cases were reported in West Bank in 2011, 54.3% of those 
cases were females. The cancer incidence rate was (64.2) per 100,000 of population. 
38% of the cases were over 65 years of age and 57% were between 15 and 65. The 
geographical distribution of reported cancer cases shows that Bethlehem governorate 
reports the highest figures with an incidence rate of 111.3 per 100,000 populations as 
shown in figure (2.1) (MOH, 2012).  
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 Figure (2.1): Distribution of Reported Cancer Cases Incidence Rate per 100,000 by 
Governorate, West Bank, Palestine, 2011. (MOH, 2012) 
 
The most common cancer in Palestine is breast cancer (11.8%) and it is the first in 
females, while the first in males was the colon cancer (9.7%) and was the second overall 
cancer. The third was stomach cancer (9%) as shown in figure (2.2) (MOH, 2012).  
 
 
 
Figure (2.2): Most Common Cancer Cases, West Bank, Palestine, 2011. (MOH, 2012) 
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As cancer is the second leading cause of death in Palestine and in the region (MOH, 
2012; Bingley & Clark, 2009). This represents a significant need for Palliative Care 
service in the Middle East region, including Palestine (Bingley & Clark, 2009). The 
national health strategy vision is to have “Better quality of life for the Palestinian people 
through controlling cancer prevalence in Palestine” (National Strategy for Cancer 
Prevention and control, 2009).  
 
2.2.6. Quality of Life (QoL): 
WHO defines QoL as “an individual’s perception of their position in life in the context 
of the culture and value systems in which they live and in relation to their goals, 
expectations, and standards and concerns. It is a broad-ranging concept affected in a 
complex way by the person’s physical health, psychological state, level of 
independence, social relationships, and their relationships to salient features of their 
environment” (WHO, 1997; Bowling, 2003).  
The Center for Disease Prevention and Control (CDC) define QoL as “a broad 
multidimensional concept that usually includes self-reported measures of physical and 
mental health” (CDC, 2012 b). 
Health related quality of life (HRQoL) is defined as “individual’s definition of their 
overall satisfaction with life, or, a sense of personal psychological, physical and social 
well-being in being self-determining, independent and satisfied with control of disease 
processes” (O’Connor, 2004).  
It has been discussed that (HRQoL) researches have shown the human side of cancer 
care and played a strong role as a predictor for survival. As well as, they helped in the 
decision making process for both the physician and the patient, throughout weighing 
costs and benefits of the deferent care modalities. (Schwartz and Sprangers, 2002)   
 
2.2.7. Palliative Care (PC):  
WHO defines Palliative care as “an approach that improves the quality of life of patients 
and their families facing the problem associated with life-threatening illness, through 
the prevention and relief of suffering by means of early identification and impeccable 
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assessment and treatment of pain and other problems, physical, psychosocial, and 
spiritual. Palliative care: 
• provides relief from pain and other distressing symptoms; 
• affirms life and regards dying as a normal process; 
• intends neither to hasten or postpone death; 
• integrates the psychological and spiritual aspects of patient care; 
• offers a support system to help patients live as actively as possible until death; 
• offers a support system to help the family cope during the patients illness and in 
their own bereavement; 
• uses a team approach to address the needs of patients and their families, 
including bereavement counseling, if indicated; 
• will enhance quality of life, and may also positively influence the course of 
illness; 
• Is applicable early in the course of illness, in conjunction with other therapies 
that are intended to prolong life, such as chemotherapy or radiation therapy, and 
includes those investigations needed to better understand and manage distressing 
clinical complications.” (WHO, 2012). 
Meier and Brawley (2011) articulated Palliative care (PC) as a “broad construct defining 
a continuum that serves patients and families from the time of diagnosis with a chronic 
or acute progressive illness throughout the entire course of the disease”. Early PC 
intervention, in accordance with the usual standard treatment for cancer was found to 
have better outcomes such as better QoL, mood, and survival (Yennurajalingam et al, 
2010). It can be provided in hospital or outside it, and it emphasizes on expert and 
professional symptoms management (Meier and Brawley, 2011). 
The goal of PC is to prevent and relieve suffering to achieve the best QoL for cancer 
patients; it also includes the family members in this endeavor. This expands the 
traditional model of disease treatment to include the goal of aiming for better QoL and 
functions for patient and family (Theofilou, 2012).  
PC is considered as human right in many universal declarations. Of these declarations 
are the Universal Declaration of Human Rights for the right to standard living and 
healthy well-being, equal access to preventive, curative and palliative health services, 
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avoidable pain management, and essential drugs. The goal is to have PC and pain 
treatment on the agenda of the policy makers in each country health system (Breitbart, 
2011). It is a public health strategy adapted by the WHO since 1990, who produced the 
WHO public health model for palliative care (Stjernsward et al, 2007a). (Figure: 2.3) 
 
 
Figure (2.3): WHO Public Health Model for Palliative Care (adapted from Stjernsward 
et al, 2007a). 
 
It is a public health issue to deal with people with cancer in the proper way (Sepulveda 
et al, 2002). This has special concern as cancer is the second leading cause of death in 
Palestine (MOH, 2012), and as palliative care and pain control is considered as one of 
the human rights (Breitbart, 2011).  
The WHO defined gaps to bridge in the way to implement PC programs. Of these; are 
considering PC as a priority public health problem, by countries, and integrating it into 
the national health policies. As well, it advocated for key components of comprehensive 
PC programs such as policy development, education and training, drug availability, and 
providing good quality care (including home-based care) (Sepulveda et al, 2002; and 
Stjernsward et al, 2007a).  
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2.2.8. Pain:  
Pain is considered one of the most important symptoms when talking about cancer. As 
well, it is considered one of the main factors that have an apparent effect on the QoL of 
patients with cancer. Pain is defined in many ways, one of the reliable and simple ones 
is “An unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage” (IASP, 2011).  
 
2.2.9. QoL Domains:   
There are several dimensions of QoL of cancer patients. Here are some definitions of 
those domains of the QoL as defined by Schwartz and Sprangers (2002); first, Physical 
function was defined as “the ability to perform a range of activities of daily living”. On 
the other hand, Symptoms were said to be “patients’ subjective perceptions of an 
abnormal physical or psychological state”. Also, Functioning are “assessments of ability 
to perform specific tasks or functions, such as physical, social, emotional, and role 
functioning”. Furthermore, General health perceptions are “patients’ global perceptions 
about their health and include the values patients attach to different symptoms or 
functional impairments”. And finally, Overall QoL is “a measure of life satisfaction that 
may be unrelated to health”. For example, overall QoL may be strongly influenced by 
factors such as an individual’s economic and employment status, family situation, or the 
political environment (Schwartz and Sprangers, 2002). 
 
2.3 Previous Studies Review  
 
2.3.1. QoL and Influencing Factors: 
Major associations with health related quality of life (HRQoL), in neighboring Arab 
country, were found with age, stage of cancer, radiotherapy treatment, and fatigue 
(Alawadi and Ohaeri, 2009). On the other hand, in two seperate studies in Iran, it was 
found that no correlation is present between QoL and age, sex, marital status, duration 
of disease, economic conditions, educational level, and occupational function; but, with 
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cycles of chemotherapy (more than two cycles) (Dehkordi et al, 2009 and Heydarnejad 
et al, 2011)). In a third one in Turkey by Pinar et al (2003) they found that duration of 
the disease and type of cancer, presence of metastasis, and type of treatment had no 
effect on QOL.  
From a different view, Meier and Brawley (2011) pointed toward other studies, by Satin 
et al (2009) and Giese-Davis et al (2011) that presented depression as independent 
predictor of shortened survival. While Alawadi & Ohaeri (2009) found that younger 
Kuwaiti patients with breast cancer had lower (poorer) HRQoL scores, and that social 
functioning had the highest proportion of variance for GQoL. Other predictors were role 
function for physical function and vice versa, and cognitive for emotional function and 
vice versa. The financial difficulty had highly significant prediction of GQoL (P< 
0.007) and social functioning (Alawadi and Ohaeri, 2009). Internationally, Scott et al 
(2007) found that the role and social functioning aspects have more apparent effect on 
QoL in Islamic countries.  
 
Pain and Fatigue 
Bostrom et al (2003) concluded that pain has a negative impact on QoL, especially on 
physical health. This pain usually increases towards the final stages of life, and they 
concluded that it is an unnecessary burden, which can be prevented. 
This was also apparent in a multi center cohort prospective study that was done in 
Thailand. Thienthong et al (2006) found that a change of scores of pain of at least three 
points out of 10 had a significant statistical and clinical effect on the QoL of 520 cancer 
patients who was included in their study. The conclusion of this study suggests the high 
importance of pain management for better QoL of cancer patients.  
Furthermore, Meier and Brawley (2011) argued that a review of 52 studies, which were 
reviewed by Beuken-van Everdingen in 2007 in their study “Prevalence of pain in 
patients with cancer: A systematic review of the past 40 years”, found that pain 
prevalence among cancer patients was 53%; with 64% prevalence among patients with 
advanced stages, and rating of pain as moderate to severe in one third of those who 
reported it. In addition to that, pain was associated with adverse outcomes such as 
depression, functional decline, and patient misery (Meier and Brawley, 2011). It can 
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happen in cluster with other symptoms, such as fatigue, insomnia, and mood 
disturbance, and negatively affect QoL and functional status of cancer patients (Cheng 
and Lee, 2010).  
Regionally, Alawadi & Ohaeri (2009) found in their study of Kuwaiti cancer patients 
that the commonest problem areas were, also, pain, dyspnea, sleep disturbance, and 
poor appetite. As well, Fatigue found to have the highest correlation (r=0.21, P˂0.01) 
with GQoL in the same study (Alawadi & Ohaeri, 2009). Better QoL was also found in 
patients with “all-low” cluster of four symptoms experience; including fatigue and pain 
(Pud et al, 2008). Internationally, Scott et al (2007) found in their Meta analysis study 
that fatigue is the most strongly associated factor with overall QoL. While Heydarnejad 
et al (2011) found the Iranian patients with pain have lower QoL.  
 
Demographic Factors  
Guner et al (2006) found in their study of the demographic factors effects on Turkish 
cancer patients that the total QoL mean scores were lower in men, illiterate patients, and 
those unsatisfied with their income. The lowest scores were in the over 65 years of age. 
In another study in Turkey by Pinar et al (2003) the results concluded that 
sociodemographic factors contribute to poorer QoL of cancer patients, namely they 
found that older cancer patients have lower QoL. Additionally, in another Turkish 
study, statistically significant relationship was found between QoL of cancer patients 
and education and employment status (Uzun et al, 2004).  
In Turkey, older cancer patients believed that cancer is the end of the road and had low 
expectations of themselves as well of the society, the thing that negatively affected their 
QoL (Guner et al, 2006). Also, Koo et al (2012) found that elderly patients with 
advanced cancer have different QoL scores that tend to be worse than younger patients 
upon assessment using (EORTC) QLQ-C15-PAL and (EORTC) QLQ-C30 tools. On the 
contrary, Alawadi & Ohaeri (2009) found in their study of Kuwaiti cancer patients that 
there is more symptom intensity and worse functioning in younger patients.  
Furthermore, highest QoL was in unmarried, in Turkey, as they have less responsibility 
by living with the family and gaining its support. While worst QoL was in widows as 
they lack the support of both family and spouse (Guner et al, 2006). Also, they 
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discussed that better QoL in educated patients may was due to better coping 
mechanisms or better access, finding and benefiting from resources. In the same 
prospect, the Illiterate patients had the lowest QOL scores (Pinar et al, 2003). 
Financial burden has its effects also. Higher income was associated with better QoL. 
This was explained by Guner et al (2006) who said that patients with the higher income 
have better ability to find resources in less burden and stress. As well, Alawadi & 
Ohaeri (2009) found significant association of cancer with financial burden on cancer 
patients and their families, even though, treatment is free of charge. But they also 
stressed the social system support; they said that family social support and institutional 
support have a role in improving psychosocial wellbeing of those patients.  
 
Clinical Factors  
In the study of Kuwait, 59% of the cancer cases were in stages III and IV. Those with 
advanced disease had worse functioning; especially role function. As well, radiotherapy 
treatment found significantly associated with more fatigue (Alawadi and Ohaeri, 2009). 
On the other hand, in the study of Turkey by Pinar et al (2003) they found that duration 
of the disease and type of cancer, presence of metastasis, and type of treatment had no 
effect on QOL. However, hospitalized patients had lower QOL scores than patients 
treated on an outpatient-basis (Pinar et al, 2003).  
 
2.3.2. Local, Regional and International Studies on QoL: 
In a regional study in Kuwait, the GQoL found to be 45.3% with poor to average 
functioning (Alawadi & Ohaeri, 2009). In Turkey, Pinar et al (2003) measured GQoL, 
using different measurement tool (Multidimensional Quality of Life Scale-Cancer 2; 
MQOLS-CA2), to be 66.2 out of 100 points. In a study in Iran, QoL was fairly 
favorable (66% of cases) or favorable (23%) in cancer patients. it was found that the 
most common problems in Iranian patients to be fear about future, thinking about the 
disease and its consequences, impatience, and depression (Dehkordi et al, 2009). 
Moreover, most of cancer patients, in the Middle East region, prefer to die at home due 
to presence of multiple traditional and social reasons. This stresses the need for home-
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based services as a high priority in the health care system for better QoL (Silbermann, 
2012). 
In Palestine particularly, Bailony et al (2010) in their study; Cancer registration and 
healthcare access in West Bank, found that the concentration of cancer cases is in the 
districts that are considered metropolitan and where the referral hospitals are located.  
Also, it was found in a non-published study done to assess factors influencing QoL of 
breast cancer patients in Palestine that marital status, economic status, and level of 
education were not significantly associated with QoL of those patients. Furthermore, it 
found that cancer in Palestine is diagnosed at late stage, and the surveyed sample had 
high spirituality beliefs (Samar & Saca, 2009).  
As well, one study was done in 2010 to measure the QoL of 70 Palestinian cancer 
patients (Thweib, 2011). Results found that the QoL of Palestinian cancer patients is 
low in all QoL domains. More intense symptoms were found when compared with 
regional countries. This study stressed the importance of palliative care service for 
Palestinian cancer patients. the factors that were found to be associated with global 
quality of life (GQoL) and QoL domains for the Palestinian cancer patients were pain, 
gender, fatigue, income, and cancer stage (Thweib, 2011). 
Nevertheless, palliative care is not present in Palestine yet, and it is not integrated 
within the health care system (Khleif & Shawawreh, 2011; Khleif, 2010; and Bingley & 
Clark, 2009). One study findings illustrated the main problems in the region in lack of 
fund or governmental support, and lack of awareness for need for such service among 
the public as well as the policy makers and professionals (Bingley & Clark, 2009).  
The main areas for attention are professional training, public awareness, health policies 
regarding opioids use and dispensing, accessibility to essential PC drugs, and 
integrating palliative care into the health system, service provision and health education 
(Khleif & Shawawreh, 2011; Khleif, 2010; Bingley & Clark, 2009).  
Silbermann (2012) discussed the culture of taboo and stigma of cancer and its pain. He 
said that people in this region consider it as part of disease and accept it, they use non-
pharmacological modalities. The stress is on assessment of pain and distress to be 
routine practice. He concluded that of the barriers to PC are also the protective attitudes 
of the family of patient. 
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Scott et al (2007) in their international Meta analysis study about the effects of 
geographical and cultural aspects on the study tool; EORTC QLQ-C30 questionnaire, 
found that there is effect of these aspects among different cultural groups, which has its 
implications for international comparisons that shows differences between cultures.  
On the other hand, a qualitative study conducted in Canada by Shahidi, Bernier and 
Cohen (2010) found eight domains upon content analysis of 110 answers of terminally 
ill cancer patients that affect QoL. These were physical condition and symptoms, 
psychological status, existential, relationships and support, quality of care, physical 
environment and living facilities, hobbies and daily activities, and finances. 
 
2.3.3. Palliative Care: …way to better QoL… 
Stjernsward et al (2007a) discussed that it is estimated that 7 million new cancer cases 
each year are not cured and die within a year of diagnosis, 60% of cancer patients suffer 
from significant pain, and 35 million people around the world are in need and can 
benefit from palliative care (PC) service.  
It is recommended in the literature that to recognize the value of PC there is need for 
competent palliative medicine. This can be done through including PC requirements in 
the training programs of oncology trainees, and through system redesigns that has PC as 
essential part of its standard cancer care, protocols, and delivery models. This will need, 
off course, necessary investments in resources; both human and logistic (Meier and 
Brawley, 2011). The tragedy is the non-availability of PC for most of the world’s 
population (Stjernsward et al, 2007a).  
Meier and Brawley (2011) discussed the need for palliative care for better QoL for 
cancer patients and their families. They argued that palliative care should be for all 
patients with cancer and not only at the end-of-life care or what so called hospice care; 
as the later focus on caring of patients with limited life expectancy and mainly provided 
at home.  
And so, palliative care medicine and practitioners work with other specialists on 
providing care to patients with curative and life-prolonging therapies (Theofilou, 2012; 
Meier & Brawley, 2011). Furthermore, the need for earlier and greater involvement of 
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PC in the treatment of cancer was argued, as a result of the accumulated evidence of 
benefits of PC in alleviating symptoms distress in those patients and improving 
outcomes of care (Meier and Brawley, 2011) and provide them with better QoL 
(Stjernsward et al, 2007a).  
In this context, Meier and Brawley (2011) stressed the importance of promoting quality 
of care for cancer. They suggested new delivery and payment models aiming for 
promoting quality of care which may increase the incentives toward whole-person 
quality care.  
On the other hand, Bakitas et al (2009) Compared, in their randomized controlled trial, 
participants receiving usual oncology care, and those who received a nurse-led, 
palliative care-focused intervention in the fields of physical and psychosocial aspects. 
They found statistically and clinically significant effects of nursing-led palliative care 
interventions on better QoL and mood of patients with advanced cancer.  
Patients with cancer have many symptoms. On top of that are the physical symptoms 
including pain, which are highly prevalent in those patients, and have a major impact on 
many aspects of quality of life. This contradicts with the aim of palliative care 
(Mercadante et al, 2000). In their studies, Temel et al (2010) and Meier and Brawley 
(2011) found that early palliative care along with standard oncologic treatment resulted 
in better quality of life, mood, and prolonged survival. While Paci, et al (2001) found 
that QoL measures can be used to assess the outcome for patients who are involved in 
palliative care service. 
Furthermore, PC is not only associated with better QoL of cancer patients themselves, it 
is also found to play a role in protecting the family and care givers of those patients. 
Meier and Brawley (2011) explored other studies findings of increased mortality and 
post-traumatic stress and grief disorders in family and caregivers of died cancer 
patients. So, PC is needed for the whole context of the patient.  
From a different perspective, unnecessary suffering and costs for patients, families, and 
society in general are related to lack of good policies. Stjernsward et al (2007b) 
suggested development of national cancer control policy in order to integrate PC into 
the health care system and as a priority aspect in the national health plan. And then, to 
  22
incorporate PC and pain management in service delivery for cancer patients, which 
improves their QoL (Uzun et al, 2004).  
But unfortunately, Silbermann (2012) explained that the Middle East countries still lack 
governmental policies that recognize PC. The patients, mostly, prefer to die at home due 
to presence of multiple traditional and social reasons in the Middle East region. This 
stresses the need for home-based services as a high priority in the health care system 
planning (Silbermann, 2012).  
Lamas& Rosenbaum (2012) explained that the root of the problem, in a way or another, 
lays in physician’s perception about palliative care, as many physicians believe that 
discussing pain control is admitting defeat; they are afraid of treating pain as they are 
afraid of patients’ addiction to morphine.   
This clearly stresses the need for PC services of cancer patients in Palestine in order to 
improve their QoL and decrease their suffering, as well as their families and caregivers. 
The implications, off course, are far beyond the mere patient. It is for the benefit and 
effectiveness of the whole health care system.  
 
2.4 Studies reviewing the Assessment Tool (EORTC QLQ-C30) 
HRQoL is an essential component in the care of cancer and chronic diseases. 
Generating data about QoL is accessible by using a valid and reliable tool to extract the 
data from its source; which is the patient perceptions (Theofilou, 2011). Patients are 
seen as the best possible source of data on the impact of treatment (Schwartz and 
Sprangers, 2002).  
Theofilou (2012) discussed the factors necessary to choose a tool, among over 1000 
available tools, to measure patient perception of QoL. Of the many factors he discussed 
are considering the aims and reasons for outcome, coverage of item of interest, validity 
and reliability, respondent item burden, patient-related factors in palliative care, and the 
concept of spirituality; in other words, an instrument with robust psychometrics and 
valid collection methods, and when it is disease-specific.  
Theofilou (2012) discussed most frequently used tools to measure QoL in general and 
specific diseases patients. He compared the development, validity, and reliability of 
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those tools. The conclusion is the (EORTC) QLQ-C30 tool, that is used for this 
research, ranged of the best instruments among other tools, and ranged from good to 
excellent in its rating for validity and reliability. Dehkordi et al (2009) consider it as the 
most widely applicable tool. 
The EORTC quality of life questionnaire (QLQ) is an integrated system for assessing 
the health related quality of life (HRQoL) of cancer patients. The core questionnaire is 
the product of more than a decade of collaborative research. More than 2200 studies so 
far used it, with less than 2% of missing data (Fayers et al, 2001). This tool was 
developed over data collected from centers in 13 countries and it is specific to measure 
QoL in cancer patients. Its item scores are linearly transformed to a range from 0 to 100 
(Theofilou, 2012), and is based upon the widely applied Likert method of summated 
scales (Fayers et al, 2001).  
Alawadi & Ohaeri (2009) and Thweib (2011) choose it for its reliability and validity in 
diverse cultures including Arab countries, availability of data body to compare own 
results with, and availability of ready Arabic translation of the tool by the original 
author. It has a scoring manual with it that we used to score out data and enter it to the 
statistical software Statistical Package for Social Sciences (Fayers et al, 2001).  
Other studies have validated this tool, for example; Awad et al (2008) assessed the 
psychometric properties of the Arabic version of the tool for Arabic-speaking 
populations and concluded that it is a reliable and valid tool for assessment of QoL in 
Arab patients with cancer. The questionnaires' validity was confirmed using "known 
group comparisons," which showed that the QLQ-C30 discriminated between 
mastectomy and lumpectomy patients on the emotional and cognitive function scales (P 
< 0.001). (Awad et al, 2008). Questionnaire reliability was assessed using Cronbach's 
alpha coefficient, in which the values were all >0.7, with the exception of cognitive 
function and pain in the QLQ-C30 (Cronbach's alpha 0.67 and 0.51, respectively). 
(Awad et al, 2008). 
Safaee & Dehkordi (2007) examined reliability and validity of it for use in Iran, and 
Uwer et al (2011) studied responsiveness of it in colorectal cancer patients in France. 
They found it more responsive in chemotherapy patients, particularly in functional 
scales.  
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As described in the tool scoring manual, there are a number of ways to ease the 
interpretation of QLQ-C30 results. One can report the raw scores in addition to the 
transformed scores. Scores range from 0 to 100; a higher score represents a higher 
("better") level of functioning or GQoL, or a higher ("worse") level of symptoms. The 
author of the tool recommended the use of Global health status / QoL scale (Q29 and 
Q30) as the overall summary measure of QoL (Fayers et al, 2001).  
Many previous studies used the cutoff scale score of 33% to interpret the results 
(Thweib, 2001; Alawadi & Ohaeri, 2009). That was adopted based on suggestions from 
an empirical general population study (as cited by Alawadi & Ohaeri (2009) from 
Fayers PM: Interpreting quality of life data: population-based reference data for the 
EORTC QLQ-C30, 2001). We are also using these methods of categorizing patients 
QoL scores in this study.  
It has been argued that the use of these measuring tools provided evidence which can be 
used for evaluating the needs and feelings of the cancer patients, the thing that is crucial 
for professionals, as well as, managers in the health care system (Theofilou, 2012).  
 
2.5 Economic and Public Perspective of Palliative Care 
Millions of people around the world, with a majority of occurrence in developing 
countries, have great suffering and economic hardship due to life threatening illnesses 
such as cancer. The key feasible alternative to the urgent needs of those people to 
improve their QoL, according to WHO global perspective, is to develop an effective, 
low-cost approach of palliative care service of good quality and coverage. The best way 
to do so, in countries with strong family support and poor health infrastructure, is home-
based palliative care (Sepulveda et al, 2002; and Stjernsward et al, 2007a).   
Assessment of QoL and interpretation of its results and data is important for supporting 
the generation of policies and legislations. It will also help in allocating resources, 
building strategic plans, and monitor effectiveness of community based interventions 
(Theofilou, 2011). As well, Rogers et al (2012) found in UK cancer patients that more 
financial burden is associated with cancer and resulting in poorer QoL.  
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Outcome measurement, which are based on measured reported outcome by patients, has 
major role in improving, not only the quality of palliative care, but also its efficiency 
and availability. It is considered an effective tool to assess and monitor care and QoL in 
palliative care services for cancer patients. Furthermore, this can help focusing on 
improving quality of services (Theofilou, 2012).  
Schwartz and Sprangers (2002) and Theofilou (2011) discussed that data of the 
assessment of QoL can help in comparisons between different treatments the thing that 
can be used in prioritizing actions, allocating resources, evaluating effectiveness, 
measuring outcomes, and analyzing cost-utility. This is particularly apparent when 
looking at the modern technologies and its subsequent increase in the costs of medical 
interventions, and the need for the proof of effectiveness and quality of the care 
provided.  
Meier and Brawley (2011) discussed that PC teams can support mobilization of 
resources in the community for sustainable and safe living environment for patients and 
families after discharge from hospitals. Additionally, such interventions have low costs 
and no or minimal risks. PC service found to reduce unnecessary use of hospitals, 
diagnostics, treatments, and invasive procedures. Rogers et al (2012) concluded that 
multi disciplinary teams play an important role in addressing patients’ needs early and 
providing them with advice for better access to the best benefits and least costs.  
Husseini et al (2009) discussed the high cost of care; indirect loss of production, and the 
societal stress. This is the result of the high morbidity and mortality of cardiovascular 
and cancer diseases as major killers in Palestine. They added that a large proportion of 
the expenditure on health in Palestine is on expensive curative care outside the area.  
Meier and Brawley (2011) stressed the importance of promoting quality of care for 
cancer. They suggested new delivery and payment models aiming for promoting quality 
of care which may increase the incentives toward whole-person quality care. As many 
therapies to control cancer are ineffective and expensive (Stjernsward et al, 2007a). 
It is recommended in the literature that, to recognize the value of PC, there is need for 
competent palliative medicine. This can be done through system redesign that has PC as 
essential part of its standard cancer care, protocols, and delivery models. This will need, 
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off course, necessary investments in resources; both human and logistic (Meier and 
Brawley, 2011).  
Husseini et al (2009) argued that the challenge of chronic diseases, including cancer, is 
not the only one. The national economy, strategic planning, health-care policy 
formulation, and national priority setting are affected by the Israeli occupation. The 
geographic and administrative fragmentations of occupied Palestine, the military 
checkpoints and barriers to movement, and the separation wall and many other fences 
and barriers are all having their damaging effects on the health care system abilities and 
deliverability. In addition to adding to the physical suffering of patients and the 
financial costs since they have to travel for treatment (Husseini et al, 2009; Physicians 
for Human Rights website, 2012).  
 
2.6 Summary  
  
 QoL is subjective in nature. At the same time it can be reliably and validly measured, 
but keeping the focus on the patient as the primary source of information (Schwartz and 
Sprangers, 2002). As health care providers and as leaders in palliative care, we need to 
measure patients’ perceptions of their well-being, or QoL. This is important for both; 
for having the ability to perform high quality patient care by professionals, and for 
being accountable for monitoring and measuring the impact of services and treatments 
by the program managers (Theofilou, 2012).  
Throughout this chapter of literature review we explored a wide variety of studies as 
well as articles and books. We came out with the conclusion that HRQoL assessment is 
an important public health tool (Theofilou, 2011). It was clearly apparent the need for 
palliative care (PC) services for cancer patients in Palestine in order to improve their 
QoL and decrease their suffering, as well as their families and caregivers. The 
implications, off course, are far beyond the mere patient entity; it is for the benefit, 
efficiency, and effectiveness of the whole health care system. 
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To conclude, the literature review was supporting to the rational that we conducted to 
justify the aim for this research. The national and international data revealed almost 
consensus on the value of assessment of QoL of cancer patients in monitoring care, 
proposing actions, regulating policies, saving costs, and alleviating suffering of cancer 
patients and their families. This is uniquely applicable to Palestinian cancer patients, 
especially in the present health care system that is struggling in many ways; explicitly 
the absence of palliative care from the system.  
 
 
Table (2.1): Summary of reviewed studies of QoL of cancer patients.  
# Study Main Purpose 
Methodology 
(design, sample, place, 
tool) 
Data Analysis Findings 
1 Outcome Measurement 
in Palliative Care; QoL. 
(Theofilou, 2012)   
 
To focus on best practices in 
selecting QOL instruments, as 
well as review and evaluate 
current QOL instruments. 
Review of available 
literature for QoL 
measurement tools.  
Comparative 
analysis of tools 
based on validity & 
reliability.  
Choosing a tool depends mainly on the 
type of study, condition to be measured, 
and the researcher orientation to scientific 
and clinical situation. Collaborations 
between clinicians and researchers greatly 
enhance the feasibility and capacity for 
implementing outcomes programs. More 
accurate determination HRQoL when 
disease specific instruments are used.  
2 Patients' perception of 
the financial impact of 
head and neck cancer 
and the relationship to 
health related quality of 
life. 
(Rogers et al, 2012) 
To ask patients about the 
financial burden of having 
head & neck cancer, and to 
explore its relation with 
HRQoL. 
Cross-sectional survey 
447 respondents  
Mersey region, UK  
Questionnaire  
Statistical analysis 
for responses to the 
questionnaire.  
Patients with worse physical and social 
emotional functioning experienced more 
notable financial burden, more difficult 
life circumstances and greater financial 
difficulty and loss in income, more 
dissatisfaction with how well they took 
care of their own financial needs. This has 
a serious impact on financial aspects of 
patients' lives and seems to be associated 
with a poor HRQoL.  
3 Quality of Life of 
Palestinian Cancer 
Patients. 
 (Thweib, 2011) 
To highlight the concept of 
QOL for Palestinian cancer 
patients through providing an 
understanding about influences 
of cancer and chemotherapy on 
QOL of cancer patient. 
Cross-sectional 
descriptive study. 
70 cases. 
Palestine. 
EORTC QLQ-C30. 
Statistical analysis 
using SPSS software 
for descriptive, 
correlations, and 
means tests.  
Results about QOL were low in all 
aspects; most of them were less 
than the half of full function, and, more 
intense symptoms and 
negative effects were found to be in 
Palestinian cancer patients 
4 Factors affecting quality 
of life in cancer patients 
undergoing 
chemotherapy. 
(Heydarnejad et al, 
2011). 
To evaluate the QoL in cancer 
patients with solid tumors and 
at the different chemotherapy 
cycles.  
Cross-sectional 
descriptive study. 
200 cases. 
Iran. 
EORTC QLQ-C30. 
Statistical analysis 
using SPSS software 
for descriptive, 
correlations, and 
means tests. 
A chemotherapy cycle may improve QoL 
in patients with solid tumors. Patients 
with pain have lower QoL.  
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5 Effects of pain, fatigue, 
insomnia, and mood 
disturbance on 
functional status and 
quality of life of elderly 
patients with cancer. 
(Cheng & Lee, 2010) 
Describes prevalence of pain, 
fatigue, insomnia, and mood 
disturbance in elderly cancer 
patients. The inter-correlations 
among these symptoms and the 
relationship to functional 
status and QoL during cancer 
therapy. 
Cross-sectional study 
used secondary data from 
a convenience sample of 
120 patients in Hong 
Kong, China.  
 
Statistical analysis 
for descriptive and 
correlations.  
Pain, fatigue, insomnia, and mood 
disturbance are highly prevalent in elderly 
patients who undergone cancer therapy. 
These four symptoms may occur in a 
cluster and may negatively influence 
elderly patients' functional status and QoL 
during cancer therapy. 
6 Factors influenced QoL 
for women with breast 
cancer in Palestine. 
(Samara et al, 2009) 
to investigate the main factors 
that influence the quality of 
life for women with breast 
cancer in Palestine 
Cross-sectional 
descriptive study.  
108 cases. 
Palestine.  
Ferrell and Grants (1995) 
QoL assessment tool.  
Descriptive 
statistics. 
Marital status, economic status, and level 
of education were not significantly 
correlated to the four domains of quality 
of life.  
Cancer in Palestine is diagnosed at late 
stage.  
Women had higher mean scores 
according to their spiritual well being.  
7 Health - related QoL of 
Kuwaiti women with 
breast cancer: a 
comparative study using 
the EORTC QoL 
Questionnaire. 
(Alawadi & Ohaeri, 
2009)   
To highlight the health-related 
QoL of Kuwaiti women with 
breast cancer, in comparison 
with the international data, and 
assessed the socio-
demographic and clinical 
variables that predict the five 
functional scales and GQOL 
scale of the QLQ – C30. 
Cross-sectional 
descriptive study. 
348 cases.  
Kuwait.  
EORTC QLQ – C30 and 
its breast specific module 
(BR-23). 
Statistical analysis 
using SPSS software 
for descriptive, 
correlations, and 
means tests.  
Kuwaiti women had clinically 
significantly poorer GQoL and functional 
scale scores, and more intense symptom 
experience. Younger women had poorer 
HRQOL scores. In regression analysis, 
social functioning accounted for the 
highest proportion of variance for GQOL. 
8 QoL in Cancer Patients 
undergoing 
Chemotherapy 
(Dehkordi et al, 2009)   
 
To describe the QoL in cancer 
patients with solid tumors and 
at different chemotherapy 
cycles. 
Cross-sectional 
descriptive study.  
200 cases.  
Iran.  
EORTC QLQ-C30 
Statistical analysis 
using SPSS software 
for descriptive, 
correlations, and 
means tests.  
 There were no correlation between the 
QoL and age, sex, marital status, and 
duration of disease, economic conditions, 
occupational function, and patients’ 
educational level. Nevertheless, a 
significant correlation was found with the 
no. of chemotherapy cycles (>2cycles) 
9 Cardiovascular, 
Diabetes & Cancer in 
the occupied Palestinian 
territory.  
(Husseini et al, 2009) 
To identify any relevant 
scientific reports about chronic 
diseases in the occupied 
Palestinian territory.  
Analysis report of 
available data based on 
specific search strategy 
and selection criteria. 
Palestine.  
Gathering data from 
different resources, 
national surveys, and 
epidemiological 
studies. Then 
Heart disease, cerebrovascular disease, 
and cancer are the major causes of 
morbidity and mortality in the occupied 
Palestinian territory, resulting in a high 
direct cost of care, high indirect cost in 
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Search through Medline 
(1966–2008) with 
specific search terms. 
completeness and 
quality of data 
assessed & compiled 
loss of production, and much societal 
stress.  
10 Effects of a palliative 
care intervention on 
clinical outcomes in 
patients with advanced 
cancer. 
(Bakitas et al, 2009) 
To determine the effect of a 
nursing-led intervention on 
quality of life, symptom 
intensity, mood, and resource 
use in patients with advanced 
cancer 
Randomized Controlled 
Trial of Multi-
component, psycho-
educational intervention 
case control study. 
322 patients. 
NCI, USA. 
Tools: Functional 
Assessment of Chronic 
Illness Therapy for 
Palliative Care, 
Edmonton Symptom 
Assessment Scale, Center 
for Epidemiological 
Studies Depression Scale. 
Statistical analysis 
for intervention 
effects, descriptive, 
correlations, and 
means tests.  
Compared with participants receiving 
usual oncology care, those receiving a 
nurse-led, palliative care–focused 
intervention addressing physical, 
psychosocial, and care coordination 
provided concurrently with oncology care 
had higher scores for quality of life and 
mood, but did not have improvements in 
symptom intensity scores or reduced days 
in the hospital or ICU or emergency 
department visits.  
11 Validation of the 
European Organization 
for Research and 
Treatment of Cancer 
Quality of Life 
Questionnaires for 
Arabic-speaking 
Populations.  
(Awad et al, 2008) 
To assess the psychometric 
properties of the Arabic 
version of the EORTC general 
QoL questionnaire (QLQ-C30) 
and of the breast cancer-
specific questionnaire (QLQ-
BR23).  
Cross-sectional. 
87 patients. 
United Arab Emirates.  
EORTC QLQ-C30, 
QLQ-BR23. 
Statistical analysis 
using SPSS software 
for descriptive, 
correlations, and 
means tests. 
Arabic versions of the EORTC QLQ-C30 
and QLQ-BR23 are reliable and valid 
tools for assessment of quality of life in 
Arab patients with cancer. 
12 The relationship 
between overall quality 
of life and its sub-
dimensions was 
influenced by culture: 
analysis of an 
international database. 
(Scott et al, 2007) 
To investigate whether 
geographic and cultural factors 
influence the relationship 
between the global health 
status quality of life (QL) scale 
score of the EORTC QLQ-C30 
questionnaire and seven other 
subscales representing fatigue, 
pain, physical, role, emotional, 
cognitive, & social functioning 
Meta analysis study. 
Large international 
database of QLQ-C30 
responses.  
 
Linear regression 
model used to 
predict QL scale 
scores. Using 
STATA software 
Included interactions 
between 
geographical/cultural 
groupings & seven 
other scale scores. 
The results provided evidence that 
different cultural groups may emphasize 
different aspects of their QoL. This has 
implications for studies using QoL 
questionnaires in international 
comparisons. 
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13 QoL and socio-
demographic 
characteristics of 
patients with cancer in 
Turkey. 
(Guner et al, 2006)   
To determine whether a 
relationship exists between 
QoL and the 
sociodemographic 
characteristics of gender, age, 
marital status, educational 
level, occupation, and level of 
income in patients with cancer 
in Turkey.  
Exploratory study using a 
convenience sample.  
620 cases. 
Turkey.  
Face-to-face interviews 
to fill Rolls-Royce 
Quality-of-Life Scale.  
Statistical analysis 
for descriptive, 
correlations, and 
means tests.  
Men, older adults, widowed spouses, 
patients with lower levels of education, 
housewives, and those with lower income 
had lower QOL scores.  
14  Quality of life in 
women with breast 
cancer in Turkey. 
(Uzun et al, 2004) 
 
To determine QoL of Turkish 
women with breast cancer, and 
to examine whether QoL was 
related to sociodemographic or 
clinical variables.  
Descriptive study. 
72 cases.  
Turkey. 
Quality of Life Scale 
(QoLS), and the Visual 
Analogue Scale (VAS) 
Descriptive 
statistics.  
Two sociodemographic variables 
(educational background and employment 
status) were related to QoL of women 
with breast cancer. And affected QoL in 
varying degrees. 
15 Assessment of QoL in 
Turkish Cancer patients. 
(Pinar et al, 2003)   
 
To evaluate the QoL and 
affecting factors on it in 
Turkish cancer patients.  
Cross-sectional study 
using self-report 
questionnaire. 188 cases. 
Turkey. Turkish version 
of Multidimensional 
Quality of Life Scale-
Cancer 2.  
Statistical analysis 
using SPSS software 
for descriptive, 
correlations, and 
means tests.  
Sociodemographic factors rather than 
cancer related factors could contribute to 
poorer QoL. Associations found between 
poorer QoL and older age, illiterate, and 
hospitalized patients.  
 
  
 
 
 
 
 
 
 
 
 
Chapter Three  
Conceptual Framework  
 
3.1 Conceptual Framework 
Do the Palestinian cancer patients have their QoL preserved? Does this affected by any 
unique cultural, social, ideological or political factors?  
Is the QoL of the Palestinian cancer patients affected by pain and other symptoms 
management in hospitals in the West Bank in its specific socio-demographic context? 
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 Stage of disease: 
Early 
Advanced  
 
 
Socio-
demographic  
factors
 
 
 
 
 
 
 
 
 
 
 
Figure (3.1): Conceptual framework of the study; different factors affecting QoL in 
anticipated direct and indirect relationships.  
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3.2 Conceptual Definitions  
Conceptual Framework 
It is “a conceptual model broadly presents an understanding of the phenomenon of interest 
and reflects the assumptions and philosophic views of the model’s designer. Conceptual 
models can serve as springboards for generating research hypotheses” (Polit & Beck, 
2003).  
The current study conceptual framework represents the different factors affecting QoL of 
the cancer patient in Palestine. The model shows that QoL and its domains are affected 
directly by the sociodemographic factors, stage of the disease, and level of pain and 
symptom control. Also, they are affected indirectly by care setting. Moreover, there are 
some relationships between the different independent factors as shown in figure (3.1).  
 
QoL Definition  
WHO defines QOL as “an individual’s perception of their position in life in the context of 
the culture and value systems in which they live and in relation to their goals, expectations, 
and standards and concerns. It is a broad-ranging concept affected in a complex way by the 
person’s physical health, psychological state, level of independence, social relationships, 
and their relationships to salient features of their environment” (Bowling, 2003). 
 
Pain Definition 
Pain is defined in many ways, one of the reliable and simple ones is “An unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage” (IASP, 2011).  
QoL Domains (Functions) definitions:   
Physical function: “the ability to perform a range of activities of daily living”.  
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Symptoms: “patients’ subjective perceptions of an abnormal physical or psychological 
state”. 
Functioning: are “assessments of ability to perform specific tasks or functions, such as 
physical, social, emotional, and role functioning”.  
General health perceptions: are “patients’ global perceptions about their health and include 
the values patients attach to different symptoms or functional impairments”.  
Overall QoL: is “a measure of life satisfaction that may be unrelated to health. For 
example, overall QoL may be strongly influenced by factors such as an individual’s 
economic and employment status, family situation, or the political environment.”  
(Schwartz and Sprangers, 2002). 
 
3.3 Operational Definitions 
Dependant variables:  
EORTC QLQ C-30 (EORTC ) provides a Scoring Manual which includes 
the operational definitions (EORTC, 2009). 
Global Quality of Life (GQoL):  
29. How would you rate your overall health during the past week?  
30. How would you rate your overall quality of life during the past week? 
Physical Function (PF): 
1. Do you have any trouble doing strenuous activities, like carrying a heavy shopping 
bag or a suitcase? 
2. Do you have any trouble taking a long walk? 
3. Do you have any trouble take a short walk outside of the house? 
4. Do have to stay in bed or a chair for most of the day? 
5. Do you need help with eating, dressing, washing yourself or using the toilet? 
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Role Function (RF): 
6. Were you limited in doing either your work or other daily activities? 
7. Were you limited in pursuing your hobbies or other leisure time activities? 
Social Function (SF): 
26. Has your physical condition or medical treatment interfered with your family life? 
27. Has your physical condition or medical treatment interfered with your social 
activities? 
Emotional Function (EF): 
21. Did you feel tense? 
22. Did you worry? 
23. Did you feel irritable? 
24. Did you feel depressed? 
Cognitive Function (CF): 
20. Have you had difficulty in concentrating on things, like reading a newspaper or 
watching television? 
25. Have you had difficulty remembering things? 
Financial Difficulties (FI): 
28. Has your physical condition or medical treatment caused you financial difficulties? 
 
Fatigue (FA):  
10. Did you need to rest?  
12. Have you felt weak?  
18. Were you tired?  
Nausea & Vomiting (NV):  
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14. Have you felt nauseated?  
15. Have you vomited?  
Pain (PA):  
9. Have you had pain? 
19. Did pain interfere with your daily activities?  
Dyspnea (DY):  
8. Were you short of breath? 
Insomnia (SL):  
11. Have you had trouble sleeping?  
Appetite Loss (AP):  
13. Have you lacked appetite?  
Constipation (CO):  
16. Have you been constipated?  
Diarrhea (DI):  
17. Have you had diarrhea?  
 
Independent variables  
These include sociodemographic and clinical variables: 
Gender: male or female.  
Age: from 18 and above; this was classified to three age groups which are below 40, from 
41 to 64, and above 65 years old.  
Educational level: either illiterate, primary school, secondary school, or university.  
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Residence: either in a city, village, or camp.  
Governorate: either one of Palestine governorates; Jenin, Tobas, Tulkarm, Nablus, 
Qalqelia, Salfit, Ramallah & Beirah, Jericho, Jerusalem, Bethlehem, and Hebron.  
 Income: classified as either less than 2000 NIS, from 2000 to 4000 NIS, or more than 4000 
NIS.  
Caregiver: either the patient is self care independent, depends on family member to take 
care of him/ her, depends on a paid person to take care of him/ her, or any combination of 
the previous three options; self care and family member, self care and paid person, family 
member and paid person, or the three options.  
Marital Status: either the patient is single, married, or other than that; which includes 
divorced, widow, separated, or any other option.  
Living condition: either living alone, with family, or other. 
Housing: either the patient is living in a rented house or an owned one.  
Place of treatment: is the hospital; either in outpatient or in-patient departments. The three 
hospitals are Augusta Victoria Hospital, Watani Hospital, or Beit Jala Hospital.  
Department: is the ward; inpatient or outpatient.  
Stage of disease: will be determined from the patients files based on the medical diagnosis 
and staging. The first and second stages will be considered as early disease, the third and 
fourth stages of cancer patients will be considered late disease.  
Setting variable: there are three main settings that treat patients with cancer in Palestine; 
these are Beit Jala and AL Watani governmental hospitals, and Augusta Victoria non-
governmental hospital. In each setting patients are either in out-patient or in in-patient 
departments.  
Duration: is the time span of treatment; less 3 months, more than 6 months, or in between 
the two periods.   
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Region: is the area of the West Bank of Palestine; north, middle, or south. 
 
  
 
 
 
 
 
 
 
 
Chapter Four  
Methodology  
 
4.1 Introduction  
In this chapter we explored and discussed the design of this research and the sampling 
methodology that was followed to identify and approach the sample cases of cancer 
patients who participated in this study. Settings where the study took place and some of 
their characteristics and data were discussed as well. 
 
4.2 Research Design  
In this study a triangulation design is used through quantitative descriptive correlation 
and qualitative phenomenological methods. In the qualitative part, the living 
experiences of cancer patients from different areas of Palestine were explored. That was 
done through direct in-depth-interviews by the researcher with participants who 
attended for cancer treatment in one of the selected centers.  
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Schwartz and Sprangers (2002) cited in their article from Krause and Jay (1994) that 
qualitative research revealed that the frame of reference defer from respondent to 
respondent while answering the questions in the QoL questionnaires. They added that 
the specific references vary by age and education.  
In the quantitative part, we used a cross-sectional descriptive design using a self-filling 
questionnaire to collect the data from cancer patients from different settings in 
Palestine. This was used to describe different variables affecting the GQoL, QoL 
domains functions, and symptoms of cancer patients. This method was chosen as it 
describes these variables from the patients’ point of view, it is feasible and applicable to 
do by the researcher, and because this area of study was never been studied in such 
extensive and in-depth way and using such method is good for doing such primary 
studies. This type of study is preferable when there is a time limitation (Polit & Beck, 
2003). 
 
4.3 Sampling Methodology  
 
Population  
The exact numbers of cancer cases in the West Bank of Palestine is not known, due to 
the scarcity and inaccuracy of information available and reported. Palestinian cancer 
registry is not systematically updated and hospitals did not have accurate count of active 
cancer patients on treatment. Upon contacting the Palestinian MOH, the Palestinian 
health information center, and the three cancer treating hospitals, the researcher came 
out with estimation of the population of the study.  
Based on the statistics of MOH annual health report (2011), there were 1350 new cancer 
cases in 2010 (of which, 1278 cases are above 15 years old), and 1312 cases in 2009, 
with mortality of 727 deaths in 2010 from cancer. Also, by keeping in mind that the 
course of treatment for cancer is from six months to two years (so the patient is either 
cured or dead, and in both cases is out of the population count); this makes the 
estimated count of active cancer cases at the time of planning for this study to be around 
2000 cases.  
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Selection criteria 
Inclusion criteria  
• Cancer patients above the age of fifteen years old.   
• Cancer patients attending and have files in any of the three main hospitals for 
cancer treatment; Beit Jala hospital in Bethlehem, Al-Watani hospital in Nablus, 
and Augusta Victoria hospitals (AVH) in Jerusalem.  
Exclusion criteria  
• Any patient who have any surgical intervention within the last thirty days, or  
• Any patient who have systematic disease or mental incompetence, which may 
prevent him/ her from being able to answer the questionnaire or complete the 
interview.   
 
Sample  
A purposive sample of 10 participants was chosen for the qualitative part based on 
saturation of data, as evaluated by the researcher and the supervisor. This is acceptable 
method in qualitative research. Polit & Beck (2003) stated that the principle of data 
saturation occurs when themes and categories in the data become repetitive; that is no 
new information can be generated by further data collection.  
A convenient sample of 323 respondents was chosen for the quantitative part. This 
sample size was calculated to achieve statistical significance (0.05 error margin), and 
using the online sample size calculators (Raosoft, 2012; Survey System, 2012). 
Convenient sample use was obligatory due to unavailability of accurate data, no general 
data base to draw a random sample from, hospitals could not provide us with an exact 
number of active patients on treatment, and very poor information available for patients' 
contacts, addresses, or telephone numbers.  
Moreover, samples from each setting were based on each hospital's staff estimation of 
the size of their patients from the total population of cancer patients. Estimation were; 
more than half for Beit Jala hospital, around one-third for AVH, and around one-tenth 
for Watani hospital. The data was collected during a period of three months.  
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4.4 Study Settings 
There were two governmental hospitals included in the study; Beit Jala hospital in 
Bethlehem in the southern region and Al-Watani hospitals in Nablus in the northern 
region, and one non-governmental setting; Augusta Victoria hospital (AVH) in 
Jerusalem in the middle region of the West Bank (WB) of Palestine.  
Beit Jala Hospital: is the main governmental center for cancer treatment in Palestine. Its 
capacity is 119 beds and treats all types of cancer and cancer patients, including 
pediatric patients. It has a separate oncology department of 25 in-patient beds. It has 
also a day care unit for chemotherapy for cancer patients. The hospital has out-patient 
oncology clinics four days per week. It is considered the referral hospital for cancer in 
the government and treats patients from all over the West Bank of Palestine (MOH, 
2011).  
Al-Watani Hospital: is a secondary governmental center to treat cancer patients. Its 
capacity is 55 beds and treats adult cancer patients only. There is no specific oncology 
department in it and patients are admitted to the medical ward. It has a day care unit that 
provides assessment, diagnosis, and treatment for patients (MOH, 2011).   
Augusta Victoria hospital (AVH): is the only non-governmental center to treat cancer 
patients. It depends on referrals of patients from the government. It has been located in 
Jerusalem since 1950, and work on a mix of charitable and private bases. Its capacity is 
164 beds and has nine major departments; including the cancer center that has medical, 
surgical and radiation units. It treats all types of cancers and patients, including children 
(AVH website, 2012).  
 
4.5 Permissions and Ethical consideration 
The Research Review Committee of the School of Public Health at Al-Quds University 
reviewed and approved this research. The Palestinian MOH was contacted for 
permission to access the two governmental hospitals (Annex 10), as well as Augusta 
Victoria hospital (Annex 9), and all of them allowed us access to patients’ files and to 
conduct survey and interviews. 
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Patients consents were taken by informed consent (Annex: 8), either verbal or written, 
after full explanation of the study and its objectives. Patients were assured anonymity of 
participation, and confidentiality of the data collected. The qualitative part participants 
were also asked for agreement to voice record the interviews. All participants were 
aware of the fact that they can withdraw from the study (interview) at any time.  
The permission to use the tool was also granted from the European Organization for 
Research and Treatment of Cancer (EORTC ), who developed it. The 
tool is free of charge for academic uses (EORTC, 2011). The researcher had contacted 
the EORTC by email and got the required permission and approval to use their 
assessment tool as shown in annex (7).  
 
4.6 The Assessment Tools  
The qualitative part study tool consisted of a list of questions. This list is prepared by 
the researcher, after thorough review of literature, and approved by the thesis 
supervisor, as well as enriched by the review of the experts in their validation process of 
the research tools. It consists of questions about QoL perception and determinants from 
the patients view point. These questions were somehow adapted from the questions of 
the QoL questionnaire and were as follows: 
1. How did the disease affect your daily living? What are the interactions of the 
disease with your daily life? 
2. How do you deal with the disease? 
3. What are the arrangements you need to do in order to get health care services? 
4. How do you evaluate the health care services you are receiving or had received? 
5. What are the things / measures that should be available in order for you to have 
a high quality of life as a cancer patient? 
6. How do you see, in general, the community/ social context view of cancer and 
cancer patient in Palestine?  
The quantitative part study tool consisted of two sections. The first section is the 
demographic data including age, gender, educational level, place of residence, 
governorate of residence, monthly income, caregiver, marital status, living conditions, 
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house ownership, place of treatment, department of care, stage of disease, and duration 
of treatment.  
The second section is measure of QoL of cancer patients by European Organization for 
Research and Treatment of Cancer (EORTC ). It has been translated and 
validated in 81 languages –one of them is Arabic. It is free of charge for academic uses 
(EORTC, 2011). This tool was used to assess QoL of cancer patients in the region, 
including Palestine, and found to be valid tool (Thweib, 2011). Moreover, Uwer et al 
(2011) found in their study of the responsiveness of the tool that the EORTC QLQ-C30 
questionnaire is more responsive in patients receiving chemotherapy than other two 
tools designed to measure QoL. The questionnaires' validity was confirmed, in Arab 
population, using "known group comparisons," which showed that this tool 
discriminated between mastectomy and lumpectomy patients on the emotional and 
cognitive function scales (P < 0.001). (Awad et al, 2008). 
 
EORTC Tool (Aaronson, 1993): 
The European Organization for Research and Treatment of Cancer (EORTC) Quality of 
Life Questionnaire Core 30 (QLQC30) Version 3.0 consists of 30 items; 28 four-point 
scale items and two seven-point scale items. It consists of five multi-item scales 
measuring functionality in physical, role, social, emotional, and cognitive dimensions; 
three multi-item symptom scales measuring fatigue, pain, and nausea and vomiting; six 
single-item symptom measuring dyspnea, insomnia, appetite loss, constipation, 
diarrhea, and financial difficulties; and a global health and QoL scale (Theofilou, 2012; 
and Fayers et al, 2001).  
Validity and reliability of the tool was tested in many cultures and languages (Safaee & 
Dehkordi, 2007; Theofilou, 2012; Dehkordi et al, 2009; Uwer et al, 2011), including 
Arabic language (Awad et al, 2008). Alawadi & Ohaeri (2009) and Thweib (2011) 
choose it for its reliability and validity in diverse cultures including Arab countries, 
availability of data body to compare own results with, and availability of ready Arabic 
translation of the tool by the original author.  
National and regional studies (Alawadi & Ohaeri, 2009; Thweib, 2011) used the cutoff 
scale score of 33% to interpret the results of the QLQ-C30 questionnaire. That was 
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adopted based on suggestions from an empirical general population study (as cited by 
Alawadi & Ohaeri (2009) from Fayers PM: Interpreting quality of life data: population-
based reference data for the EORTC QLQ-C30, 2001). We are using the same method 
of categorizing patients QoL scores in this study.  
Scoring linear conversion was done according to the EORTC QLQ-C30 scoring 
manual. Scores range from 0 to 100; a higher score represents a higher ("better") level 
of functioning or GQoL, or a higher ("worse") level of symptoms (Fayers et al, 2001).  
 
Pilot Study  
A pilot study was done to verify the research tool and questions, and to identify any 
special concerns or uniqueness of cancer patients in Palestine. It was conducted in one 
of the hospital settings and included 15 patients for the quantitative survey and one 
patient for the qualitative interview.  
The results of this pilot study were used to modify the questions in order to best suit the 
local cancer patients especially in relation to data collection procedure. Minor changes 
were found to be necessary after the pilot study. These changes were limited to 
rephrasing some words for clarity reasons and consistency.  
 
Validity and Reliability of the Questionnaire  
Validity of the questionnaire for use with Palestinian cancer patients was assured by 
experts’ review of the questionnaire and its items. The questionnaire was reviewed by a 
specialized palliative care doctor, a specialized palliative care nurse, an oncologist, a 
social worker, and an expert in research methodology and design (Annex 11). Experts 
confirmed suitability of the questionnaire items and questions to Palestinian cancer 
patients, and that they are measuring what they are intended to measure. Off course their 
inputs in both the qualitative and quantitative questions were incorporated and 
integrated into the study tools and produced the final tool for the research.  
As well, validity was confirmed through calculating the intra class correlation 
coefficient of the questionnaire items (questions) with the total degree of the tool, as 
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shown in table (4.1) below. The results showed high statistical significance (P<0.0001, 
2-tailed), with strong positive correlation (range from r=0.28 to r=0.79) in all items, 
except of questions 29 and 30 were it was strong negative correlation (r= -0.61 and -
0.53 respectively). This resembles the direction of the correlation but preserving the 
strength; as the intra class correlation coefficient is like the interclass correlation 
(Pearson’s), which is confined to the interval (-1, +1) (Wikipedia, 2012). 
 
Table (4.1): Intra class correlation coefficient of the questionnaire items with the total 
degree of the tool. 
# Questions / Items Pearson 
Correlation 
(r) 
P value  
(2-tailed) 
1 Do you have any trouble doing strenuous activities, like carrying a 
heavy shopping bag or a suitcase? 
0.54 <0.001 
2 Do you have any trouble taking a long walk? 0.62 <0.001 
3 Do you have any trouble take a short walk outside of the house? 0.63 <0.001 
4 Do have to stay in bed or a chair for most of the day? 0.65 <0.001 
5 Do you need help with eating, dressing, washing yourself or using 
the toilet? 
0.57 <0.001 
6 Were you limited in doing either your work or other daily activities? 0.61 <0.001 
7 Were you limited in pursuing your hobbies or other leisure time 
activities? 
0.64 <0.001 
8 Were you short of breath? 0.57 <0.001 
9 Have you had pain? 0.68 <0.001 
10 Did you need a rest? 0.66 <0.001 
11 Have you had trouble sleeping? 0.58 <0.001 
12 Have you felt weak? 0.78 <0.001 
13 Have you lacked appetite? 0.60 <0.001 
14 Have you felt nauseated? 0.56 <0.001 
15 Have you vomited? 0.41 <0.001 
16 Have you been constipated? 0.50 <0.001 
17 Have you had diarrhea? 0.28 <0.001 
18 Were you tired? 0.77 <0.001 
19 Did pain interfere with your daily activities? 0.79 <0.001 
20 Have you had difficulty in concentrating on things, like reading a 
newspaper or watching television? 
0.68 <0.001 
21 Did you feel tense? 0.65 <0.001 
22 Did you worry? 0.70 <0.001 
23 Did you feel irritable? 0.59 <0.001 
24 Did you feel depressed? 0.63 <0.001 
25 Have you had difficulty remembering things? 0.42 <0.001 
26 Has your physical condition or medical treatment interfered with 
your family life? 
0.58 <0.001 
27 Has your physical condition or medical treatment interfered with 
your social activities? 
0.61 <0.001 
28 Has your physical condition or medical treatment caused you 
financial difficulties? 
0.51 <0.001 
29 How would you rate your overall health during the past week? -0.61 <0.001 
30 How would you rate your overall quality of life during the past 
week? 
-0.53 <0.001 
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Reliability; internal consistency or responsiveness to change, was examined by using 
Cronbach's alpha test. Cronbach's alpha determines the internal consistency or average 
correlation of items in a survey instrument to gauge its reliability. However, an alpha of 
0.7 or above is normally considered to indicate a reliable set of items (Greasley, 2008; 
Awad et al, 2008). In this study, the overall Cronbach’s Alpha reliability test was 0.87 
and this gives the tool a high degree of reliability, see table (4.2) for detailed results. 
 
Table (4.2): Internal reliability of questionnaire (Cronbach’s Alpha test) 
 No. of items Cronbach’s 
Alpha 
Overall reliability  30 0.87 
GQoL 2 0.88 
Physical Function (PF)  5 0.84 
Role function (RF)  2 0.90 
Emotional function (EF)  4 0.87 
Cognitive function (CF)  2 0.53 
Social function (SF)  2 0.89 
pain (PA)  2 0.82 
 
 
Awad et al (2008) tested the reliability of the QLQ-C30 using Cronbach's alpha 
coefficient, in which the values were all >0.7, with the exception of cognitive function 
and pain (0.67 and 0.51, respectively), and they concluded that the tool is reliable for 
use in Arab population to assess QoL of cancer patients (Awad et al, 2008).  
It is noticeable that cognitive function reliability is low, as well as in regional studies, 
the thing that maybe due to decreased ability of the tool to assess this aspect or inability 
of the respondents to understand it well. On the other hand, it is usually not easy for the 
person to admit of having decreased cognitive ability, the thing that maybe reflected in 
this low reliability score.  
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4.7 Data Collection 
Qualitative part: The researcher interviewed 10 participants using face-to-face in-depth-
interview technique. Each one of them was interviewed separately in private place. The 
interviewees were chosen from the three settings; AVH, Watani, and Beit Jala hospitals. 
The in-depth-interviews were conducted during May and June 2012. The length of each 
interview ranged from 30 to 50 minutes. All interviews were recorded on digital voice 
recorder. The recorded material was saved and coded by number, place of interview, sex 
of patient, age of patient, place of residence, diagnosis, date and time of interview, and 
the duration of each interview.  
Quantitative part: Self-administered questionnaires were distributed to 350 patients who 
were waiting for oncology out-patient clinics, taking chemotherapy session in the day 
case department, or admitted as in-patients. That was done during May and June 2012. 
Each participant was asked for willingness to participate and if was enrolled before in 
the study; this guaranteed no repetition or duplication of cases. 323 questionnaires were 
returned producing 92% response rate.  Privacy of patients guaranteed by offering them 
to fill in the questionnaire themselves or by the researcher on one-to-one bases. Data, 
then, entered into the Statistical Package for Social Sciences software (SPSS 19).  
 
4.8 Data Analysis  
Qualitative Data Analysis 
The researcher used the verbatim method of transcribing the recorded in-depth-
interviews. Then the transcriptions were reviewed by three experts; an expert in 
research and research methodologies with interest and experience in analyzing in-depth-
interviews, a specialized palliative care nurse, and the researcher. Also, the thesis 
supervisor reviewed the end-result themes as well.  
The analysis of the data was based on using the thematic analysis method based on the 
study objectives and the research questions. Firstly, the three reviewers produced the 
themes independently through repeated readings of the interviews transcriptions, coding 
of sentences and phrases, and eliciting ideas and themes. Then, the reviewers conducted 
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meetings to discuss the interviews and the coding, and then, agreed on common themes 
for each question based on the answers of the participants.  
Analysis was for unique factors (themes) related to QoL of cancer patients in Palestine. 
The generated themes were distributed in the table of themes which contained the main 
themes, sub-themes, divisions under sub-themes, and quotations of participants’ 
responses (Annex: 2). Then, these themes were processed for some features like 
repetition and the most common issues. These were arranged to show frequencies and 
ranking and used in the discussion part to support some of the significant results that 
were generated by the quantitative analysis.  
 
Quantitative Data Analysis 
The statistical package for social sciences (IBM® SPSS® version 19) was used to enter 
the raw data. The EORTC manual was used for coding the data. ANOVA, t-test, Chi 
square, and Pearson’s correlation tests, to test relationships and correlations between 
GQoL, QoL domains, and Symptoms with socio-demographic and condition factors, 
were used. Then, predictors of GQoL, QoL domains, and the most significant symptoms 
and issues related to them were produced using regression analysis. Tables and figures 
used, where statistically significant data presented only within the text body.  
 
4.9 Summary   
This study used a triangulated (qualitative, quantitative) methodology in assessing the 
QoL of the cancer patients in the West Bank of Palestine. This research collected the 
data through structured in-depth-interviews and through a questionnaire tool. The data 
was processed manually and through SPSS statistical package testing. This was done 
according to international and local standards of research, taking into consideration the 
ethical and scientific rules and obligations. Reliability and validity of the study tool was 
assured through statistical and experts testing, as well as through extensive literature 
review. That supported the study and its importance and vitality for cancer patients in 
Palestine.  
 
  
 
 
 
 
 
 
 
 
 
Chapter Five  
Results  
 
5.1 Introduction  
 
This chapter consists of two parts. Part one is presenting quantitative results. It will explore 
the demographic characteristics of the respondents. Other items are also presented such as 
diagnosis diversity, places, services for treatment outside the main hospitals facility, and 
needs as expressed by the patients themselves.  
Presentation of GQoL, QoL domains functioning, and symptoms averages and percentages 
are follow. Some classifications according to region and treating hospital are done in 
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correlation to severity of three items; GQoL, pain, and financial difficulties. A 33% cut-off 
point classification was used to identify the percentage of the respondents who are 
considered to have either the severe symptoms (>66%) or the poor QoL (<33%). This 
classification was based on other studies, (Alawadi & Ohaeri, 2009; Thweib, 2011), for 
better understanding of the results of the QoL assessment tool.  
Part two is presenting qualitative results. These include presenting the demographic data of 
the participants from different regions and governorates of the West Bank of Palestine. 
Then the main themes resulted from these interviews are presented. Consensus and 
agreements on most apparent themes and issues were presented, then presentation of 
resulted subthemes and divisions from the main themes are articulated. Quotations for the 
most important and distinctive issues were also expressed.  
 
5.2 Quantitative Results 
This section includes the presentation of the quantitative socio-demographic data, and the 
results of the data generated from the EORTC QLQ-C30 tool including respondents’ 
physical function (PF), social function (SF), role function (RF), cognitive function (CF), 
emotional function (EF), and symptoms of fatigue (FA), pain (PA), nausea and vomiting 
(NV), dyspnea (DY), constipation (CO), diarrhea (DI), insomnia (SL), appetite loss (AP), 
as well as financial difficulties (FI).  
 
5.2.1. Socio-Demographic Characteristics: 
The total number of the respondents involved in this study is 323 patients (92% response 
rate). Socio-demographic and financial characteristics, as well as characteristics related to 
their disease status and treatment related issues were explored and presented in this section.  
Figure (5.1) shows the distribution of participants according to the governorate they live in. 
It shows that the majority of respondents are from the south (58.2%), while (17%) from the 
middle, and (19.4%) from the north of the West Bank of Palestine.  
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Figure (5.1): Distribution of participants according to district  
 
Figure (5.2) shows the distribution of the cancer cases over the governorates of the West 
Bank of Palestine (MOH, 2011). In the current study the respondents’ distribution is 
congruent with that of the MOH reported cases, with some minimal deviations.  
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Figure (5.2): Distribution of cancer cases over governorates of West Bank of Palestine 
(source MOH annual report, 2011). 
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Socio-demographic characteristics for the participants in this study are presented in table 
(5.1). It shows that 58.2% are females, mean age is 52.7 years (SD=15.2), and the majority 
of cases are in the age group of 41 to 64 years (59.4%).  
Of the total participants, majority had low education; 20.1% were illiterate, 37% had 
primary education, and only 13.2% had high education as shown in table (5.1). The table 
shows also that 55.4% of participants were from villages against 39.6% from cities, and 
only 4.7% from camps.  
The majority of cases (75.2%) were very poor with an income less than 2000 NIS, 20.9% 
had income of less than 4000NIS, and only 3.9% of participants had income more than 
4000NIS per month as shown in table (5.1). This means that 75.2% of the Palestinians have 
severe poverty. The Palestinian statistics determined the relative poverty line and the deep 
poverty line according to consumption patterns (for reference household consisted of 2 
adults and 3 children) in the Palestinian Territory in 2012 of 2,293 NIS, and 1,832 NIS 
respectively. It showed poverty rate among Palestinian individuals of 17.8% in the West 
Bank (PCBS, 2012). This was due to loss of jobs by cancer patients after they got the 
disease in most of the cases.  
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Table (5.1): Socio-demographic characteristics of the respondents. 
 Frequency Percentage 
Sex  Male  135 41.8 
Female  188 58.2 
Age Group* ≤ 40 yrs 60 18.9 
41 - 64 yrs 189 59.4 
≥ 65 yrs 69 21.7 
Educational level  Illiterate 64 20.1 
Primary 118 37.0 
Secondary 95 29.8 
University 42 13.2 
Place of residence City 125 39.6 
Village 175 55.4 
Camp 15 4.7 
Monthly income Less than 2000 
NIS 
234 75.2 
2000 - 4000 NIS 65 20.9 
More than 4000 
NIS 
12 3.9 
Marital status Single 38 11.8 
Married 247 76.7 
Other 37 11.5 
Living condition Living alone 26 8.1 
Living with family 292 90.7 
Other 4 1.2 
House ownership Rented house 27 8.4 
Owned house 296 91.6 
*Mean age is 52.7 years (SD=15.2).  
 
The study findings showed that marital status of participants was 76.7% married, 11.8% 
single, and 11.5% widow, divorced, or separated. Also, the majority (90.7%) is living with 
their families, and only 8.1% of participants are living alone, while some (1.2%) had other 
living conditions such as living in geriatric house or do not have place to live in. On the 
other hand, 91.6% of participants had owned their houses, while 8.4% were living in rented 
houses as shown in table (5.1).  
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Table (5.2) shows that the majority of respondents (62.2%) were treated at Beit Jala 
Hospital in Bethlehem, 29.7% were at Augusta Victoria Hospital in Jerusalem, and 8% at 
Watani Hospital in Nablus. The concentration of cancer cases was in the outpatient 
departments (73.7%), while the inpatients were 26.3%. The study revealed that most of the 
participants were on chemotherapy treatment (52.2%), and 36.2% had a combination of the 
all types of treatments, of which are 10.6% had used alternative medicine in accordance 
with their medical treatment. 
 
Table (5.2): Place & type of treatment and the person taking-care of the cancer patients. 
  Frequency Percentage 
Place of treatment Beit Jala Hospital 201 62.2 
Watani Hospital 26 8.0 
AVH 96 29.7 
Type of treatment Chemotherapy 167 52.2 
Radiotherapy 17 5.3 
Surgical treatment 20 6.3 
Combinations 119 36.2 
Department of care Outpatient clinic 238 73.7 
In-patient ward 85 26.3 
Person taking care 
of patient 
Self caring  111 34.5 
Family member 132 41.0 
Paid person 1 0.3 
Both; self caring & 
Family member 
78 24.2 
 
Table (5.2) shows that 34.5% of participants are taking-care of themselves. But (41%) of 
the participants expressed that someone from the family members is taking care of them in 
their sickness, while 24.2% were taking care of themselves with help from a family 
member.  
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Table (5.3) shows that the majority of respondents (71.4%) were in advanced disease 
condition with (35.7%) in the third stage and (35.7%) in the fourth stage, while only 
(24.2%) in stage two and (2.5%) in stage one. This is higher than international figure for 
advanced stages (NCI, 2012).  
 
Table (5.3): Stage of cancer and duration of treatment since diagnosis.  
 
 Frequency Percentage 
Stage of disease stage 1 8 2.5 
stage 2 76 24.2 
stage 3 112 35.7 
stage 4 112 35.7 
Unknown 6 1.9 
Time span of 
treatment 
less than 3 months 67 21.0 
3 - 6 months 53 16.6 
more than 6 
months 
199 62.4 
 
In table (5.3) the duration of treatment for the participants was mainly longer than six 
months (62.4%), 21% less than three month duration, and 16.6% were between 3-6 months.  
Table (5.4) shows the distribution of cancer diagnoses for the participants. The most 
common cancer is breast cancer (31.6%) of all cases (males and females) while colon 
cancer was 14.2% of all cases.  
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Table (5.4): Distribution of cancer Diagnoses among the sample of the study according to 
frequency of occurrence. 
 Frequency Percentage 
Breast cancer 102 31.6 
Colon cancer 46 14.2 
Prostate cancer 21 6.5 
Lymphoma 19 5.9 
Leukemia 18 5.6 
Stomach cancer 16 5.0 
Lung cancer 14 4.3 
Brain cancer 12 3.7 
Skin carcinoma 11 3.4 
Ovarian & Uterine  9 2.8 
Thyroid cancer 6 1.9 
Kidney cancer 6 1.9 
Unknown 5 1.5 
Other cancers 5 1.5 
Laryngeal cancer 4 1.2 
Pancreatic cancer 4 1.2 
Gallbladder cancer 3 0.9 
Bone cancer 2 0.6 
Sarcoma 2 0.6 
Esophageal cancer 1 0.3 
Total 306 94.6 
 
Figure (5.3) shows that; these results are in accordance with the national data for the first 
two most-common cancers in Palestine (MOH, 2011).  
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Figure (5.3): The 10 most common cancer types in current study, compared to those 
presented by MOH annual report, 2011.  
 
5.2.2. Respondents’ Needs for Other Services:  
 
Table (5.5) presents the places that the participants are seeking for other services, in this 
study, beside the main hospital they are treated in. They articulated these places as 
alternative places to go to when they have needs for other services that are either not 
available at the hospital  of treatment or because the hospital is far away. It shows that 
18.9% used private services, 14.6% used governmental health services (GHS), and the 
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others used NGOs, abroad, UNRWA, Ministry of Social Affairs (MOSA), or religious 
entity. Nevertheless, the majority (35%) said “No Place” which not necessarily means the 
absence of the need, but the absence of the alternative.  
 
Table (5.5): Other places used by participants besides the hospital of treatment. 
 
 Frequency Percentage 
No place 113 35.0 
Private center 61 18.9 
GHS  47 14.6 
Abroad 12 3.7 
NGOs 7 2.2 
UNRWA 6 1.9 
MOSA 5 1.5 
Religious entity 1 0.3 
Total 252 78.1 
 
 
In table (5.6), around 16% needed to do diagnostic testing outside the treating hospital. 
15.2% needed to have treatment or medication outside the hospital for their symptoms such 
as pain. 5.3% needed to seek financial supports, 1.2% needed to have fluids and blood 
infusions, and 0.6% needed laboratory testing in other place. Nevertheless, 35% of 
participants did not use services outside the treating hospital; this does not necessarily mean 
the absence of the need, but the absence of the alternative. 
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Table (5.6): Other services used by the participants outside the hospital of treatment. 
 Frequency Percentage 
No service 113 35.0 
Diagnostic tests 52 16.1 
Pain & symptoms meds and Rx 49 15.2 
Financial support 17 5.3 
Blood & fluids 4 1.2 
Lab. tests 2 0.6 
Total 237 73.4 
 
The participants expressed the following (Table: 5.7) as their needs when they were asked 
for things that they needed throughout the course of treatment: (25.1%) expressed the need 
for financial aids in covering the expenses accompanied with disease, such as 
transportation, food, and accommodation, 12.1% needed medications and treatment such as 
chemotherapy, symptom management medications and 2.8% expressed the need for 
diagnostic facilities availability in their local area. However, 24.5% of respondents 
indicated that they need “nothing”. This was noticed to be as a reflex to show 
dissatisfaction and anger with the available services for them.  
 
Table (5.7): Needed services that are not available at the hospital of treatment as expressed 
by participants. 
 Frequency Percentage 
Financial aids 81 25.1 
No expressed needs 79 24.5 
Availability of meds & Rx 39 12.1 
Diagnostic facilities 9 2.8 
Home nursing care 8 2.5 
Psychosocial support 6 1.9 
Non-distant treatment center 5 1.5 
Less waiting time 3 0.9 
Medical & Mechanical supplies 3 0.9 
Health education 3 0.9 
Transportation availability 3 0.9 
Total 239 74 
 
62 
 
 Other needs were home nursing care (2.5%), psychosocial support services (1.9%), non-
distant hospital for treatment (1.5%), less waiting time especially in the outpatient clinics 
(0.9%), medical and mechanical supplies such as wheel chairs, artificial cosmetic parts, and 
disposables (0.9%), health education (0.9%), and availability of easy transportation (0.9%) 
especially in the presence of the separation wall.  
 
5.2.3. Means for GQoL, Functions, and Symptoms: 
Table (5.8) presents the mean of the global health status and QoL (GQoL) of the 
participating cancer patients. The average mean of GQoL was 41.8% (SD=26), this means 
less than half of the full GQoL, which means a very low mean. In this scale measure, the 
higher the percentage (from 0 to 100) is the better QoL for those patients.  
Five other functions or QoL domains were measured also as shown in table (5.8). All the 
functions were below the half of the full function, except for cognitive function (60.5%). 
The average was for Physical function 48.5%, role function 48.8%, emotional function 
46%, and social function 50%. The table also presents the number of participants in each 
domain and the standard deviations. This shows it clearly that the GQoL and other QoL 
domains are very low and under half of the full function in this scale.  
 
Table (5.8): Means for GQoL and QoL Domains (Functions) for participants. 
 N Mean* Std. Error 
Global health status (GQoL) 315 41.8 1.5 
Physical functioning (PF) 300 48.5 1.6 
Role functioning (RF) 314 48.8 2.2 
Emotional functioning (EF)  306 46.0 1.7 
Cognitive functioning (CF) 310 60.5 1.7 
Social functioning (SF) 314 50.0 2.1 
*Higher mean is better GQoL or better functioning.  
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The most distressing symptoms, of the eight symptoms measured for the participants in this 
study as shown in table (5.9), were fatigue (66.6%) and pain (63%). This is considered a 
very high score on this scale from 0 to 100, as the higher the result is the worse symptom to 
experience by cancer patients. Other symptoms were insomnia (56.4%), appetite loss 
(45.3%), dyspnea (37.2%), constipation (36.3%), nausea and vomiting (31.5%), and 
diarrhea (18.5%).  
 
Table (5.9): Means for Symptoms and Financial difficulties for the participants. 
 N Mean* Std. Error 
Fatigue (FA) 311 66.6 1.6 
Financial difficulties (FI) 318 64.6 2.1 
Pain (PA) 311 63.0 1.9 
Insomnia (SL) 317 56.4 2.2 
Appetite loss (AP)  317 45.3 2.2 
Dyspnea (DY) 317 37.2 2.1 
Constipation (CO) 319 36.3 2.3 
Nausea & vomiting (NV) 311 31.5 1.9 
Diarrhea (DI) 319 18.5 1.7 
*Higher mean is worse symptoms or worse financial difficulties.  
 
Table (5.9) shows mean for the expressed financial difficulties (64.6%) experienced by 
participants in this study. This represents a high financial burden added on the Palestinian 
cancer patients.  
 
5.2.4.  33% Cut-Off point Classification: 
The 33% cut-off point classification is used to identify the percentage of the sample that are 
either in the lower third or in the upper third of this classification. That is; those who are 
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considered to have either the severe symptoms (>66%) or the poor QoL (<33%). This 
classification was based on other studies, (Alawadi & Ohaeri, 2009; Thweib, 2011), for 
better understanding of the results of the QoL assessment tool results. 
The next paragraphs present the results of the study in terms of QoL domains and 
symptoms using the 33% cut-off point classification.  
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33% to 66%
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11.30%
26.70%
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Fatigue (mean=66.6)
below 33%
33% to 66%
over 66%
 
Figure (5.4): 33% cut-off point classification of GQoL and fatigue.  
 
In figure (5.4), around 62% of participants had severe fatigue (>66% cut-off point), and 
48.6% of participants had moderate GQoL (33% to 66%).  
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25.70%
22.80%
N&V (mean=31.5)
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33% to 66%
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18.30%
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59.20%
Pain (mean=63.0)
below 33%
33% to 66%
over 66%  
Figure (5.5): 33% cut-off point classification of nausea & vomiting and pain.  
65 
 
In figure (5.5), 51.5%of participants had mild nausea and vomiting (<33%), and 59.2% of 
participants had severe pain (>66%).  
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Figure (5.6): 33% cut-off point classification of dyspnea and insomnia.  
 
In figure (5.6), 40.1% of participants had mild dyspnea (<33%), and 55.5% of participants 
had severe insomnia (>66%). 
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Figure (5.7): 33% cut-off point classification of appetite loss and constipation.  
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In figure (5.7), 43.9% of participants had severe loss of appetite (>66%), and 49.2% of 
participants had mild constipation (<33%). 
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Figure (5.8): 33% cut-off point classification of diarrhea and financial difficulties.  
 
In figure (5.8), 66.8% of participants had mild diarrhea (<33%), and 67% of participants 
had severe financial difficulties (>66%). 
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Figure (5.9): 33% cut-off point classification of PF and RF.  
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In figure (5.9), 42.3% of participants had moderate physical function (between 33% and 
66%), and 47.1% of participants had a good role function (>66%). 
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Figure (5.10): 33% cut-off point classification of EF and CF.  
 
In figure (5.10), the participants were distributed between moderate and good emotional 
function (34.6%), and 54.8% of participants had a good cognitive function (>66%). 
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Figure (5.11): 33% cut-off point classification of SF.  
 
In figure (5.11), 47.8% of participants had a good social function (>66%).  
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5.2.5. Relationship between patients’ characteristics and GQoL, QoL 
domains, and the most significant symptoms and issues; (t-test & ANOVA):  
Table (5.10) indicates that there were significant differences at the level (α=0.05) between 
the means of PF and RF components attributed to age group of the participants. Tukey test 
shows that the differences in PF were between the age group (18-40) and (41-64) and (≥65) 
in favor of the younger age groups. This indicates that the younger the cancer patients the 
better Physical Function they have. However, Tukey test shows that the differences in RF 
were between the (≥65) and the age groups (18-40) and (41-64) in favor of younger ages. 
This means that the younger the participants the better Role Function they have.  
Table (5.10) indicates that there were significant differences at the level (α=0.05) between 
the means of GQoL, PF, RF, EF, CF, and SF components attributed to Educational level 
of the participants. Tukey test shows that the differences in GQoL were between the 
illiterate and secondary/ university levels in favor of the later; and the differences between 
the primary/ secondary and university in favor of university. This indicates that the higher 
the educational level the better the QoL of the cancer patients. However, Tukey test shows 
that the differences in PF were between the illiterate and primary/ secondary/ university 
levels in favor of the later; and the differences between the primary and university in favor 
of university. This indicates that the higher the educational level the better the Physical 
Function of the cancer patients. Moreover, Tukey test shows that the differences in RF 
were between the illiterate and secondary/ university levels in favor of the later. This means 
that patients with secondary and university levels have better Role Function. In addition, 
Tukey test shows that the differences in EF were between the illiterate and secondary/ 
university levels in favor of the later. This means that patients with secondary and 
university levels have better Emotional Function. Finally, Tukey test shows that the 
differences in SF were not significant. However, the means show that the higher the 
educational level the better the Social Function of the respondents. 
Table (5.10) indicates that there were significant differences at the level (α=0.05) between 
the means of GQoL, PF and EF components attributed to monthly income of the 
participants. Tukey test shows that the differences in GQoL were between the classes 
(<2000 NIS) and (2000-4000 NIS) and (>4000 NIS) in favor of the higher income patients. 
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This indicates that the higher income of the cancer patients the better QoL they have. 
However, Tukey test shows that the differences in PF and EF were between the (>4000 
NIS) and the classes (<2000 NIS) and (2000-4000 NIS) in favor of (>4000 NIS) class. This 
means that the higher income the better Physical and emotional Function of the 
participants.  
Table (5.10) indicates that there were significant differences at the level (α=0.05) between 
the means of PF components attributed to marital status of the participants. Tukey test 
shows that the differences in PF were between the singles and those who are married or 
other status (widow, divorced) in favor of the single patients. This indicates that the single 
participants have the better physical function. 
Table (5.10) indicates that there were significant differences at the level (α=0.05) between 
the means of GQoL, PF, CF, and SF components attributed to department of care of the 
participants. The differences in GQoL were in favor of the outpatient department, with a 
higher mean of responses to better GQoL for outpatients compared to inpatients. However, 
the differences in PF, CF, and SF were in favor of outpatients, indicating that outpatients 
reported better Physical, cognitive, and social Functions compared to inpatients.  
Table (5.10): Patients GQoL and QoL five domains according to their socio-demographic characteristics (ANOVA & t-test).  
 
Variables 
GQoL Physical Function Role Function Social Function Cognitive Function Emotional Function 
Mean  T / F  P-
value 
Mean T / F  P-
value 
Mean T / F  P-
value 
Mean  T / 
F  
P-
value 
Mean T / F  P-
value 
Mean T / F  P-
value 
Gender  Male  41.6 -0.1 0.9 48.1 -0.2 0.8 49.0 0.1 1.0 48.3 -0.7 0.5 61.5 0.5 0.6 49.5 1.7 0.1 
Female  41.9   48.8   48.7   51.2   59.8   43.5   
Age group 18- 40 46.4 1.9 0.15 63.3 17.9* <0.01 61.5 7.2* <0.01 50.0 0.7 0.47 63.1 1.3 0.27 48.4 1.0 0.38 
41-64 41.8 48.6 49.8 51.7 61.4 46.7 
>65 37.3 34.5 36.0 45.3 55.1 41.4 
Educational 
level  
illiterate 32.8 7.3* 
 
<0.01 31.5 14.8* <0.01 34.7 5.0* <0.01 41.4 1.8* <0.01 46.9 7.6 0.15 35.6 5.9* <0.01 
primary 40.4 48.3   47.3   52.9   62.8   44.3   
secondary 43.5 55.9   55.7   50.5   61.5   51.7   
university 56.1 63.3   59.6   56.3   74.6   58.1   
Place of 
residence 
city 43.6 0.6 0.56 48.9 0.3 0.75 49.9 0.8 0.46 53.5 1.6 0.20 62.2 1.0 0.35 44.8 0.5 0.58 
village 40.3 47.3   48.9   47.9   59.7   46.6   
camp 42.3 52.4   36.7   37.2   50.0   38.3   
Monthly 
income 
<2000 
NIS 
38.1 12.9* <0.01 46.1 8.6* <0.01 46.1 2.0 0.14 47.0 2.7 0.07 58.0 1.9 0.14 43.6 6.2* <0.01 
2000 - 
4000  
49.3 47.5   51.8   56.2   65.1   47.4   
>4000 
NIS 
69.4 79.4   66.7   65.3   69.4   74.3   
person 
taking care 
of patient 
self caring  45.6 1.3 0.27 59.1 8.6* <0.01 56.3 2.3 0.07 56.1 1.4 0.23 64.5 1.6 0.19 49.1 1.0 0.40 
family  40.1 41.1   46.9   46.9   60.2   43.3   
paid persn 25.0 46.7   50.0   50.0   83.3   75.0   
Both  39.5 45.9   41.7   47.0   55.0   45.5   
Marital 
status 
single 42.8 0.6 0.56 62.0 6.2* <0.01 60.4 2.2 0.12 57.7 1.0 0.39 63.5 0.6 0.55 46.3 1.0 0.36 
married 42.4 48.0   48.1   48.8   59.4   47.2   
other 37.6 39.0   42.6   48.6   64.3   39.3   
Living 
condition 
alone 47.0 2.1 0.12 52.2 0.2 0.80 58.7 1.8 0.16 51.3 0.04 0.96 64.0 0.2 0.83 41.3 0.3 0.74 
with 
family 
41.6 48.1   48.3   49.9   60.2   46.5   
Other 18.8 46.7   20.8   45.8   58.3   45.8   
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Table (5.10 a): Patients GQoL and QoL five domains according to their socio-demographic characteristics (ANOVA & t-test).   
Variables 
GQoL Physical Function Role Function Social Function Cognitive Function Emotional Function 
Mean  T / F  P-
value 
Mean T / F  P-
value 
Mean T / F  P-
value 
Mean  T / 
F  
P-
value 
Mean T / F  P-
value 
Mean T / F  P-
value 
House 
ownership 
rented  32.4 -1.9 0.1 42.5 -1.1 0.3 34.6 -2.0 0.1 37.8 -1.7 0.1 61.5 0.2 0.9 37.3 -1.5 0.1 
owned  42.6 49.0 50.1 51.1 60.4 46.8   
Place of 
treatment 
Bet Jala H 39.3 2.5 0.08 46.6 2.0 0.14 47.3 1.2 0.30 48.1 0.8 0.47 59.0 0.6 0.54 43.7 1.6 0.21 
Watani H 48.1 45.6   42.7   55.8   62.7   47.4   
AVH 45.3 53.5   53.7   52.3   63.0   50.6   
Department 
of care 
Outpatient  44.6 3.3* <0.01 52.3 4.0* <0.01 51.2 1.7 0.084 52.9 2.3* <0.05 63.5 3.0* <0.01 47.1 1.0 0.312 
In-patient  33.8 38.2 42.2 42.1 51.9 43.1 
Stage of 
disease 
stage 1 55.2 14.1* <0.01 71.7 25.8* <0.01 87.5 14.0* <0.01 64.6 8.6* <0.01 75.0 10.5* <0.01 55.2 18.3* <0.01 
stage 2 57.5 67.5   68.3   68.5   74.3   67.3   
stage 3 41.4 51.5   47.2   48.8   61.0   44.6   
stage 4 31.0 32.0   32.9   38.2   48.3   32.2   
Unknown 34.7 36.7   77.8   41.7   83.3   70.0   
Time span 
of 
treatment 
< 3 month 48.2 5.1* 0.01 56.4 5.6* <0.01 54.0 2.5 0.08 56.3 2.3 0.11 59.9 1.1 0.33 51.8 2.0 0.13 
3 - 6 mon 46.5 54.0   56.5   54.7   66.0   47.9   
> 6 month 38.0 44.4   45.1   46.6   59.0   43.3   
Region  Northern  47.8 5.7* <0.01 47.9 5.9* <0.01 47.0 1.7 0.18 51.4 6.6* <0.01 60.5 4.0* 0.02 48.1 3.3* 0.04 
Middle  48.0 59.1   57.0   64.8   70.4   53.2   
Southern  37.8 44.3   46.2   44.6   57.1   41.8   
 
Table (5.10) indicates that there were significant differences at the level (α=0.05) between 
the means of GQoL, PF, RF, EF, CF, and SF components attributed to stage of disease of 
the participants. Tukey test shows that the differences in GQoL were between stages (4) 
and stages (2 & 3) in favor of the later. This indicates that the earlier the stage the better 
the QoL of the participants. However, Tukey test shows that the differences in PF were 
between stage (4) and stages (1&2&3) in favor of the later; and the differences between (2) 
and (3) in favor of stage (2). This indicates that the earlier the stage the better the Physical 
Function of the participants. Moreover, Tukey test shows that the differences in RF were 
between stage (4) and stages (1&2&3) in favor of the later; and the differences between 
stage (3) and stages (1&2&4) in favor of stages (1 &2) as they have the higher means. This 
means that participants with stages (1&2) have better Role Function than stages (3 &4). In 
addition, Tukey test shows that the differences in EF and CF were between stage (4) and 
stages (2&3) in favor of the later; and the differences between stage (3) and (2) in favor of 
stage (2). This means that participants with earlier stages have better Emotional and 
cognitive Functions. Finally, Tukey test shows that the differences in SF were between 
stages (2) and stages (3&4) in favor of stage (2). This means that participants with stage 
(2) have better Social Function. 
Table (5.10) indicates that there were significant differences at the level (α=0.05) between 
the means of GQoL and PF components attributed to duration of treatment of the 
participants. Tukey test shows that the differences in GQoL and PF were between the 
duration of less than 3 months and more than 6 months in favor of the later. This indicates 
that the longer the duration of treatment the worse the QoL and physical function of the 
participants.  
Table (5.10) indicates that there were significant differences at the level (α=0.05) between 
the means of GQoL, PF, RF, EF, CF, and SF components attributed to region of living of 
the participants. Tukey test shows that the differences in GQoL were between the southern 
and both northern and middle regions in favor of the later. This indicates that there is lower 
level of QoL of the participants who are living in the southern region of the West Bank of 
Palestine. However, Tukey test shows that the differences in PF, CF, and SF were between 
the south and middle in favor of the middle. This means that Physical, cognitive, and 
social Functions of the participants are worse/ lower in those living in the southern region 
of the West Bank.  
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The following items are found statistically non-significant for comparison of means upon 
testing with t-test and ANOVA with GQoL, PF, RF, SF, CF, EF; those factors are gender, 
Place of residence, Living condition, House ownership, Place of treatment, and the Type of 
treatment.   
Table (5.11): Patients’ FA, FI, and PA according to their socio-demographic 
characteristics (ANOVA &t-test). 
Variables 
FA FI PA 
Mean  T / F  P-
value 
Mean T / F  P-
value 
Mean  T / F  P-
value 
Gender  Male  64.6 -1.0 0.3 66.9 1.0 0.3 62.9 0.05 1.0 
Female  68.0   62.9   63.0   
Age group <18-40 59.5 5.5* <0.01 61.0 0.4 0.64 58.3 2.0 0.14 
41-64 65.8 65.9 62.2 
>65 75.8 66.2 69.9 
Educational 
level  
illiterate 82.0 14.5* 
 
<0.01 74.5 4.6* <0.01 78.1 9.3* <0.01 
primary 68.4 65.2   63.3   
Secondary 60.7 62.7   58.3   
University 48.6 48.0   43.7   
Place of 
residence 
city 68.1 0.4 0.70 58.5 2.9 0.06 61.3 0.8 0.47 
village 65.7 68.0   63.9   
camp 70.6 73.3   72.2   
Monthly 
income 
< 2000 NIS 69.8 10.4* 
 
<0.01 71.0 20.7* <0.01 65.5 6.9* <0.01 
2000 - 4000  64.2 49.0   60.3   
> 4000 NIS 33.3 19.4   29.2   
person 
taking care 
of patient 
self caring  60.8 3.3* 0.02 62.3 0.7 0.57 57.6 1.4 0.23 
family memb 70.6 64.1   66.3   
paid person 22.2 100.0   50.0   
Both (1&2) 68.4 67.9   65.6   
Marital 
status 
single 61.9 0.8 0.44 50.0 4.0* 0.02 54.4 1.4 0.24 
married 66.5 66.0   64.5   
other 70.6 72.1   62.2   
Living 
condition 
living alone 65.3 1.3 0.29 64.0 1.1 0.33 60.4 0.8 0.46 
with family 66.4 64.1   62.8   
other 88.9 91.7   83.3   
House 
ownership 
rented house 72.0 1.0 0.3 79.5 2.2* 0.01 73.7 1.7 0.1 
owned house 66.1 63.2   62.0   
Place of 
treatment 
Beit Jala H. 68.7 1.5 0.24 65.3 0.3 0.71 65.6 2.0 0.13 
Watani H. 61.8 59.0   52.7   
AVH 63.4 64.6   60.1   
Department 
of care 
Outpatient  63.2 -3.5* 0.001 62.1 -2.0* 0.046 58.4 -4.2* 0.001 
In-patient  75.8 71.4 75.5 
Stage of 
disease 
stage 1 54.2 25.1* <0.01 41.7 5.1* <0.01 47.9 19.4* <0.01 
stage 2 45.8 53.2   39.3   
stage 3 66.5 62.5   62.7   
stage 4 82.5 74.8   80.2   
Unknown 51.9 72.2   61.1   
Time span 
of 
treatment 
< 3 months 62.3 3.5* 0.03 59.7 2.4 0.09 58.3 1.9 0.15 
3 - 6 months 60.3 57.9   57.7   
> 6 months 70.0 68.2   65.9   
Region  Northern  65.0 3.1 0.05* 66.7 3.2 0.04* 58.3 2.0 0.14 
Middle  59.3 53.9   58.2   
Southern  69.9 67.8   66.4   
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Table (5.11) indicates that there were significant differences at the level (α=0.05) between 
the means of FA components attributed to age group of the participants. Tukey test shows 
that the differences in FA were between the age group (>65) and the age groups (18-40) 
and (41-64) in favor of older ages. This means that the older the cancer patients in this 
study the more Fatigue they have. However, pain and financial difficulties did not reach 
the statistical significance, but the means show more pain and more financial difficulties as 
the patients are more advancing in age.  
Table (5.11) indicates that there were significant differences at the level (α=0.05) between 
the means of FA, PA, and FI components attributed to educational level of the 
participants. Tukey test shows that the differences in FA were between the illiterate and 
primary, secondary, and university levels in favor of the illiterate; and the differences 
between the primary and university in favor of primary. This indicates that the higher the 
educational level of the respondents the less the Fatigue. However, Tukey test shows that 
the differences in PA were between the illiterate and primary, secondary, and university 
levels in favor of the illiterate; and the differences between the primary and university in 
favor of primary. This indicates that the higher the educational level of the participants the 
less the Pain they suffer. In addition, Tukey test shows that the differences in FI were 
between the illiterate and primary with university level in favor of the formers. This means 
that the participants with university degree have less financial difficulties.  
Table (5.11) indicates that there were significant differences at the level (α=0.05) between 
the means of FA, PA and FI components attributed to monthly income of the participants. 
Tukey test shows that the differences in FI were between the classes (<2000 NIS) and 
(2000-4000 NIS) and (>4000 NIS) in favor of the less income patients. This indicates that 
the less income the respondents the more financial difficulties they have. However, Tukey 
test shows that the differences in FA and PA were between the (>4000 NIS) and the classes 
(<2000 NIS) and (2000-4000 NIS) in favor of the less income classes. This means that the 
less income the more Fatigue and pain symptoms distress the respondents.  
Table (5.11) indicates that there were significant differences at the level (α=0.05) between 
the means of FI components attributed to marital status of the participants. Tukey test 
shows that the differences in FI were between the singles and those who are married or 
other status (widow, divorced) in favor of the other status patients. This means that the 
widow and divorced participants have more financial difficulties. 
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Table (5.11) indicates that there were significant differences at the level (α=0.05) between 
the means of FI components attributed to House ownership of the participants. The 
differences in FI were in favor of the rented houses, with a higher mean of responses to 
more financial difficulties for rented houses compared to owned houses ownership.  
Table (5.11) indicates that there were significant differences at the level (α=0.05) between 
the means of FA, FI, and PA components attributed to department of care of the 
participants. The differences in FA, FI, and PA were in favor of the inpatient department, 
with a higher mean of responses to more intense symptoms and issues (fatigue, pain, 
financial difficulties) for inpatients compared to outpatients.  
Table (5.11) indicates that there were significant differences at the level (α=0.05) between 
the means of FA, FI, and PA components attributed to stage of disease of the participants. 
Tukey test shows that the differences in FA and PA were between stage (4) and stages 
(1&2&3) in favor of stage (4) which has a higher mean; and the differences between (2) 
and (3) in favor of stage (3). This indicates that the later the stage the worse the fatigue 
and pain of the cancer patients. However, Tukey test shows that the differences in FI were 
between stage (4) and stage (2) in favor of (4). This indicates that the later the stage the 
more the financial difficulties for the participants. 
Table (5.11) indicates that there were significant differences at the level (α=0.05) between 
the means of FA components attributed to duration of treatment of the participants. 
Tukey test shows that the differences in FA were in favor of the longer duration. This 
means that the longer the duration of treatment the more the fatigue of the participants.  
Table (5.11) indicates that there were significant differences at the level (α=0.05) between 
the means of FA and FI components attributed to region of the participants. Tukey test 
shows that the differences in FA and FI were between the middle and southern region in 
favor of the southern. This means that the participants who are living in the southern region 
of the West Bank of Palestine have the more fatigue symptoms and financial difficulties. 
The following items are found to be statistically non-significant for comparison of means 
upon testing with t-test and ANOVA for FA, FI, and PA; these factors are gender, Place of 
residence, Living condition, Place of treatment, and the Type of treatment. 
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According to the region of the West Bank of Palestine, figure (5.12) presents poorer 
GQoL, EF, PF, SF, and CF, and more intense symptom and financial difficulties in the 
southern region in comparison with the middle or the northern regions. 
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Figure (5.12): Statistically significant (p<0.05) variables (Means for GQoL and other 
domains) according to region. 
 
5.2.6. The relationship between GQoL and symptoms associated with 
cancer (Pearson’s correlation): 
 
The results show that there is a significant negative/ inverse relationship at the level 
(α=0.05) between the GQoL and symptoms associated with cancer and financial 
difficulties. These relationships were strongest with pain (r = -0.622, p< 0.001), fatigue (r = 
-0.620, p< 0.001), insomnia (r = -0.447, p< 0.001), dyspnea (r = -0.423, p< 0.001), and 
financial difficulties (r = -0.393, p< 0.001) as shown in table (5.12). Further details 
available in Annex (1). 
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Table (5.12): Significant relationships between GQoL and cancer symptoms and financial 
difficulties (Pearson’s correlation).   
  FA N&V Pain DY SL AP CO DI FI 
R -0.62 -0.39 -0.62 -0.423 -0.447 -0.39 -0.33 -0.224 -0.39
p-
value 
< 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01
 
 
5.2.7. The relationship between stage of cancer and independent variables: 
  
In cross tabulation between cancer stage and other independent variables, significant 
relationship with the educational level was found as shown in figure (5.13). It is clear that 
low educated respondents had more advanced stages of cancer (stage III and IV); 88.7% of 
illiterates have advanced stage cancer, while 57.5% only in the university level.  
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Figure (5.13): The relationship between stage (1-4) of cancer and educational level of 
respondents; Cross tabulation (Chi square test (χ²)  
 
78 
 
5.2.8. Predictors of GQoL and QoL domains; (Regression analysis):  
In the regression model we included all variables that were significant according to P value 
in the bivariate analysis (P < 0.05), and we presented only those that were still significant 
in the regression analysis.  
According to table (5.13) there is significant relationship at the level (α=0.05) between the 
GQoL and educational level, monthly income, stage of cancer, and duration of treatment 
for cancer. 
 
Table (5.13): Regression analysis: significant relationship between GQoL and independent 
variables. 
Independent variables 
F-value 
(ANOVA)
P-value
β-Value 
(Regression) 
P-value 
Education of patient 7.3 <0.01 0.118 0.041 
Monthly income 12.9 <0.01 0.186 0.001 
Stage of disease 14.1 <0.01 -0.304 <0.001 
Time span of treatment 5.1 =0.01 -0.108 0.042 
R square (R²) = 0.251 
 
The strongest predictor of GQoL was the stage of cancer with a negative relationship; as 
the increase in stage means worse GQoL, then the monthly income with a positive 
relationship, then the educational level with a positive relationship, then finally the 
duration of cancer treatment with a negative relationship (figure 5.14). The coefficient of 
determination (R²) shows that 25.1% of the variance of the GQoL explained by the 
independent variables shown in table (5.13).  
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Figure (5.14): Predictors of GQoL according to regression analysis of significant variables 
(P <0.05).  
 
According to table (5.14) there is a significant relationship at the level (α=0.05) between 
the PF and educational level, person taking care of the patient, department of treatment 
(outpatient or inpatient), stage of cancer, age, and duration of treatment for cancer.  
 
Table (5.14): Regression analysis: significant relationship between Physical function and 
the independent variables. 
Independent variables 
F-value 
(ANOVA)
P-value
β-Value 
(Regression) 
P-value 
Education of patient 14.8 <0.01 0.18 0.002 
Department of care (t-value) 4.0 <0.01 -0.21 <0.001 
Stage of disease 25.8 <0.01 -0.37 <0.001 
Time span of treatment 5.6 <0.01 -0.10 0.043 
Age Group 17.9 <0.01 -0.19 0.001 
 R square (R²) = 0.406 
 
The strongest predictor of PF was the stage of cancer with a negative relationship, then the 
department with worse effect on PF for inpatients, then the age with a negative effect, then 
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the educational level with a positive relationship, then finally the duration of cancer 
treatment with a negative relationship. The coefficient of determination (R²) shows that 
40.6% of the variance of the PF explained by the independent variables shown in table 
(5.14). 
According to table (5.15) there is a significant relationship at the level (α=0.05) between 
the RF and the stage of cancer.  
 
Table (5.15): Regression analysis: significant relationship between Role function and 
stage of disease. 
Independent variables 
F-value 
(ANOVA)
P-value
β-Value 
(Regression) 
P-value 
Stage of disease 14.0 <0.01 -0.31 <0.001 
 R square (R²) = 0.154 
 
The strongest predictor of RF was the stage of cancer with a negative relationship. The 
coefficient of determination (R²) shows that 15.4% of the variance of the RF explained by 
the stage of cancer as shown in table (5.15). 
According to table (5.16) there is a significant relationship at the level (α=0.05) between 
the SF and the stage of cancer. 
 
Table (5.16): Regression analysis: significant relationship between Social function and the 
stage of disease. 
Independent variables 
F-value 
(ANOVA)
P-value
β-Value 
(Regression) 
P-value 
Stage of disease 8.6 <0.01 -0.27 <0.001 
 R square (R²) = 0.098 
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The strongest predictor of SF was the stage of cancer with a negative relationship. The 
coefficient of determination (R²) shows that 9.8% of the variance of the SF explained by 
the stage as shown in table (5.16). 
According to table (5.17) that there is significant relationship at the level (α=0.05) between 
the CF and the variables of department of treatment (outpatient or inpatient), and stage of 
cancer. 
 
Table (5.17): Regression analysis: significant relationship between Cognitive function and 
the independent variables. 
Independent variables 
F-value 
(ANOVA)
P-value
β-Value 
(Regression) 
P-value 
Stage of disease 10.5 <0.01 -0.26 <0.001 
Department of care (t-value) 3.0 <0.01 -0.14 0.015 
 R square (R²) = 0.097 
 
The strongest predictor of CF was the stage of cancer with a negative relationship, then the 
department with worse effect on CF for inpatients. The coefficient of determination (R²) 
shows that 9.7% of the variance of the CF explained by the independent variables shown in 
table (5.17). 
According to table (5.18) there is a significant relationship at the level (α=0.05) between 
the EF and the variables of educational level, and stage of cancer. 
 
Table (5.18): Regression analysis: significant relationship between Emotional function 
and the independent variables. 
Independent variables 
F-value 
(ANOVA)
P-value
β-Value 
(Regression) 
P-value 
Stage of disease 18.3 <0.01 -0.35 <0.001 
Education of patient 5.9 <0.01 0.15 0.012 
 R square (R²) = 0.182 
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The strongest predictor of EF was the stage of cancer with a negative relationship, then the 
educational level with a positive relationship. The coefficient of determination (R²) shows 
that 18.2% of the variance of the EF explained by the independent variables shown in table 
(5.18). 
According to table (5.19) there is a significant relationship at the level (α=0.05) between 
the FA and the variables of educational level, department of treatment (outpatient or 
inpatient), stage of cancer.  
 
Table (5.19): Regression analysis: significant relationship between Fatigue and the 
independent variables. 
 
Independent variables 
F-value 
(ANOVA)
P-value
β-Value 
(Regression) 
P-value 
Stage of disease 25.1 <0.01 0.32 < 0.001 
Education of patient 14.5 <0.01 -0.22 < 0.001 
Department of care 3.5 <0.01 0.15 0.004 
 R square (R²) = 0.278 
 
The strongest predictor of FA was the stage of cancer with a positive relationship, then the 
educational level with a negative relationship, then the department with worse effect on FA 
for inpatients. The coefficient of determination (R²) shows that 27.8% of the variance of 
the FA explained by the independent variables shown in table (5.19). 
According to table (5.20) there is a significant relationship at the level (α=0.05) between 
the FI and the variables of stage of cancer, and monthly income. 
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Table (5.20): Regression analysis: significant relationship between Financial difficulties 
and the independent variables. 
Independent variables 
F-value 
(ANOVA)
P-value
β-Value 
(Regression) 
P-value 
Stage of disease 5.1 <0.01 0.17 0.002 
Monthly income 20.7 <0.01 -0.31 < 0.001
 R square (R²) = 0.180 
 
The strongest predictor of FI was the monthly income of the cancer patient with a negative 
relationship indicating more financial difficulties with less income, then the cancer stage 
with a positive relationship indicating more financial difficulties with advanced stages of 
cancer. The coefficient of determination (R²) shows that 18% of the variance of the FI 
explained by the independent variables shown in table (5.20). 
According to table (5.21) there is significant relationship at the level (α=0.05) between the 
PA and the variables of educational level, department of treatment (outpatient or inpatient), 
and stage of cancer. 
 
Table (5.21): Regression analysis: significant relationship between Pain and the 
independent variables. 
Independent variables 
F-value 
(ANOVA)
P-value
β-Value 
(Regression) 
P-value 
Education of patient 9.3 <0.01 -0.208 <0.001 
Department of care (t-value) -4.2 <0.01 0.176 0.001 
Stage of disease 19.4 <0.01 0.359 <0.001 
 R square (R²) = 0.266 
The strongest predictor of PA was the stage of cancer with a positive relationship 
indicating more severe pain in advanced cancer stages, then the educational level with a 
negative relationship indicating less pain for highly educated patients, then the department 
(outpatient or inpatient) with worse effect on PA for inpatients. The coefficient of 
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determination (R²) shows that 26.6% of the variance of the PA explained by the 
independent variables shown in table (5.21).  
 
5.3 Qualitative Results  
5.3.1. Demographic characteristics of the qualitative sample: 
The qualitative part consists of 10 in-depth-interviews that were conducted with cancer 
patients from different areas of the West Bank of Palestine. Also, those patients were from 
different ages, genders, backgrounds, and diagnoses. Table (5.22) shows the characteristics 
of informants.  
The cases were from most areas of the West Bank; Hebron, Bethlehem, Jenin, Ramallah, 
and Nablus. The participants’ age ranged from 25 to 70 years old and 6 females and 4 
males. The diagnoses were breast cancer, lymphoma, uterine cancer, leukemia, colon 
cancer, brain cancer, and lung cancer.  
 
Table (5.22): Characteristics of respondents.  
 
Sex  Age Area  Diagnosis  
Female  50 Hebron  Breast Ca 
Female  25 Bethlehem  Lymphoma  
Female  42 Jenin  Uterine Ca 
Male  60 Hebron  Leukemia  
Male  46 Ramallah  Colon Ca 
Male  70 Hebron  Colon Ca 
Female  41 Hebron  Breast Ca 
Female  34 Nablus  Brain Ca 
Female  46 Ramallah  Breast Ca 
Male  60 Hebron  Lung Ca 
 
 
85 
 
5.3.2. Thematic Analysis: 
Through the thematic analysis of the in-depth-interviews in this study, seven categories 
were identified. The categories were originated from the main questions of the interviews 
and based on the participants’ responses. These categories were; (a) Effects of cancer on 
the daily life, (b) Personal perceptions of cancer, (c) Factors affecting coping status with 
cancer, (d) Patients’ beliefs regarding treatment, (e) Barriers to service delivery, (f) 
Satisfaction of patients with service delivery, and (g) Community perceptions for cancer 
and cancer patients. Moreover, patients’ needs were identified and discussed in terms of 
QoL.  
For each category, several themes were indentified. Annex (2) illustrates and categorizes 
all these data, as well as, provides the supporting original text in Arabic as the patients had 
said literally. Also, the table provides English translation of the most important quotations 
of participants’ responses that are included in the body of the text in this study.  
 
1. Effects of cancer on the daily life. 
The effects of cancer on the daily life of patients were classified into five themes; physical, 
social, psychological, sexual, and financial. The physical effects were apparent mainly 
through pain and fatigue from the disease process and chemotherapy treatment, besides 
some other physical symptoms like edema and bleeding. A female breast cancer patient 
from Hebron governorate who aged 50 years said;  
 
“All my strength collapses; I didn’t have the power to stand to drink water. The pain is the 
worst; even it is worse than cancer itself” 
 
Another female patient from Nablus governorate (34 years) with brain cancer said;  
 
“I have a lot of fatigue; I feel tired when I take the chemotherapy, sometimes I fall unconscious 
when I am at the hospital, also, there is pain in my back… I can’t take it anymore, all the times 
I am in the bed” 
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Role performance were concentrated around issues like the relationships among the 
family and the family feelings toward each others, roles and duties of family members, and 
resulted fear, anxiety, stress and burden of having a cancer patient in the family. A breast 
cancer female patient from the south area said;  
 
“The most important thing to me is to be with my kids; their feelings were abnormal, I was 
away outside home, I was taking hypnotic and sleep for hours, they were lost in that time.” 
 
Sexuality: it was through the expression of frigidity and cold feelings among spouses, 
expression of low desire and unwillingness for a relationship, feeling of fatigue, and even 
refusal of continuing the marriage in some cases. A breast cancer patient of 41 years old 
said;  
 
“After chemotherapy, I feel tired when I am back at home. Off course, this cause indolence and 
frigidity at home… whatever, it has an effect.” 
 
Another patient said;  
 
“I have no desire, I don’t think about it, actually nothing is between us now. Actually I asked 
for divorce before I had my surgery.”  
 
Psychologically, the effects were illustrated in fear due to unawareness and poor 
understanding of the disease process and treatment consequences, death ideation, denial, 
hopelessness, sadness, coupled to disease and hospital, troubling feelings, and negative 
impact of the disease in life aspects. A male colon cancer patient from the south who is 70 
years old said;  
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“They told me you are in need for urgent surgery; I was terrified… how they are going to open 
my abdomen!? So, I ran away for six months, then I was really tired, so, I said do it and open 
my abdomen… if I’ll die, let me die.”  
 
This example showed that physician does not give enough explanation for the patients and 
patients are unaware of their rights toward their role in the treatment plan that depends on 
real understanding of their health problem. Such lack of knowledge may lead to anxiety 
and fear among patients. it seems that patients do not have the courage to ask questions 
because they believe that their treatment is physician’s decision. In addition, they fear that 
asking questions may upset the physicians and this affects their treatment.  
 
2. Personal perceptions of cancer. 
Patients’ perceptions of their disease status, causes, and consequences were classified into 
self integration with the disease, shame feeling from being a cancer patient, and feeling of 
guilt from being diseased. A 25 years female with lymphoma said;  
 
“Indeed, I am the only one with cancer in my area of living.”  
 
Their ideations, beliefs, and understanding for their disease were that cancer is death, fear 
from discovering that they have the disease, incurability of cancer, and no necessity for 
pain management as it causes addiction. Death anxiety was clear through a 42 years old 
patient with uterine cancer from Jenin said;  
 
“I think I am going to die and that’s it, this disease means death and I am already going to 
die… actually, all those with this disease are died.”  
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Also, they link cancer causes with other treatments they had taken, with the Israeli nuclear 
weapon, with chemical factories, food preservatives and fruits & vegetables fertilizers, 
with smoking, or contagion. One participant said; 
 
“I don’t think there is complete cure for cancer… I think my disease was caused by hormonal 
therapy for infertility, or some people are saying it is the nuclear weapon of Israel and its 
factories in Dimona.”  
 
And sometimes, they are considering it as ordeal, test or mercy from God, or sometimes, as 
punishment for doing sins or expiation to remove these sins. Spirituality was clear through 
what a leukemia patient from Hebron area speech;  
 
“The disease cause is from God, it is not shame or demerit, it is mercy; our God is testing us by 
the disease, it is mercy and expiation of sins.”  
 
They believed also, that acceptance of the disease and its pain is a must and no need to 
take actions against it, as cure is something beyond capabilities of human beings, or 
sometimes it depends on their spirit and morale. A patient from the north said;  
 
“I am feeling that I’ll be taking treatment for all my life; indeed I am not aware of the cause of 
this disease.”  
 
3. Factors affecting coping status with cancer. 
Through analysis of the cancer patients’ responses, several factors were illustrated that 
might have effect on the patients’ acceptance of the cancer, and in enhancing their ability 
to cope. These factors were having commitment toward others and having goal in life, 
personality, attitudes, knowledge, and having faith and religious beliefs which had an 
apparent effect on patients through enforcing their abilities and strengthening their 
spirituality, also, having a support system from social and familial context or from the 
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treating professionals. Role performance was apparent in a female patient from Bethlehem 
who said while describing her commitment toward her family;  
 
“The woman lives in this life mostly for her kids; especially that mine are girls.”  
 
Personal factors that helped patients to overcome the struggle of having cancer in many 
times were illustrated in having better ability to fight against troubles in life due to 
experience with the disease, having own house and privacy, having patience and ability to 
tolerate, having own competence, and having knowledge about their condition. A 46 years 
old patient with breast cancer from Ramallah said describing her ability to cope with the 
disease;  
 
“What helped me was that I know what my disease is, and I believe it is easier than other 
types… thank God, I am patient and accepting my condition… may God cure us by Doaa 
(supplication).”  
 
Faith and religious beliefs (spirituality) of patients were clearly apparent in supporting 
them and providing them with strength and power to stand in front of such disease. Their 
rationales of faith in front of disease were that cure is only from God. The need for strong 
faith in such condition through praying and reading Quran, obedience of God will and 
destiny, acceptance of death as being with the hands of God and that death is the final end 
anyway, “Tawakul” or trust in God that he is taking care of human, faith that disease is 
mercy from God to expiate sins and not a punishment, and the Islamic directives of 
combining the best possible treatment with full faith and supplication to God. A lung 
cancer patient who is 60 years old said while explaining his way of dealing with cancer and 
how he is coping with the disease;  
 
“Faith in Allah (God) helped me through; he is the cause and the cure of the disease… firstly, 
we are in the hands of God; he is “AL-Shafi” the healer… and the person needs to accept it, 
needs to be faithful in God… for me, this is before everything, even before treatment.”  
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The support system was another factor which helped patients to overcome and cope with 
cancer. The support that the patients have is mainly from their families and social context, 
and in some cases there was some support and education from the health care providers. A 
patient said in her answer toward the inquiry about support from the health team;  
 
“The nurse is the one who was helping us, he is the one who is giving us the treatment and he 
is the one who is providing advices and education.”  
 
Moreover, patients expressed their satisfaction with all types of help and support from 
anyone in the community, and they stressed on the psychological and emotional effects of 
that type of support for overcoming the crises of cancer, especially in the absence of any 
other specialized or professional support system. In that context a 42 years old cancer 
patient from Jenin said;  
 
“All of them helped me… my husband, my relatives, and the neighbors... thank God, but the 
help of my husband was the most. They were all with me on the day of my surgery, which 
really made me relaxed; I went into the surgery calm and reassured as they were around me… 
off course;  the family provides help, thanks God.”  
 
Another patient who is 70 years old and has colon cancer said; 
 
“I swear by God that nothing helped me at all, no body except of my children who helped me.”  
 
4. Patients’ beliefs regarding treatment. 
 
Patients’ beliefs and understanding regarding their treatment for cancer were classified into 
two parts; toward curative medicine and toward other integrative modalities of medicine. 
Informants’ attitudes were either positive or negative towards these treatments according 
to their experiences. A patient from the south said;  
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“last thing, I had severe pain in my abdomen and in my back, maybe due to the large amount of 
medication which I am taking; as any medication may affect the liver, and I am trying to avoid 
such thing and take care… maybe I should bear the pain better than bearing the medication side 
effects.”  
Another patient from the north said;  
 
“They told me take Anise, Chamomile, and other herbs… with no benefit, no benefit at all.”  
 
5. Barriers to service delivery. 
The barriers were classified into economical, political, and policy and regulation. The 
economic barriers were treatment related expenses such as costs of transportation, and 
food and accommodation for the companion, which are usually not easy for them to 
handle. Therefore, there is need for policy and regulations that enable easy access to 
treatment centers and accommodation facilities that would decrease patients suffering. This 
was expressed by one patient while explaining her problem;  
 
“The transportations are not covered by the insurance, as well as accommodation and food. I 
hope if they can provide bus to take us to hospital, I am not satisfied with the distance I travel, 
it is hard for me. I hope there is nearer chemotherapy treatment for us in Hebron.”  
 
The political barriers are related to difficulty in accessing hospitals for treatment because 
of check points and need for permits to enter East Jerusalem. Moreover, travelling for long 
distance from north to south. A 34 years old patient from Nablus area explained her 
struggle with access to care to East Jerusalem hospitals as follows;  
 
“And the way to hospital has many, many difficulties… on the metal rotating barriers and at 
the checkpoints… too much. I have to change my address to AL-Ram because it is easier for 
me to do the permit paper there. My brothers are all young men, and they were abundant and 
forbidden from passing the wall checkpoint. I was in Augusta Victoria and Makkasid 
hospitals… everybody has his relatives around him, and I was setting alone in my bed like a 
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monkey… I swear by God, I was feeling strangled, I hoped there is anyone of my brothers 
there… of my family… that would be of great help.”  
 
6. Satisfaction of patients with service delivery. 
Patients’ satisfaction is one of the important themes derived from their responses to open 
ended questions. Those classified as with healthcare personnel, medical equipments, 
supplies, services, and referral system.  
Some respondents were dissatisfied with healthcare personnel, medical treatment plan, 
pain management, assessment routine, diagnostic testing, and alternative remedies. A 
lymphoma patient from the south said;  
 
“The doctor said to me not to take medications for the chemotherapy treatment, but only 
Paracetamol, they told me to take that for pain, indeed, it did not work, it was good in 
decreasing headache… I was immobile and struggling with pain for days.” 
 
Another patient from the north said;  
 
“There is medication for pain… or maybe there is not… I don’t know. When I have pain, they 
told me you will get used to it with time and the pain will fade… I think they were not telling 
the truth.”  
 
On the other hand, some respondents expressed their satisfaction with the health care 
providers and their hard efforts to meet the high need and load of patients with their limited 
numbers and capacities. A 60 years old patient from Hebron said;  
 
“I have good trust in the team, they are good… excellent, the nurse here is extra excellent.” 
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There was also “service provider induced demand” in some cases. This was through 
guiding patients to use some healthcare services instead of others; even it was sometimes 
costly and difficult to reach for patients. A 41 years old female patient with breast cancer 
told her story when she had mastectomy surgery;  
 
“We have insurance, but first action we had gone to a private doctor who referred us to a 
private hospital. This is not good from the doctor… he knew that we have insurance, and we 
are poor, and the surgery costs a lot. He was supposed to refer us to the governmental hospital, 
they can do the surgery not less competently, he should refer us… but he didn’t. We did pay a 
lot of money to the private hospital.”  
 
Moreover, some respondents were not satisfied with psychosocial support and 
communication of healthcare professionals. Mainly, in communicating bad news to 
patient and family, and dealing with them in anger and toughness, not helping or 
supporting them, hiding the truth about the disease, unavailability of care and support over 
the phone, unethical attitude toward patients, and not enough or missing explanation and 
education. One of the respondents said; 
 
“The doctor informed me in coldly lethal nerves, as if telling me you have flu: you have a 
malignant cancer in your brain… I fainted on the spot; I was on the ground unconscious. When 
I was awake again … he informed me it needs operation and surgical resection… again, and as 
the first time. That made me mad… two times, I was informed in the same way, as telling a 
story.”  
 
On the other hand, some patients were satisfied with staff communication, sharing in 
decision making about their disease and treatment plans, providing advices and 
instructions, and availability of support over the phone.  
 
“The doctor informed me that it is a small lump, and you have to decide with your family… 
imagine, I was born again, I took my decision. This is a human being, he treated me as human 
being… indeed, I am no-more sick after that.”  
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Other source of dissatisfaction was with health education and awareness provided to 
patients and their families. This included insufficient teaching and explanation, absence of 
educational and awareness material and brochures, and inadequate instructions to deal with 
the disease symptoms and side effects. A patient of 41 years old said;  
 
“Indeed, all respect is due to my nurse, more than anybody else. That is because the physician 
wrote the order only, but the nurse gave us the advices, for all patients, not only me, but for all 
… may God will reward him the best remuneration ever.”  
 
A second theme was related to medical equipments, supplies, and services. This included 
dissatisfaction with quality and scarcity of some diagnostic testing and examination at the 
governmental health system. A 46 colon cancer patient from middle said;  
 
“There are some tests available in the government, but others are available outside, not all tests 
are available.”  
 
Also it was mentioned by some respondents the unavailability of medicine and symptom 
management medications sometimes as a source of discomfort. A leukemia patient of 60 
years from the south said;  
 
“The essential medications are available here, but the other medications; we need to buy it 
sometimes from outside pharmacies. The treatment is OK; sometimes there are some shortages, 
but not all the times.”  
 
Moreover, some respondents were unhappy with poor environment, hygiene, cleanness, 
crowdedness, lack of privacy, and small space for clinical care. A 25 years old patient who 
had lymphoma said;  
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“The patients are crowded over each others, there is no privacy. The governmental hospital 
needs to enlarge the areas, so to comfort the patients, it is better for their self-esteem and 
psychology… indeed, when I came to the hospital I get sicker.”  
 
Third theme that was derived from the referral system, coverage of medications and 
procedures include shortage in medications, long waiting lists, complicated referral 
process, and favoritism. One patient said;  
 
“I had surgery in private hospital and paid for it, because it was not available at the 
governmental hospital. I have health insurance, but they kept delaying my surgery… and the 
doctor advised me not to delay my surgery more, he said: it is not good for you. So, I had it in 
private hospital.”  
 
7. Community perceptions of cancer patients.  
 
This included pity feelings with cancer patients, stigmatization of having cancer, 
perceiving it as fatal and serious disease, considering it as punishment from God, and 
sometimes solidarity and help.  
Example is perception of patient as dying person. One patient said;  
 
“The way people look to me is painful; they have pity and sympathy with that poor patient. 
This is too bad, it affects my psychology. Our community does not accept it, they usually say 
may God heal you and preserve you for your kids… they let you feel it is the end of your life.”  
 
Another example of stigmatization is what a breast cancer patient said;  
 
“My mother-in-law wanted to marry her son to another wife… also, people tried not to inform 
me that other cancer patients already died. Also it is hurting when people say cancer is a 
hereditary disease, this stigmatizes my daughters.” 
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Also, a male leukemia patient said;  
 
“It is terrifying disease, people perceive it as dangerous… they are usually asking about the 
cancer patient… how is he? Did he die? Is he still alive?” 
 
Another example for punishment is the opinion of a 41 years old female patient; 
  
“People think that cancer patients are not faithful people, they are not believers that this is 
ordeal and test from God… they say that this person did mistakes so he got cancer.”  
 
An example of solidarity and support is in what a 46 years old breast cancer patient 
expressed;  
 
“Everybody was kind with me, supporting my spirits, was good to me, compassion and 
cooperative… thanks God.”  
 
And what a 70 years old colon cancer patient stated;  
 
“People… they don’t help at all… nothing at all.”  
 
Expressed Patients’ Needs  
 
Respondents’ needs were related to treatment plan, financial support, psychosocial support, 
and system management. This included good interpersonal, professional, supportive 
relationship; such as telling truth and communicating bad news. A 60 years old male from 
the south said;  
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“They hide the news from me… the doctor had told my children. It was by chance that I heard 
them speaking, they should told me, because hiding the truth is not good. I hope they told me, 
that would be much-more nicer and better, but hearing them speaking by chance, that’s really 
bad, it affected me indeed.”  
 
Another 34 years old female from the north said;  
 
“I was calling for somebody to check my I.V canula, I mean, the least thing to ask for, he said: 
I am busy, call someone else, call the doctor; you see; I feel like I am a bad guest at their 
home.”  
 
It, also, included sharing information, decision making, and health education. A breast 
cancer patient from Hebron area said;  
 
“Dealing with the disease is ok for me; I do what doctors are saying, I have no experience in 
such things. But I like everything to be clear for me; I want to know everything about my case 
and my disease.”  
 
Also, this included availability of medication, diagnostic tests, supplies, and cosmetic 
prosthetics and materials. One patient said;  
 
“When the medication is not available, we buy it by cash, and moreover, these tests are very 
expensive, a thousand and a thousand and eight… it should be available; sometimes we were 
obliged to do them outside.”  
 
Financial support to cover transportation costs, house sanitation, extra expenses 
associated with disease and treatment such as food and accommodation. A patient from 
Nablus area who was coming to the south for treatment said;  
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“The way from Nablus is very far, I need at least a hundred shekels just for transportation, not 
counting any food or drink.”  
 
Also, this included social and psychological, spiritual and emotional support. One patient 
said; 
 
“Every human, especially the patient, needs counseling. But I did not find anybody to cover 
this need in the hospital.”  
 
Moreover, it included need for support groups. A cancer patient from Jenin articulated 
the support of a cancer survival;  
 
“All cancer patients whom I know had died, but only this woman survived. She had talked to 
me and helped me, she improved my spirits and morale, she had the disease and she is still 
alive!”  
 
Also, respondents stressed on healthcare provision management related needs such as 
better waiting time management, referral availability, palliative care availability, enough 
capacity and facility, and screening and early detection services, workload management 
and organization of flow of patients especially in the outpatient clinics. A patient who was 
in several hospitals for treatment for her cancer for the last two years said;  
 
“It is the order in the outpatient clinics, there is no order; I am usually from 10am till 6pm, also 
in the other hospital; they thought I am crying because I am angry with my husband or my 
family… but, I am here since 7am, waiting till 1pm for the result of the blood test… I ask 
them, but they say: do you think you are the only one at the hospital… indeed, I am the first 
one here, even before they start their work in the morning… when I do the blood test outside in 
a lab, it takes five minutes, but they do not accept it.”  
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Other needs related to accessible, well equipped health services. One of the comments was;  
 
“They took me to Ramallah… they did not have a free bed for me. I wish there is a near 
treatment center… I wish indeed.”  
 
5.4 Summary  
  
The quantitative part main results were the poor GQoL (41.8%), the poor functionality, and 
the severe symptoms of the Palestinian cancer patients. These included fatigue (66.6%), 
pain (63%), and insomnia (56.4%), financial difficulties (64.6%). Many socio-
demographic and clinical factors found to be statistically significant at (p<0.05) in relation 
to the GQoL, QoL functions, symptoms severity, and financial difficulties. The most 
common factors were stage, educational level, department of care, region, and monthly 
income. Other significant relationships were between GQoL with FA, NV, PA, DY, SL, 
AP, CO, DI, and FI. Moreover, there was a significant relationship between educational 
level of participants and their cancer stage. Predictors of poor QoL were advanced stage of 
cancer (β= -0.37, p<0.001), low income (β= 0.19, p=0.001), low educational level (β= 
0.12, p=0.04), and long duration of treatment (β= -0.12, p=0.04).  
The qualitative part of this study generated eight themes which were affecting respondents’ 
daily life, personal perceptions of cancer, factors affecting coping status with cancer, 
patients’ beliefs regarding treatment, barriers to service delivery, satisfaction of patients, 
patients’ needs, and community perceptions of cancer patients.  
The results of this study are supporting the need for palliative care service for those 
patients to control their pain and symptoms in order to improve their QoL, the need of 
integrating palliative care within the Palestinian healthcare system and health policies, and 
provided base line data of the QoL of cancer patients in Palestine. 
 
  
 
 
 
 
 
 
 
 
Chapter Six  
Discussion and Conclusion 
 
6.1 Introduction   
This study provides basic understanding of factors affecting the Palestinian cancer patients’ 
perception of their QoL and their symptoms management. Also, it assessed the scores of 
the Quality of life domains of cancer patients in Palestine using a statistically significant 
and representative sampling size. As well, it included a qualitative part, which provided 
some vital information that is unique and specific to the Palestinian cancer patients.  
Moreover, it identified predictors of poor QoL and functions. This is important because this 
is how we can prioritize our endeavors toward improving the QoL of cancer patients, 
particularly under current economical, social, and political conditions.  
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The following sections discuss the main results of this study; it includes QoL of Palestinian 
cancer patients and the factors affecting it, the predictors of poor QoL, comparison with 
other studies in the same field, as well as, some other issue that was highlighted through the 
study such as significant family role and the desperate need for palliative care integration 
within the national health care system. Moreover, recommendations for policy makers, 
healthcare organizations and researchers were highlighted.  
6.2 Quality of Life of respondent cancer patients  
QoL of the respondents were very poor (41.8%) in comparison with other studies from the 
region. Also, when using the 33% cut-off point the majority of respondents (79.4%) were 
below the good functioning point. In a study in Kuwait, the GQoL was 45.3% with poor to 
average functioning (Alawadi & Ohaeri, 2009). In Turkey, Pinar et al (2003) GQoL was 
66.2 out of 100 points. In a study in Iran, QoL was fairly favorable (66%) or favorable 
(23%) in cancer patients (Dehkordi et al, 2009). This was statistically and clinically 
significant and reflected on all aspects of patients’ life. 
Also, there was significant relationship between QoL and educational level, income, 
department of care, stage of cancer, duration of treatment, and region. As well as, there 
were significant effects on QoL from FA, NV, PA, DY, SL, AP, CO, DI, and FI. Predictors 
of QoL were respectively arranged according to degree of effect as the stage of cancer (β= -
0.3, p<0.001), monthly income (β= 0.19, p=0.001), educational level of patient (β= 0.12, 
p=0.04), and duration of treatment (β= -0.12, p=0.04).  Moreover, QoL was worse than 
national and international data (Dweib, 2011; Samara & Saca, 2009; Alasadi & Ohaeri, 
2009; Pinar et al, 2003; Scott et al, 2007).  
In this study, there was no significant relationship between GQoL and place of treatment, 
house ownership, living condition, and marital status, person taking care of the patient, 
place of residence, age, and gender. Whereas major associations with HRQoL were found 
in Kuwait with age, stage of cancer, radiotherapy treatment, and fatigue (Alawadi and 
Ohaeri, 2009). On the other hand, in Iran, it was found that no correlation present between 
QoL and age, sex, marital status, duration of disease, economic conditions, educational 
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level, and occupational function; but, with cycles of chemotherapy (more than 2) (Dehkordi 
et al, 2009).  
In the qualitative part of the study, patients expressed their needs for improved QoL 
through describing their feelings, satisfaction and needs. This poor QoL results stress the 
need for intervention to preserve the QoL of cancer patients by better care, early detection, 
holistic multiple team approach, and better pain and symptoms control. This should be done 
on all levels including policy maker, health professionals, organizations in the field of 
cancer care, patient support groups, and patients and their caregivers.  
 
6.2.1. QoL Domains / Functions:  
Most of the functions were below the half of the full function. The means were between 
46% and 60.5%. Pain and fatigue were found to be significantly and strongly correlated in a 
negative relationship with all the functions. Also, when using the 33% cut-off point, the 
majority of cancer patients (especially PF, EF, and SF) were below the good functioning 
point, which intensifies these results.  
General look at the results of this study, in comparison with other studies (table 6.1), 
presents variations in QoL functions that were lower or within the same level of other 
studies (Thweib, 2011; Alawadi & Ohaeri, 2009; Samara & Saca, 2009; Scott et al, 2007). 
This is another indicator for the bad situation for Palestinian cancer patients. This 
emphasizes the need for in-depth studies to explore in more details all aspects of the cancer 
patient life and needs.  
 
6.2.2. Symptoms and Difficulties:  
 
The most distressing symptoms and difficulties in this study were fatigue (66.6%), financial 
difficulties (64.6%), and pain (63%). Also, when using the 33% cut-off point, the majority 
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of cancer patients experienced very bad symptoms and high financial burden (almost two 
thirds of the patients were in the high burden area).  
Qualitative interviews supported this finding. This was clearly stated by 34 years old cancer 
patient;  
 
“I have a lot of fatigue; I feel tired when I take the chemotherapy, sometimes I fall unconscious 
when I am at the hospital, also, there is pain in my back… I can’t take it anymore, all the times 
I am in the bed” 
 
Other studies presented similar findings. Pain and fatigue were the most prevalent and 
severe among majority of cancer patients in many studies.  Also, these were found 
associated with QoL and adverse outcomes such as depression, functional decline, and 
patient misery (Meier and Brawley, 2011; Alawadi & Ohaeri, 2009). On the contrary, Pud 
et al (2008) found better QoL in patients with less fatigue and pain. 
This was indicator of the harsh conditions that the cancer patients live in, especially within 
the Palestinian context under the known fact of poverty and the Israeli occupation policies, 
which is affecting access of users to care.  
In summary table (6.1) shows that Palestinian patients QoL is the poorest if compared to 
Kuwait, Turkey, and UK cancer patients.  
The poorer QoL of Palestinian cancer patients on comparison might be due to the 
deteriorating socio-economic and political situation in the country, or lack of professional 
and specialized care to support cancer patients.  
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 Table (6.1): Comparison of GQoL, QoL functions, most severe symptoms, and financial 
difficulties of cancer patients in different studies.   
 
 Current 
study  
Palestine 
(Khleif, 
2012) 
QoL Cancer 
Palestine 
(Thweib, 
2011) 
QoL Breast 
Cancer  
Palestine * 
(Samara & 
Saca, 2009) 
QoL Breast Ca  
Kuwait 
(Alawadi & 
Ohaeri, 2009) 
QoL 
Cancer 
Turkey  
(Pinar et 
al, 2003) 
QoL 
Cancer  
UK  
(Scott et 
al, 2007) 
 
GQoL 
 
41.8% 48% 49% * 45.3% 66.2% 63.8% 
 
PF 
 
48.5% 47.8% 55.4% * 52.6% --- 79.7% 
 
SF 
 
50.0% 49.2% 45.8% * 61.2% --- 72.4% 
 
EF 
 
46.0% 48.4% 44% * 60.3% --- 74.9% 
 
CF 
 
60.5% 57.6% --- 59.9% --- 82.7% 
 
RF 
 
48.8% 47.8% --- 55.1% --- 55.1% 
Most 
severe 
symptoms  
FA (66.6%) 
PA (63%) 
SL (56.4%) 
SL (59.5%) 
FA (59.2%) 
PA (58.5%) 
Spirituality PA, DY, SL, and AP --- FA, PA 
FI  64.6% 52.3% --- --- --- --- 
*In this study, results were calculated using linear transformation of the Likert scale.  
 
6.3 Factors associated with poor QoL and worse Symptoms 
 
Many factors identified through this study to be associated with poor QoL and worse 
symptoms and difficulties. These were grouped into sociodemographic factors and clinical 
factors as follows.  
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6.3.1. Associated Sociodemographic Factors:  
These included the factors that were mostly discussed in the literature as associated factors 
with QoL of cancer patients. These were gender, age, marital status, education, income, and 
region.  
 
Gender 
Distribution of females to males in the study sample (58.2% to 41.8%) was similar to that 
of the cancer patients’ distribution in Palestine (54.3% to 45.7%) according to MOH report 
of 2011. But gender was not statistically significant with any of the QoL domains or 
symptoms. Also, there was no difference noticed in responses of patients to in-depth-
interviews between males and females in expressing their needs or satisfaction. However, 
Guner et al (2006) found in their study of Turkish cancer patients that women perceive less 
negative impact of cancer on their lives than men do.  
 
Age 
In this study Mean age was 52.7 years (SD=15.2) where younger patients had significant 
better in their physical and role functions and less fatigue. However, there were no 
significant relationship between GQoL and age. On the other hand, other studies found that 
older cancer patients have lower QoL (Guner et al, 2006; Pinar et al, 2003; Koo et al, 
2012). On the contrary, Alawadi & Ohaeri (2009) found in their study of Kuwaiti cancer 
patients that there were more symptom intensity and worse functioning in younger patients.  
Qualitative results showed perception of cancer as a fatal disease and representing the end 
of life, but that was not apparent to be linked to being older. However, Guner et al (2006) 
stated that older cancer patients believed that cancer is the end of the road and had low 
expectations of themselves as well as of the society, the thing that negatively affected their 
QoL.  
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Also, results of this study showed that older patients had more fatigue and poorer physical 
and role functions.  
 
Marital status and family support  
 
In this study, there was statistical significance between marital status as being married and 
poor physical function and more financial difficulties. Guner et al (2006) found that highest 
QoL was in unmarried as they have less family responsibilities, while worst QoL was in 
widows as they lack the support of both family and spouse.  
On the other hand, in the qualitative part, patients expressed high perception and value of 
family support, help, and encouragement, especially the supportive role of spouse. Also, 
having children and family was a factor that helped them overcome the disease and gave 
them power to fight it. Patients stressed on the psychological and emotional effects of that 
type of support for overcoming the crises of cancer, especially in the absence of any other 
specialized or professional support system.  
This indicates the important role of family support within the Palestinian context; 
especially that 90.7% of patients in this study are living with their families and 41% 
expressed that someone from the family members is taking care of them in their sickness. 
The Palestinian culture and society highly value the solidarity of the community members 
as a whole, and specifically the close family members. This is unique in the Palestinian 
culture; people help and support each other on different aspects either physically, socially, 
emotionally, or even financially. On the other hand, this is sometimes compensating for the 
missing professional counseling and support system within the health care system in 
Palestine, due to lack of resources and low level of awareness of patients to the need for 
such professional support.  
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Education  
In this study, 57.1% of patients were under secondary education, of which 20.1% were 
illiterates. This was significantly associated with poor GQoL, low functions (PF, RF, SF, 
and EF) and high FA, FI, and PA. Similar results found in literature; illiterate patients had 
the lowest QoL scores (Pinar et al, 2003). Guner et al (2006) concluded that better QoL in 
educated patients may be due to better coping mechanisms, better access, and /or finding 
and benefiting from resources.  
Knowledge is very important in the fight against cancer. Patients expressed knowledge, 
besides their faith, as the tool that enables them to cope through the in-depth-interviews.  
It is clear that educational level has apparent effect on cancer patients’ QoL and symptoms 
experience, and is a predictor for QoL.  
 
Income  
The majority of cases (75.2%) were very poor with an income less than 2000 NIS. This is 
even below the poverty line (2,293 NIS) in Palestine (PCBS, 2012). Also, higher income 
was significantly associated with better GQoL and QoL domains, and worse symptoms and 
financial difficulties.  
Similarly, higher income was associated with better QoL as patients have better ability to 
find resources in less burden and stress (Guner et al, 2006; Alawadi and Ohaeri, 2009). In-
depth-interviews showed that financial difficulties and associated costs have high burden 
on cancer patients.  
This was exacerbated by the fact that most cancer patients’ lose their jobs after they got the 
disease, besides the extra expenses associated with treatment. In addition, FI was worse for 
those living in rented houses, living in the south, less educated, in advanced disease stage, 
hospitalized, and married with more familial responsibilities.  
This indicates the need for social and welfare support system for those patients. The 
government through its ministries, especially ministry of social affairs, has a major role and 
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responsibility toward such intervention. It was clear that it is not enough to have cancer 
treatment free of charge, but also to cover associated expenses and financial burden that is 
unbearable by those vulnerable cancer patients.  
 
Region  
In this study, poorer GQoL, EF, PF, SF, and CF, and more fatigue and financial difficulties 
were found significant in the southern region of the West Bank in comparison with the 
middle or the northern regions. Also, 58.2% of the cases were from the south. In addition, 
this was noticed through patients’ perceptions of cancer in the qualitative part. A 60 years 
old lung cancer patient from Hebron area said;  
 
“I think it is due to the nuclear radiation from the reactor of Dimona in Israel… there are more 
cases in the southern areas.” 
 
This might be an issue, even though; more attention to conditions of patients and available 
healthcare services are needed.  
 
6.3.2. Associated Clinical Factors:  
 
These included the most apparent factors associated with the QoL of cancer patients. These 
were stage of cancer, current treatment, department of care, and duration of disease.  
 
Stage of cancer  
In this study, (71.4%) had advanced stage of cancer. This is higher than international 
figures. For example, advanced cancers recorded 59% in Kuwait (Alawadi and Ohaeri, 
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2009). Moreover, this study found that the stage was significantly high in affecting all 
aspects of QoL functions and symptoms. This is congruent with literature. Alawadi and 
Ohaeri (2009) found those with advanced cancer to have worse functioning. 
In addition, significant relationship found between stage and educational level of patients. 
(88.7% of illiterates had advanced stages of cancer, while 57.5% only of university degree 
patients).  
This is an important indicator of the massive need for intensive awareness campaigns, early 
detection, and education for the community as a whole, and to patients and their families as 
specific. Moreover, education and training of health care professionals on better detection 
and classification of cancer is high priority.   
 
Current treatment 
 
The study revealed that the main type of treatment was the chemotherapy treatment 
(52.2%). There were no significant association between type of treatment and QoL. Similar 
results found by Pinar et al (2003) in Turkey. On the contrary, Alawadi & Ohaeri (2009) 
found significant association of radiotherapy treatment with more fatigue in Kuwait.  
 
Department  
 
In this study, the majority of patients were outpatients (73.7%). However, there was 
significant association between inpatients and poor QoL (functions and symptoms). Pinar et 
al (2003) also found that hospitalized patients had lower QoL scores than patients treated 
on an outpatient-basis.  
Usually, patients with severe symptoms and worse conditions are hospitalized; however, 
more attention to them by healthcare providers and managers is needed.  
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Duration of treatment  
 
This study revealed that majority of patients (62.4%) had long duration with cancer and this 
had significant effect on patients’ QoL. That was not the same in other studies; Pinar et al 
(2003) found that duration of the disease and type of cancer had no effect on QoL.  
This indicates that the longer period with disease the more suffering the cancer patients in 
Palestine have. This emphasizes the need for more care and attention to such patients to 
improve their QoL.  
 
6.4 Determinants of Poor QoL   
 
This study revealed that the poorest QoL among Palestinian cancer patients was related to 
low education, poor financial condition, hospitalization, advanced stage of disease, longer 
duration of treatment, and living in the southern region. Table (6.2) shows the predictors for 
QoL, functions, symptoms, and financial difficulties, in which stage, education, and income 
were the main predictors for almost all of them.  
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Table (6.2): Statistically significant determinants for QoL (functions and symptoms). 
  
Significant Determinants (P<0.05) 
GQoL  ↓ Education, ↓income, in-patient, advanced stage, >6 months 
treatment, south W.B.  
PF Old, ↓ education, ↓income, widow/divorced, in-patient, 
advanced stage, >6 months treatment. 
RF 
 
Old, ↓ education, advanced stage. 
SF 
 
↓ Education, in-patient, advanced stage. 
CF 
 
In-patient, advanced stage. 
EF 
 
↓ Education, ↓income, advanced stage. 
FA 
 
Old, ↓ education, in-patient, advanced stage, >6 months 
treatment. 
FI ↓ Education, ↓income, live in rented house, in-patient, 
advanced stage, south W.B. 
PA 
 
↓ Education, in-patient, advanced stage. 
 
Alawadi and Ohaeri (2009) found that poorer HRQoL scores were associated with younger 
patients, financial difficulty, social function, role function, physical function, cognitive 
function, and emotional function. Other studies found predicting relationship between 
depression and shortened survival (Meier and Brawley, 2011). Scott et al (2007) found that 
role and social functions have greater influence in Islamic countries than UK. While, Cheng 
and Lee (2010) concluded that Chinese cancer patients poorer QoL is associated with a 
cluster of symptoms including pain and fatigue. Rogers et al (2012) found that UK cancer 
patients with more financial burden are associated with poorer QoL. 
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These results are of high value in determining the most vulnerable cancer patients within 
the general population of cancer patients. This would be of great value for policy makers 
and health care planners, for health care providers and professionals, and for fund raising 
and allocation. This would help in determining the priorities, especially under the current 
scarce resources and weak economy in Palestine.  
 
6.5 Important Themes of the Qualitative Part  
 
This study generated many themes from the in-depth-interviews with cancer patients. The 
most important were the patients’ perceptions of their disease and its treatment, patients’ 
expressed needs for better QoL, barriers to service delivery, patients’ satisfaction with 
service delivery, and community perceptions for cancer and cancer patients. Similar 
domains were generated by other international studies. Shahidi, Bernier and Cohen (2010) 
found eight domains upon content analysis of 110 answers of terminally ill cancer patients, 
which were physical condition and symptoms, psychological status, existential, 
relationships and support, quality of care, physical environment and living facilities, 
hobbies and daily activities, and finances. 
 
6.5.1. Patients’ Perception of Cancer and Treatment: 
  
This study revealed cancer patients’ perceived understanding and beliefs toward their 
disease and treatment. The main perceptions of patients were classified into self-integration 
with the disease, shame feeling from being a cancer patient, feeling of guilt from being 
diseased, incurability of cancer, no necessity for pain management, powerlessness against 
cancer, and linkage of cancer causes with surrounding environment and past events and 
sins.  
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Those perceptions were based sometimes on personal ideation, cultural beliefs and values, 
religious beliefs and faith, misunderstanding, poor knowledge, low level of awareness, or 
traditional interpretations.  
Some of these were apparent in literature as well. Mazzoti et al (2012) found that 58% of 
patients perceived their disease as severe, while 44% thinks it is difficult to cure. Dehkordi 
et al (2009) and Mazzoti et al (2012) found that psychological implications of cancer were 
anxiety, fear about future, thinking about the disease and its consequences, impatience, and 
depression.  
Patients perception usually stem from their knowledge and information available to them. 
This; off course, emphasizes the need for extensive programs of rehabilitation and training 
for healthcare professionals in the field of communicating information and supporting 
patients. Moreover, raising awareness and health education and workshops for patients are 
highly needed, especially through better use of media.  
 
6.5.2. Patients’ Needs for Improved QoL: 
 
In the study, 35% of patients expressed that they did not use other places or other services 
outside the hospital. This does not imply that they did not need such services; on the 
contrary, it is an indicator of lack of these services. That is clear through their expressed 
needs for many services in both the quantitative and the qualitative parts of this study.  
One fifth of patients used private sector for needed services, and 31.3% had diagnostic tests 
and got medication and treatment for pain and symptoms relief outside the treating hospital 
of cancer. Also, quarter of patients expressed the need for financial aid.  
This is of high importance for healthcare system policy makers, as well as for the 
healthcare providers and professionals. It is clear that patients have huge economic burden 
on them. This highlights the need for palliative care (PC) service integration into the health 
system in the efforts toward quality improvement and as a measure that is economically 
efficient and cost-effective, not only for the patient, but also for the health care system.  
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A lot of strategies were identified in the literature including; considering PC as a priority 
public health problem, integrating it into the national health policies and develop national 
cancer control policy in the national health plan, education and training, drug availability, 
providing good quality care including home-based care especially as most patients prefer to 
die at home and not able sometimes to afford coming to the hospital, promoting quality of 
care toward whole-person quality care, and family social and institutional support 
(Sepulveda et al, 2002; and Stjernsward et al, 2007a; Meier and Brawley, 2011; 
Silbermann, 2012; Alawadi and Ohaeri, 2009).  
 
6.5.3. Barriers to Service Delivery: 
In this study, the main barriers faced the informants were the expenses associated with 
treatment, and access to treatment because of the distance, and political barriers 
(checkpoints, separation wall, and siege) as result of Israeli occupation. A 34 years old 
patient from Nablus area explained her struggle with access to care to East Jerusalem 
hospitals;  
 
“And on my way to hospital I have many, many difficulties… on the metal rotating barriers and 
at the checkpoints… I have to change my address to AL-Ram because it is easier for me to do 
the permit paper there. My brothers are all young, and they were abundant and forbidden from 
passing the checkpoint. I was in Augusta Victoria and Makassid hospitals… patients have their 
relatives around them, and I was setting alone in my bed like a monkey… I swear by God, I was 
feeling strangled. I hoped there is anyone of my brothers there… of any family member… that 
would be of great help.”  
 
This reflects the heavy burden that patients have besides their misery of having cancer. This 
needs urgent intervention from all; including the Palestinian government, the healthcare 
system policy makers, the donor countries, and the international aid agencies. That might 
be through providing near and easy access to care, and making sure all required treatment 
modalities and diagnostic facilities are available. On top of that is to remove the physical 
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apartheid wall and checkpoints that are preventing patients and families from access to 
care.  
 
6.5.4. Patients’ Satisfaction with Service Delivery: 
The main expressed areas of dissatisfaction were with pain management scheme, boring 
complicated routine, bureaucratic long process to get the referral, favoritism and nepotism, 
sometimes unavailability of medication and diagnostic testing, poor symptom management 
and palliative treatment of associated conditions, inaccuracy or delay in diagnosis or test 
results, and unhygienic environment due to crowding and uncleanness.  
The majority of respondents were dissatisfied with services provided by healthcare 
professionals such as in: psychosocial support, communication and education behavior and 
ability, attitude and ethics, honesty in telling truth, and sharing in treatment decision 
making plan. But an important issue was identified regarding producer induced demand of 
some services with some patients.  
This emphasizes urgent need for the MOH to develop healthcare system policies and 
practices that ensures all needed resources and implements more monitoring on practice, to 
ensure the preservation of patients’ rights.  
 
6.5.5. Community Perception: 
 
In this study, community perceptions were pity feelings with cancer patients, stigmatization 
of cancer, perceiving it as a fatal and serious disease, considering it as a punishment from 
God, and sometimes solidarity and willingness to help. In general patients were unhappy 
with the negative views of the community.  
These findings shed light on the importance of community, as well as, the need for 
awareness campaigns toward better understanding and support for cancer patients in their 
fight against cancer.  
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 6.6 Conclusions and Implications  
 
These results suggest the need for early detection and awareness among cancer patients and 
their families, as well as awareness and education of health care providers for better care 
and symptoms management to achieve better QoL for patients. More important is the 
desperate need for integrating palliative care into the health care system in Palestine as an 
economically efficient, cost-effective and quality improvement measure.  
This study revealed that the main problem lies within two main streams; the socio-
economic factors of the patient, and the ability of the health care system to early detect, 
diagnose, treat, and provide professional support for cancer patients, such as qualified and 
trained healthcare providers in palliative care and symptom management. Stjernsward et al 
(2007a) found that 35 million people around the world are in need and can benefit from PC 
service.  
 
The integrating of cost-effective palliative care services is seen as solution to the burden on 
the healthcare system and patients. This can be done through education, training, and 
awareness to both professionals and patients.  
The results of this research are of high importance for healthcare system policy makers and 
professionals. The results exposed the extremely poor QoL of the cancer patients in 
Palestine, severe symptoms, and extra financial burden. As well, the study suggested the 
need for palliative care (PC) service integration into the health system to improve quality of 
care and as an economically efficient and cost-effective measure.  
Uzun et al (2004) suggested incorporating PC and pain management in service delivery for 
improving QoL of cancer patients. Also, Sepulveda et al (2002) suggested that it is a public 
health issue to deal with people with cancer in the proper way. Moreover, cancer is the 
second leading cause of death in Palestine (MOH, 2012), and palliative care and pain 
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control is a human right (Breitbart, 2011). This emphasizes the importance of such public 
health need.  
Within these endeavors, many gaps defined internationally to bridge in the way to 
implement PC programs. Of these; are considering PC as a priority public health problem, 
integrating it into the national health plans and develop national cancer control policy, 
effective cancer registry, education and training, drug availability, providing good quality 
care including home-based care especially as most patients prefer to die at home and not 
able sometimes to afford coming to the hospital, valuing competent palliative medicine, 
including PC requirements in the training programs of professionals, promoting whole-
person quality care, and family social and institutional support (Sepulveda et al, 2002; and 
Stjernsward et al, 2007a; Meier and Brawley, 2011; Silbermann, 2012; Alawadi and 
Ohaeri, 2009).  
 
6.7 Recommendations  
 
The results of this research are of high importance for healthcare system policy and 
professionals. This research is recommending the following notes;  
 
For the policy makers:  
 
1. Considering palliative care (PC) as a priority public health problem, integrating it 
into the national strategy for cancer. 
2. Integrating palliative care service into the health care system within the efforts 
toward quality improvement, and as a quality measure that is economically efficient 
and cost-effective.  
3. Providing good quality care including home-based care, especially as most patients 
prefer to die at home. 
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4. Valuing competent palliative medicine through education and training, and 
including PC requirements in the training programs of health care professionals. 
5. Promoting quality of care toward whole-person quality care; through system 
redesign and family social and institutional support.  
6. Having effective comprehensive prevention programs for cancer, to be implemented 
through health care system redesign. 
7. Improving quality health information systems, especially the cancer registry 
program, in order to improve data availability and consistency and accuracy. This 
will facilitate further researches and will provide better quality data for decision 
makers and stakeholders. 
8. Financial support for cancer patients, through effective role of the government 
ministries, especially the Ministry of Social Affairs.  
9. Having PC and symptoms management facilities in all areas around country, 
especially in the case of cancer patients as they are the most vulnerable population 
among all patients.  
10. Ensuring drug availability, especially those for control and management of cancer 
symptoms, and adopting essential drug list based on the international essential drug 
list for palliative care.  
11. Promoting health policies toward better advocacy and increasing awareness about 
cancer, screening, and early detection and treatment. And also address 
stigmatization of patients.  
12. Monitoring system for proper practice and provision of oncology health services.  
 
For the healthcare organizations that provide care for cancer patients:  
 
1. Promoting education on pain management and ensure correcting of wrong beliefs 
and myths, such as those related to pain management and addiction.   
2. Education and training of staff on issues related to PC, pain and symptom 
management, and communication skills.  
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3. Ensuring better management of time, especially the waiting at the outpatient 
departments.  
4. Working on formation of multidisciplinary teams, and integrating them in the care 
of cancer patients. 
5. Providing education and training for patients and their families regarding symptoms 
control and self care, especially at homes.  
6. Providing psychological support and education on issues related to disease, 
treatment, and coping mechanisms with cancer for the patients and their families.  
7. Planning health services to consider the entire life perspectives of the patient and 
not only focusing on the disease itself.  
8. Involve patients in the treatment decision making plan.  
 
Further research  
1. Prospective longitudinal cohort studies in the field of QoL of cancer patients. 
2. Disease specific research studies for different types of cancer; especially for breast 
and colon cancers as they are the most dominant in Palestine.  
3. Further studies in specific fields such as symptom control and pain management 
availability and skills,  
4. Further studies for cancer patients’ satisfaction with the provided health services. 
5. Assessment of quality of health services provision for cancer patients.  
6. More concentration on the cognitive part of the assessment tool, which showed low 
reliability in this study, as well as other regional studies.  
 
6.8 Summary  
 
The results of this study about quality of life of cancer patients were of high value and 
importance to the health policy makers and health care professionals in Palestine. Even 
though these results emphasized the international fact that the QoL of cancer patients is 
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usually poor and in need for many interventions, this study articulated the problem 
specifically in Palestinian cancer patients. This study clearly indentified the acute need for 
development of policy and clinical intervention, especially within the unique Palestinian 
context under the Israeli occupation restrictions and rules.  
Moreover, the results of this study are supporting the need for palliative care service for 
those patients to control their pain and symptoms in order to improve their QoL, and the 
need for integrating palliative care within the Palestinian health care system and policy as 
an efficient tool for reform.  
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Meetings and Personal contacts: 
• Head of oncology department at Beit Jala Hospital (May 2012): number of cancer 
cases at the hospital and hospital share of all cancer patients in West Bank of 
Palestine, Personal contact.  
• Oncologist at Beit Jala Hospital (May 2012): number of cancer cases at the 
hospital and hospital share of all cancer patients in West Bank of Palestine, 
Personal contact.  
• Quality manager at Beit Jala Hospital (May 2012): number of cancer cases at the 
hospital and hospital share of all cancer patients in West Bank of Palestine, 
Personal contact.  
• In-charge nurse of the chemotherapy unit at Beit Jala Hospital (May 2012): 
number of cancer cases at the hospital and hospital share of all cancer patients in 
West Bank of Palestine, Personal contact.  
• Head of oncology department at Agusta Victoria Hospital (May 2012): number of 
cancer cases at the hospital and hospital share of all cancer patients in West Bank 
of Palestine, Personal contact.  
• In-charge nurse of the chemotherapy unit at Augusta Victoria Hospital (May 
2012): number of cancer cases at the hospital and hospital share of all cancer 
patients in West Bank of Palestine, Personal contact.  
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• Patients’ services manager at Augusta Victoria Hospital (May 2012): number of 
cancer cases at the hospital and hospital share of all cancer patients in West Bank 
of Palestine, Personal contact.  
• In-charge of Medical records at Augusta Victoria Hospital (May 2012): number 
of cancer cases at the hospital and hospital share of all cancer patients in West 
Bank of Palestine, Personal contact.  
• In-charge nurse of the chemotherapy unit at Watani Hospital (June 2012): number 
of cancer cases at the hospital and hospital share of all cancer patients in West 
Bank of Palestine, Personal contact.  
• In-charge of the records office at AL-Watani Hospital (June 2012): number of 
cancer cases at the hospital and hospital share of all cancer patients in West Bank 
of Palestine, Personal contact.  
• Cancer registry respondent person at Ministry of Health (May 2012): number of 
cancer patients in West Bank of Palestine, Phone call.  
 
Annex (1): Pearson’s correlation: The relationship between GQoL and symptoms associated with cancer.  
Fatigue N&V Pain Dyspnea Insomnia AP Constipation Diarrhea FI 
Global health status/ 
QoL 
R -0.620 -0.391 -0.622 -0.423 -0.447 -0.387 -0.332 -0.224 -0.393
Sig. (2-tailed) < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
N 308 305 308 311 311 311 313 314 314
Fatigue 
R    0.427 0.775 0.467 0.500 0.515 0.415 0.204 0.376
Sig. (2-tailed)   < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
N   302 304 308 308 308 310 310 311
Nausea & vomiting 
R      0.382 0.340 0.279 0.554 0.327 0.251 0.196
Sig. (2-tailed)     < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.001
N     305 310 309 309 310 308 308
Pain 
R        0.429 0.502 0.445 0.382 0.205 0.425
Sig. (2-tailed)       < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
N       309 308 308 310 310 310
Dyspnea 
R          0.335 0.352 0.246 0.167 0.331
Sig. (2-tailed)         < 0.001 < 0.001 < 0.001 0.003 < 0.001
N         314 314 316 314 314
Insomnia 
R            0.417 0.239 0.187 0.230
Sig. (2-tailed)           < 0.001 < 0.001 0.001 < 0.001
N           315 316 314 314
Appetite loss 
R              0.355 0.263 0.239
Sig. (2-tailed)             < 0.001 < 0.001 < 0.001
N             316 314 314
Constipation 
R                0.107 0.242
Sig. (2-tailed)               0.058 < 0.001
N               316 316
Diarrhea 
R                  0.140
Sig. (2-tailed)                 0.013
N                 317
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Annex (2): Thematic Analysis table of the In-Depth-Interviews.  
# Categories   Themes  Subthemes    Quotations Original Arabic statement  
1 Effects of disease 
on daily life  
Physical effects  Helplessness  
 
 
 
Pain  
Helplessness  
 
Helplessness  
 
 
Role confusion  
 
C1: all my strength collapses; I didn’t 
have the power to stand to drink water. 
The pain is the worst; even it is worse 
than cancer itself.  
  
 
 
 
C8: I have a lot of fatigue; I feel tired 
when I take the chemotherapy, 
sometimes I fall unconscious when I 
am at the hospital, also, there is pain in 
my back… I can’t any more, all the 
times I am in the bed.  
ح1 : يدنع ناك ام ،اھلك يتوق راھنتب
برشا موقا ةردق..  ىتح ،ءيش دشا مللاا
هسفن ضرملا نم دشا وھ.  
ح4 :عجو يف ﷲو ..دوجوم عجولا. 
ح6: ضرملا رثا .. تلطب ناك ام رخا
هل ردقا. .سب فيزنلا ينحباذ ّيللا انا. .
ريثك ملا.  
ح8 :ريثك بعتب .. يواميكلا ذخاب اّمل
بعتب. . يف اناو ّيلع ىمغي انايحا
ىفشتسملا. .يرھظ يف ملأ ريصب و ..
ردقا تلطب ..تختلا ىلع دعاق لظب.  
ح9 :قاھرأ ..بعتب ..مروتب يديا.  
 
Social effects  Role confusion  
 
 
 
Role 
performance  
 
Projection  
 
C1: the most important thing to me is 
to be with my kids; their feelings were 
abnormal, I was away outside home, I 
was taking hypnotic and sleep for 
hours, they were lost in that era.  
 
ح1 : عم ةدوجوم نوكا يدنع ءيش مھا
يدلاو .. ريغ ناك يدلاوا روعش
يعيبط ..نكتيبلا ةرب بيغا ت .. ذخا
تاعاس مانا و مونم ..اوعاض ةرتف يف.  
ح2 :راغص مھتاسل يتانب .. يلع نرودب
ريثك ..نھيف موقا شردقب.  
ح5 :اوفاخب دلاولاا ..اوفاخب ةليعلا.  
ح7 :ضيرم ودنع ّيلا رثأتتب ةليعلا لك.  
ح8 :ّايف لوغشم لكلا. . اومدع يلھأ
 ّيلع مھلاح.  
 
Financial effects  Role 
performance  
 
 ح4 :ضرملا رثا ..رادلا بلط .. تنا
ميشغ شم ..ةبعص فورظلا. 
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Sexual life effects Hopelessness  
 
 
Role 
performance  
 
 
C1: I have no desire, I don’t think 
about it, actually nothing is between us 
now. Actually I asked for divorce 
before I had my surgery. 
 
 
C7: After chemotherapy, I feel tired 
when I am back at home. Off course, 
this cause indolence and frigidity at 
home… whatever, it has an effect. 
ح1 :ةبغر يدنع لطب .. يشا يف ام
اننيب ..ءيشلاھ يف ركفا يلاب يف شم.. 
 لبق قلاطلا تبلط اناةيلمعلا.  
ح4 : ىلع و ّيلع ريثك رثا ضرملا
يتليع ..رثأ اعبط ينعي.  
ح7 :يواميكلا جلاعلا يداھ .. عجرب
تيبلا ىلع نابعت دحاولا .. وج لمعي لاا
تيبلا يف لومخ. . نوكي امھم رثأي لاا
دحاولا.  
  
Psychological effects Helplessness  
 
Death anxiety  
 
 
Adaptation  
 
 
C6: They told me you are in need for 
urgent surgery; I was terrified… how 
they are going to open my abdomen!? 
So, I ran away for six months, then I 
was deep down tired, so, I said do it 
and open my abdomen… if I’ll die, let 
me die. 
ح6: جاع ةيلمع يوست كدب اولاقةل .. انا
تفخ ..ينوحطسي مھدب فيك تلق ..
تدرش رھشت تس ..تخرب نيدعب .. تلق
ينوحطصا صلخ ..توما يدب ..
توما.  
ح8 :يلاح تمدع اھلّوأ. . نيحلاھ و
ىفشتسملا يف سب ةفقوم يتايح.  
ح10 :ريثك رثا ضرملا ..ارول انعجر. .
لكاشملا لك يلاّوس ضرملا يناجا اّمل.  
  
2 Personal 
perceptions of the 
disease 
Self integrations  Empowerment  
 
 ح1 :نع راص ضرملا دعب ةميزع يد
ةديدج ..ةديدج ةيصخش و .. دعاسا تنك
ىضرملا و سانلا. 
Shame    ح1 : ةدحولا ينعي ،ةساسح ةطقن اھلظتب
؟بلطت حورت اھدب..  ادح بحب ام انا
عيا يلع فطب ًاد. 
Guilt   
 
Loneliness  
 
 
 
C2: Indeed, I am the only one with 
cancer in all my area of living. 
ح1 :ا ةبسنلاب يسفن ىلع لعزب ان
يزوجل.  
ح2 : انا اھيف انا يللا ةقطنملا يف ينعي
ضرملا اذھ اھيف يللا ةديحولا.  
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 / feileB
  gnidnatsrednu
  yteixna htaeD
 
 nwonknu fo raeF
 
  ytniatrecnU
 
 
 
 
 
 
 
  ssensselpleH
 
 
 
 
 
  yteixna htaeD
 
 
 
  ytniatrecnU
 
 
 
  ytilautiripS
 
 
 
 
 
 
 
 
 
 
 etelpmoc si ereht kniht t’nod I :1C
 esaesid ym kniht I …recnac rof eruc
 rof ypareht lanomroh yb desuac saw
 ti gniyas era elpoep emos ro ,ytilitrefni
 sti dna learsI fo nopaew raelcun eht si
  .anomiD ni seirotcaf
 
 
 
 
 
 
 
 
 s’taht dna eid ot gniog ma I kniht I :3C
 ma I dna htaed snaem esaesid siht ,ti
 lla ,yllautca …eid ot gniog ydaerla
  .deid era esaesid siht htiw esoht
 
 
 
 
 ti ,doG morf si esuac esaesid ehT :4C
 ;ycrem si ti ,tiremed ro emahs ton si
 ti ,esaesid eht yb su gnitset si doG ruo
  .snis fo noitaipxe dna ycrem si
 
 
 
 
 
الالم . .حتمية كنت بفكر انه نھايتي: 1ح
الواحد بصير .. ما في دواء يقدر له
خايفة . (.المورفين) عندو ادمان عليه
لانه في العائلة ھذا المرض ( افحص)
  .موجود
لأ، لا ( للسرطان)شفاء بالكامل : 1ح
سبب مرضي ھرمونات علاج  ..اعتقد
كمان بقولوا النووي في  ..العقم
 .من ديمونا. .أسرائيل، و من المصانع
بستصعب الواحد  دايما في البداية :2ح
. .بس مع المدة لازم يتقبل المرض.. 
ه كثير بفكرش بجوز لاني مش فاھمت
.. لازم الواحد يرضى بقضائه. .فيه
  .لازم يصير.. رظيت ولا ما ارظيت
سب معنويات حالشفاء من المرض : 2ح
.. سبب المرض بجوز ابتلاء. .الانسان
  .بجوز ذنوب
. .اموت و خلصبفكر اني بدي : 3ح
وانا خلص .. ھذا المرض يعني موت
يعني كل اللي صابھم ھذا . .بدي اموت
  .المرض توفّوا
بيقولوا من .. بعرفش منين بيجي: 3ح
  .اللي برشوا فيھا الأكل و من الادوية
. .وﷲ ھذا من ﷲ.. سبب المرض: 4ح
ربنا بمتحنّا .. ھذا رحمة. .فش فيه عيب
 .ذنوبرحمة و تكفير .. بالمرض
.. كلھا شغلات من رب العالمين: 5ح
.. المرض ھاظ بخوف.. بخاف شوي ّ
بده الواحد يتقبل .. ھذا أمر ربنا
اعقل و . .الموضوع و يسلم أمره لربنا
  .توكل
 231
 
  ytniatrecnU
 
  ytilautiripS
 
 
  ytniatrecnU
 
 
 
 
 
  ytniatrecnU
 
 
 
 
 
 
  ssensselpleH
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 gnikat eb ll’I taht gnileef ma I :8C
 ma I deedni ;efil ym lla rof tnemtaert
  .esaesid siht fo esuac eht fo erawa ton
 
 
 
 
 raelcun eht ot eud si ti kniht I :01C
 ni anomiD fo rotcaer eht morf syar
 eht ni sesac erom era ereht …learsI
 .htuos
.. ھذا المرض نھايته معروفة طبعا: 5ح
بعدين الاعمار بيد .. انا متقبل.. الحمد Ϳ
  .ﷲ
في ناس .. ما بعرف سبب المرض: 5ح
.. وفي ناس بقولو القھوة.. بقولو التدخين
  .يعني في شغلات كثيرة
ھي .. السرطان ھذا انا عارف: 6ح
و بقولوا .. ابصر من وين اجت.. عدوية
انا . .ھذا شو اسمو النووي قريب منّا
.. ھذا المرض لّما يصيب خلص.. داري
  .ما الك الا ﷲ
سبب المرض انا بقول من الأكل : 7ح
الظروف البيئية .. اللّي الواحد بياكله
.. او اليھود الھم أثر.. المحيطة فيه
.. بزرعوا الخضرة كلھا مواد كيماوية
بعدين المعلبات و المكبات الكيماوية 
  .كمان
حاّسة انّي رايحة أظلني طول : 8ح
وﷲ ما بعرف شو . .حياتي وانا أتعالج
  .سبب ھالمرض
سبب المرض بحكو انه بعد فترة : 9ح
ممكن بس مش .. من حبوب منع الحمل
  .اكيد
أنا بتوقع انه ھاد من شعاع : 01ح
كل ما .. النووي تاع ديمونة أسرائيل
 .تروح للجنوب في منه زيادة عن اللزوم
 
 gnitceffa srotcaF 3
 htiw noitatpada
  esaesid
 
 laog /tnemtimmoC
 efil ni
  niarts eloR
 
  lanoitomE
 yltsom efil siht ni sevil nosrep ehT :2C
 era yeht taht yllaicepse ;sdik reh rof
  .slrig
عشان  الواحد اكثر اشي بعيش: 2ح
  .بالاخص انھن بنات.. هولادا
 .كنت بس بفكر في اولادي: 3ح
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  tnemrewopmE  srotcaf lanosreP
 
 
 
 
 
 
 
  ssensselpleH
 
 
 
 
 
  ecnatpeccA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 wonk I taht saw em depleh tahW :9C
 si ti eveileb I dna ,si esaesid ym tahw
 I ,doG knaht …sepyt rehto naht reisae
 doG yam …tnatpecca dna tneitap ma
 .)noitacilppus( aaoD yb su eruc
صار عندي القدرة اقاوم اي : 1ح
  . صدمة لقدام
كنت . ..منيح  وجود بيت لحالي: 2ح
قبل اخد الدوا اكون مجھزة كل اشي في 
  .البيت
وجود الخصوصية و البيت : 3ح
  .الخاص كان منيح
.. بصبر.. شو بدي اعمل.. بصبر: 6ح
  .حكمة ربنا
بس الواحد يحاول يبتعد عن كل : 7ح
بعدين الزعل و المعنويات .. اشي بضر
ھاد بأثر سلبي او ايجابي في .. عاليةال
  .تقبل المرض
ساعدني اني عارف شو ھو : 9ح
وبقول ھذا المرض اسھل من .. مرضي
أنا صبورة و . .الحمد Ϳ.. اشي تاني
  .وربنا يشفينا بالدعاء.. متقبل
 
 / feileb suoigileR
  htiaf
  ytilautiripS
  htiaF 
 
 
 
  ssensselpleH
 
 
 
 
  ssensselpleH
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ايماني بربنا .. بس الشفا من ربنا: 2ح
  .قوي
  .بساعد.. قران أقرب.. كنت اصلّي: 3ح
.. الحمد Ϳ.. اللّي من ﷲ منيح: 4ح
 .الأيمان اللّي ساعدني
و .. نفسيتي مرتاحة جدا.. الحمد Ϳ: 5ح
بعدين . .مسلم أمري لرب العالمين
بعدين مفش .. اول اشي الأعمار بيد ﷲ
الأجل مخطوط سواء بالمرض او .. مفر
  .بغيره
  .امشي بالعلاج و ربنا ھو الشافي: 5ح
كل .. وﷲ يوم ﷲ بلطف بلطف: 6ح
  .وﷲ ربنا حكيم.. شي عند ﷲ
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  htiaF
 
 
 
   htiaF
 
 
 
  ssensselpleH
 
 
 
 
 
  ssensselpleH
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 em depleh )doG( hallA ni htiaF :01C
 fo eruc eht dna esuac eht si eh ;hguorht
 eht ni era ew ,yltsrif …esaesid eht
 eht ”ifahS-LA“ si eh ;doG fo sdnah
 ot sdeen nosrep eht dna …relaeh
 …doG ni lufhtiaf eb ot sdeen ,ti tpecca
 neve ,gnihtyreve erofeb si siht ,em rof
  .tnemtaert erofeb
.. عمر المرض ما بموت صاحبه: 7ح
يعني الواحد يخلّي .. الا انتھاء الأجل
الكريم احسن القران . .ايمانه باͿ كبير
  .علاج
.. رحمة.. لأ.. المرض مش عقاب: 8ح
حكالي من فقد .. لدرجة انّي سألت الشيخ
أحدى حبيبتيه في الدنيا عّوضه ﷲ بھما 
  .انشاء ﷲ. .في الجنّة
.. موكلة امري Ϳ.. يعني بتحّمل: 9ح
انا زي ما . .الحمد Ϳ.. ومعنوياتي كاملة
كثر  يعني ھيك من.. تقول انسانة مؤمنة
  .الدعاء ربنا يصبّرني
حطّو  اللّي.. ساعدني الأيمان باͿ: 01ح
مسلّمين أمرنا لرب العالمين .. بشيله
بّدو . .الّشافي ھو ﷲ. .درجة أولى
. .بّده يكون مؤمن باͿ.. الواحد يتقبّل
  .قبل العلاج.. عندي اياھا قبل كل شي
 
 dna laicoS metsys troppuS
 troppus lailimaf
 
 
 
 
 
  metsys troppuS
 
 
 
 
 
 
 
 
 ym …em depleh meht fo llA :3C
 eht dna ,sevitaler ym ,dnabsuh
 fo pleh eht tub ,doG knaht ...srobhgien
 erew yehT .tsom eht saw dnabsuh ym
 ,yregrus ym fo yad eht no em htiw lla
 tnew I ;dexaler em edam yllaer hcihw
 sa derussaer dna mlac yregrus eht otni
اخي ھدفه انه تظل عزيمتي قوية : 1ح
والدتي كانت تيجي . .و حياتي طبيعية
ناجية )بنت خالتي . (.مرافق)معي 
اتصلت علّي قبل الكيماوي و ( سرطان
بساعد . .ھذا ساعدني.. قالت ما تخافي
مرات، خصوصا ًالأھل و ( المجتمع)
  .القرايب
لما الواحد  ..خواتي بساعدوني: 2ح
  .بحس معنوياته احسنالناس بھتمو فيه 
قرايبي  جوزي و ..كلھم ساعدوني: 3ح
بس جوزي اكثر . .الحمد Ϳ.. و الجيران
.. يوم العملية كانو كلھم معي. .اشي
 ادخلت على العملية و ان.. ارتحت كثير
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 eht  ;esruoc ffo …em dnuora erew yeht
  .doG sknaht ,pleh sedivorp ylimaf
 
 
 
 
 gnihton taht doG yb raews I :6C
 ym fo tpecxe ydob on ,lla ta em depleh
  .depleh ohw nerdlihc
 و الاصحاب العيلة والقرايب: 5ح
ما احتجت .. كانو يشجعوني. .ساعدوني
  .الكل شجعني ما تخافش. .حدا مختص
.. وﷲ ما اشي ساعدني من مّرة: 6ح
  .ما عدا ھالاولاد ساعدونيحدا ولا 
.. ي بساعدلّ لجوزي من النوعية ا: 7ح
والكل . .يعني ھو اكبر افادة في حياتي
.. الحالة النفسية اھم شي.. وقف معي
  .برفع معنويات الواحد.. كلھم شجعوني
.. برفع المعنويات اللّي حواليك: 7ح
  .العيلة و الزوج و الأھل
لوما جوزي صابر علّي و : 8ح
.. وألا كان ما تحّملت حالي.. متحملني
  .كان زمان موتت حالي
يعني يرفعوا من .. كانوا ينصحوني: 9ح
  .معنوياتي
.. الممرض ھو اللّي كان يساعدني: 1ح
ھو اللّي بعطينا العلاج و ھو اللّي 
  .بعطينا النصائح
 lanoisseforP
 troppus
 saw ohw eno eht si esrun ehT :1C
 gnivig si ohw eno eht si eh ,su gnipleh
 ohw eno eht si eh dna tnemtaert eht su
  .noitacude dna secivda gnidivorp si
والكل .. كان يقول النا الكل بوخذ: 9ح
يعني يخلّي الأطمئنان على .. ھيك
  .قلوبنا
 seveileb s’tneitaP 4
 gnidrager
  tnemtaert
 evitaruC drawoT
  enicidem
 ym ni niap ereves dah I ,gniht tsal  :7C  gnileef niaP
 eud ebyam ,kcab ym ni dna nemodba
 noitacidem fo tnuoma egral eht ot
 noitacidem yna sa ;gnikat ma I hcihw
 ot gniyrt ma I dna ,revil eht stceffa
 …erac ekat dna gniht hcus diova
 retteb niap eht raeb dluohs I ebyam
  .noitacidem eht gniraeb taht
  .اعقل و توكل: 4ح
اخر شي صابني وجع بطن و : 7ح
. .احتمال من كثر الأدوية.. ظھر كثير
والواحد .. مھو كل علاج بأثر على الكبد
يعني الواحد .. بحاول يتواقى ويدير باله
كن يتحمل الوجع اكثر ما يتحمل مي
  .الأدوية
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Toward Integrative/ 
alternative medicine  
 
 
Hopelessness  
 
 
 
 
 
C3: They told me take Anise, 
Chamomile, and other herbs… with no 
benefit, no benefit at all.  
ح1 : برشا و هايم ىلع يلوأرقي وناك
اھنم ..ةقانلا بيلح تبرش و. 
ح2 :قاين بيلح تبرش ..حينم وكحب.  
ح3 :نوسناي يذخ وكحي وناك ..جنوباب ..
باشعا ..داف ام ..يضافلاع.  
ح5 : عبت تايناحورلا ياھ يف شنماب انا
خويشلا.  
 
5 Barriers to service 
delivery  
Economical barriers   C1: The transportations are not 
covered by the insurance, as well as 
accommodation and food. 
ح1 :أ نيمأتلا اھيطغب ام تلاصاوملا و
فيراصملا و مونلا.  
 
Political barriers    
 
C8: And the way to hospital has many, 
many difficulties… on the metal 
rotating barriers and at the 
checkpoints… too much. I have to 
change my address to AL-Ram 
because it is easier for me to do the 
permit paper there. My brothers are all 
young men, and they were abundant 
and forbidden from passing the wall 
checkpoint. I was in Augusta Victoria 
and Makkasid hospitals… everybody 
has his relatives around him, and I was 
setting alone in my bed like a 
monkey… I swear by God, I was 
feeling strangled, I hoped there is 
anyone of my brothers there… of my 
family… that would be of great help.  
ح1 :سدقلا ىلع حورا تنك امل تبلغت.  
ح2 : يف ناكس تب لمعا مزلا
ليئارسا ..ةليوحتلا يف بلغت يزوج و ..
ينما عنم ةسل يف اذا فرعب ام و.  
ح8 :ريثك ريثك ةبلغ اھيف قيرطلا و ..
ربعملا ىلع و تاطاّعملا ىلع .. ينعي
ريثك. . ناشع مارلل يناونع تّريغ
لھسا كانھ حيرصتلا لمعا. . يناوخا
بابش مھلك .. ىلع اوّرمي مھوعنمي اوناك
ربعملا .. و علطملا ىفشتسم يف ناك
دصاقملا ..ھا مھيلاوح سانلا لكلمھ ..
ةدعاق ةدرقلا يز اناو يلاحل. . ﷲو
ميظعلا ..ةقونخم ينا سحا .. ادح يف ول
يناوخا نم ..يلھأ نم ..ريثك دعاسب.  
ح9 :هاأ ..ةبلغ يف ..ميساحملا نم ..
ﷲو ةينامث ةعاسلا يتيب نم علطأ ..
قيرطلا يف ناو ءاشعلا نّذأي تارم ..
يوسن اندب وش سب. 
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أول .. غلّبونا.. ااه.. التصاريح: 01ح
رفضوني .. أمني شي اجاني مرفوض
.. بعديھا أجا تصريح يوم واحد.. أنا
  .غلبة تتدخل القدس.. غلّبونا وﷲ
 
 ot sub edivorp nac yeht fi epoh I :1C   sreirrab ecnatsiD
 deifsitas ton ma I ,latipsoh ot su ekat
 rof drah si ti ,levart I ecnatsid eht htiw
 .em
للوصول )لو انه يوفروا باص : 1ح
مش مرتاحة مع . (.لمركز العلاج
 .صعبة علينا.. المسافة
.. يعني مشوار الطريق بغلب شوي ّ: 5ح
  .اليوم كانت رايقة فش محاسيم
 
 reraen si ereht epoh I :1C  noitaluger & yciloP
 ni su rof tnemtaert yparehtomehc
  .norbeH
ياريت يكون علاج كيماوي قريب : 1ح
  .الخليلفي 
 
 htiw noitcafsitaS 6
  yreviled ecivres
 htiw noitcafsitaS
  lennosrep
 lacideM
 nalp tnemtaert
 niap dna
 tnemeganam
 
 
 
 
 
 
 
 ot ton em ot dias dah rotcod ehT :2C
 yparehtomehc eht rof noitacidem ekat
 yeht ,lomatecaraP ylno tub ,tnemtaert
 ti ,deedni ,niap rof taht ekat ot em dlot
 ni doog saw ti ,tuo ti krow ton did
 elibommi saw I …ehcadaeh gnisaerced
  .syad rof niap htiw gnilggurts dna
 
 
 
 yeht ,maet eht ni tsurt doog evah I :4C
 si ereh esrun eht ,tnellecxe …doog era
  .tnellecxe artxe
بطلب منه دواء للعظم ما بعطيني : 1ح
ما كان . .ت تروفين او اكامولالا مسكنا
كان يكتب ( طبيب العيادة)يفحصني 
 الدواء اناو لازم اطلب .. الروتين و بس
و الفحوصات، و اذا ما بطلب ما 
 .بعطوني شيء
كان الدكتور يقلي ما توخذيش : 2ح
قالولي .. بس اكمول.. علاج للكيماوي
.. ما كان يخفف.. خذي اكامول للوجع
كنت اقعد ايام  ..كان يخفف من الصداع
  .موجوعة و مش قادر اتحرك
ما .. اعطاني الدكتور حبوب: 3ح
فش غير ارجعت عنده قلّي .. زبطش
امشي .. قلّي بدك دوا للمعدة.. ھاذا الدوا
  .فواكه خضار.. خذي سوائل.. اتحركي
.. كوسيين.. ثقتي كويسة فيھم: 4ح
  .الممرض ممتاز جدا.. ممتازين
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شي .. دورالطاقم الصحي كان اله : 5ح
 .نصحوني.. طبيعي
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ro …niap rof noitacidem si erehT :8C
 .wonk t’nod I …ton si ereht ebyam
 uoy em dlot yeht ,niap evah I nehW
 eht dna emit htiw ti ot desu teg lliw
 yeht sa ,taht ekil tsuj …edaf lliw niap
  .ecneitap ym gninoptsop erew
 
 
 
باجي و بروح وﷲ ما نافعني : 6ح
لا .. من مّرة وﷲ ما نفعوني. .حاجة
اي الدكتور عمره ما .. دكاترة ولا غيرة
بس .. عمره ما صابني.. كشف علي ّ
اي ھو .. بقول بدك ھيك و بدك ھيك
  الدكتور ما بكشف؟
بقولك بعطونيش ولا .. لا.. للوجع: 6ح
  .Ϳالحمد .. اشي
بس مش .. اعطوني مسكنات للألم: 7ح
بعدين ھدول . .بس ما كانت تكفّي.. اكثر
وقّف كل الدوا و حط .. بعملوا تجارب
  .دوا جديد
ما .. ولا مافّشي.. في.. دواء للألم: 8ح
انا لّما بتألّم بحكولي مع الوقت .. بعرف
ھيك .. تتعّودي عليه و بروح الألمب
  .كأنّه تصبير.. يعني
بعد .. المسكنات كانت تكفّي: 9ح
 ..الكيماوي يعطيني ادوية و أطيب
  .الحمد Ϳ الخدماتةالصحية كانت ممتازة
  
 recudorP
 dnamed decudni
 
 
 ew yltsrif tub ,ecnarusni evah eW :7C
 ohw rotcod etavirp a ot enog dah
 .latipsoh etavirp a ot su derrefsnart
 eht morf tniop doog ton si sihT
 tog ew taht wenk eh …rotcod
 eht dna ,roop era ew dna ,ecnarusni
 ot desoppus saw eH .tol a stsoc yregrus
 ,latipsoh latnemnrevog eht ot su refer
 ssel ton yregrus eht od nac yeht
.. بتعب من العلاج بعض مرات: 4ح
اذا .. الدكتور قلّي ھذا اشي طبيعي
على طول بتحكي  بصير عندك اشي
 .معي و بتيجيني على العيادة
حنا اول شي ر.. احنا معنا تامين: 7ح
على دكتور خاص و حولنا على 
يعني ھاي نقطة غلط .. مستشفى خاص
عرف انه معنا تأمين .. من الدكتور نفسه
كان .. والعملية مكلفة.. و حالتنا على ﷲ
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 …su refer dluohs yeht ,yltnetepmoc
 eht ta yats su tel yehT .t’ndid yeht tub
 fo tol a yap did ew dna latipsoh etavirp
 yenom
  
 laicosohcysP
 dna troppus
 evitroppus
 noitacinummoc
 
 
 
 
 
 
 
 
 
 
 
 
 
  pleh gnikeeS
 
 
 
 
 
 
 
 a si ti taht em demrofni rotcod ehT :1C
 ediced ot evah uoy dna ,pmul llams
 saw I ,enigami …ylimaf ruoy htiw
 si sihT .noisiced ym koot I ,niaga nrob
 selpicnirp tuo skaeps ,gnieb namuh a
-on ma I ,deedni …sgnileef namuh fo
  .taht retfa kcis erom
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
لي انه عندك سرطان الدكتور حكا: 1ح
 مقدمات، و انه بدو استئصال،بدون 
ليش . .انھرت.. انا غميت امي غميت و
حكالنا ھيك الدكتور، سببلي ھزة 
  .ارضية
و .. كتلة صغيرة( طبيب اخر)قال لي 
اتخيلي انا .. انتي و اھلك بتاخذو القرار
اخذت .. ارجعت مولودة من جديد
ھذا انسان بحكي بمبادئ . .قراري
يعني لو انا .. بتخص احاسيس البشر
  .مريضة ببطل مريضة
ھو  ..ي كان يساعدنيالممرض ھو اللّ 
اللّي بعطينا العلاج و ھو اللّي بعطينا 
اخصائي نفسي ) ما في عندنا ..النصائح
  (.او اجتماعي
يعني في ناس محترمين و في ناس : 2ح
  .بتنفتروا في الواحد
  .ساعدني ما حدا: 3ح
ساعدت نفسي .. فش حدا ساعدني: 4ح
 .بنفسي
ما حدا خبّا عني .. ت كل اشيعرف: 5ح
.. الشباب اللّي بشتغلو محترمين.. اشي
.. يعني بتلاقي في ناس جلفة شوي
انا ارتحت في . .بشكل عام جيدين
 .التعامل معھم جدا جدا
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 evah uoy em gnillet saw eh sA :8C
 lahtel yldloc ni …taht ekil tsuj …ulf
 a evah uoy :em gnillet saw eh ,sevren
 no …niarb ruoy ni recnac tnangilam
 dnuorg eht no saw I ,tops eht
 ,niaga ekawa saw I nehW .suoicsnocnu
 ,rac eht ot tuo em deirrac rehtorb ym
 si ereht ,mih ot netsil t’nod :dias dna
 em demrofni yeht nehw ,nehT .gnihton
 niaga saw ti ,noitceser lacigrus rof si ti
 evah I taht em llet ot emit tsrif eht sa
 owt ,ssendam ekil saw ti …recnac
 ,yaw emas eht demrofni saw I ,semit
  .suoires gnihton sa
.. المنيحين ماشيين بقلب و رب: 6ح
واللّي مش .. العيّانبديرو بالھم على 
في واحد ھاظ . .بطنّشوا.. منيحين
  .صاحبي تمام.. الممرض ذھب
تلفون ازا الواحد .. يعني في دكاترة: 7ح
  .اعتاز ما بعطوه
بسأل الدكتور على التلفون : 8ح
  .يعني بفيدني.. بحكيلي
كل ما اجي بقولولي الفين دينار : 8ح
طب .. يعني زي تحميل جميلة.. دواكي
يعني ھذا بغص .. من جيبتك انت دافع
كل ما اجي بحكيلي نفس . .على قلبي
كلّه .. اتحّملي انت مش دافعة.. الاشي
  .على التأمين
بس انو يفھموني مية .. يشرحولي: 8ح
بس ھم .. أحس انو في اشي.. بالمية لأ
. .كانوا يحكوا لجوزي.. ما يحكولي
يوخذوه لبّرة و يقولوله اذا عاشت بعد 
  .و ھي الي سنتين.. كساعتين أحمد ربّ 
.. ھيك.. كأنّه بحكيلي عندك رشح: 8ح
بحكيلي عندك .. ببرودة أعصاب قاتلة
.. فأنا طب.. مرض خبيث في الدماغ
أخوي .. تا صحيت على حالي.. غميت
قلّي .. حملني و وداني على السيارة
بعدين لّما .. فش اشي.. ترّديش عليه
كانه ھّسة حكالي .. حكولي استئصال
.. زي الجنون.. من جديدمرضتي 
 ..ھيك عادي عادي.. ولا اشي.. مرتين
  .حكولي
.. أتصل في الدكتور أساله يجاوب: 9ح
  .أطمئن
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Health education 
& awareness 
 
 
 
 
 
 
 
 
 
 
C7: Indeed, the nurse had all the 
praise, even more than the doctors 
themselves. Because the doctors write 
the treatment and they go, while he 
gives us the advices, for all patients, 
not merely me, but for all … may God 
reward him all the best for us.  
ح1 :نكل  يلا ولوقي وناك ام ءابطلأا
)ضرملا نع.( .مملا انيطعي ناك ضر
ةيبطلا تاداشرلاا.  
ح2 : ادح ناك ام ةلئسا نودب سب
يشا يليكحي ..لاسب اذا سب .  
ح3 :تابيتك لاو حرش يف ناك ام.  
ح4 :تاداشرا ينوطعي وناك ام. 
ح5 :يشا لك انلوحرش.  
ح7 : لك هلا ناك ضرمملا ﷲو
لضفلا .. نم رثكامھسفن ةرتاكدلا .. نلأ
اودعب و جلاعلا اوبتكب ةرتاكدلا .. وبا اما
حئاصنلا انيطعب دمحم ..ىضرملا لكل ..
ّانع ريخلا لك هيزاجي ﷲ .. سب شم
يلا ..عيمجلل.  
 
Satisfaction with 
medical equipments 
& supplies & service 
Diagnostic tests   
 
C5: There are some tests available in 
the government, but others are 
available outside, not all tests are 
available. 
ح1 : ام مھنلا ىفشتسملا مدھي ودب يوخا
يردب ينوصخش.  
ح5 : يف و ةموكحلا يف تاصوحف يف
ةيجراخ ..ةرفوتم اھلك شم.  
 
Medication  
 
  
C4: The essential medication is 
available here, but the other 
medication; we need to buy it 
sometimes from outside pharmacies. 
The treatment is OK; sometimes there 
are some shortages, but not all the 
times.  
ح1 :رفوتم ءاودلا .. شم سب
 ً امياد..يرتشا علطا كلا لوقبةّرب نم ه.  
ح2 :بسانملا جلاعلا شف امياد .. سب
دوجوم نوكب تارم.  
ح4 :ناھ دوجوم يساسلاا اودلا .. سب
 نم تارم هيرتشنم يناثلا اودلا
ةّرب نم تايلديصلا. .سيوك جلاعلا ..
صقان يشا يف نوكب تارم ضعب ..
امياد شم سب. 
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ما كان عندي .. العلاج متوفر: 5ح
  . مشكلة
مش كلھا .. مھو بقى فش علاج: 6ح
  .موجودة
في فترات ما .. مش دايما.. الدواء: 7ح
  .بكون موجود
.. احيانا الدوا يكون مش موجود: 8ح
كثير . .اموت تأصل المستشفى و أرجع
.. و مش موجودة بعطوني الروشيتة
  .كثير كثير.. فبشتريھا من بّرة
 
    tnemnorivnE
 revo dedworc era stneitap ehT :2C
 ehT .ycavirp on si ereht ,srehto hcae
 ot deen latipsoh eht dna tnemnrevog
 ot os ,saera erac tneitap eht egralne
 sih rof retteb si ti ,tneitap eht trofmoc
 ,deedni …ygolohcysp dna meetse-fles
  .kcis teg I latipsoh eht ot emac I nehw
  .النظافة تعيسة: 1ح
ما في .. المرضى فوق بعض: 2ح
لازم الحكومة و المستشفى .. خصوصية
يوسعه اكثر عشان المريض يوخذ 
يعني لما باجي .. تهاحسن لنفسي.. راحته
  . عالمستشفى بامرض انا
الحمد .. الخدمات الصحية منيحة: 3ح
  .متوفرة و نظيفة. .Ϳ
.. ماھيالحّمامات ثلاث ايام زي : 8ح
انام على .. عدم. .نظافة فش من مّرة
تكون البّسة نايمة تحت .. السرير
  .السرير
  
 htiw noitcafsitaS
 metsys slarrefeR
  
 dna etavirp ni yregrus eht did eW :2C
 elbaliava ton saw ti esuaceb ,ti rof diap
 eW .latipsoh latnemnrevog eht ni ereh
 gniyaled tpek yeht tub ,ecnarusni evah
 ot ton em desivda rotcod eht dna …su
 si ti :dias eh ,erom yregrus ym yaled
 .edistuo ti did ew ,oS .uoy rof doog ton
  (.كلفة العلاج)ماديا ًالتأمين بغطي: 1ح
بنا لانو ما عملنا العملية على حسا: 2ح
(.. في المستشفى)توفر النا عملية ھان 
و .. بس ظلوا ياجلوا فينا.. معنا تامين 
مش .. الدكتور قلي ما تاخري حالكي
  .فعملناھا بّرة.. من صالحكي
  .بيوملقبل العملية .. اعطونا تحويلة: 3ح
 341
 
 .ما تغلبنا بالتحويلة: 4ح
  .كل شيء كان ميسر: 5ح
  .سھلة.. ما غلبوني في التحويلة: 6ح
ما في .. ما تغلبنا في التحويلة: 7ح
  .مشاكل
اي .. ھو مدير شرطة.. خالي لوما: 8ح
وبجيبلي  ورقة اي تامين بساعدني فيه
يعني لوماه كان انا بشحد على .. ايّاه
تحويلة بموت ورقة .. سھلمش . .الباب
ھيني .. ھاي خالي مسافر.. لّما اعملھا
  .في شھر سبعة وما فيش تحويلة
ما تغلبنا في .. معانا تأمين: 9ح
  .ما في غلبة.. التحويلات
  .ما تغلّبت في التحويلة: 01ح
 
 sdeeN s’tneitaP 7
 LoQ devorpmi rof
 redivorP htlaeH  nalp tnemtaerT
 noitacinummoc
   elyts
 
 
 
 
 
 
 
 
 
 
 
 
 rotcod eht …em morf ti edih yehT :4C
 ecnahc yb saw tI .nerdlihc ym dlot dah
 yeht ,gnikaeps meht draeh I taht
 eht gnidih esuaceb ,em dlot dluohs
 em dlot yeht epoh I .doog ton si hturt
-hcum eb dluow taht ,egaugnal rieht ni
 gniraeh tub ,retteb dna recin erom
يقعد .. يھتم بالمريض (الطبيب) انه: 1ح
 مرضى مش يعد عدد.. دقايق 01معه 
  .بس
حكوا .. في البداية ما حكولي: 2ح
بس انا عرفت من نظرات .. لجوزي
  .ه معي المرضالدكتور ان
وھم .. احساسي جّوا بقول اه: 3ح
  .بحكولي لألأ
بس انا بكيت .. بالصدفةاعرفت : 3ح
لازم . .قلبي من جوا حاسس انو في اشي
  .المريض يدري قبل أھل الدار
الدكتور كان حاكي .. خبّوا علي ّ: 4ح
لازم .. صدفة اسمعتھم بحكوا.. لاولادي
.. لانه يخبّوا علّي مش منيح.. حكوا لي
.. لو حكوا الي بلغتھم بتكون الطف
ھذا .. اّما انا اسمع وھم يحكوا.. احسن
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 yllaer s’taht ,ecnahc yb gnikaeps meht
  .deedni em detceffa ti ,dab
 
 
 
 
 
 
 ot ydobemos rof gnillac saw I :8C
 tsael eht ,naem I ,alunac V.I ym kcehc
 ,ysub ma I :dias eh ,rof ksa ot gniht
 uoy ;rotcod eht llac ,esle enoemos llac
 rieht ta tseug dab a ma I ekil leef I ;ees
 .emoh
  .قالولي احتمال انھا تتحول لأورام: 5ح
.. يعني ييجيه الواحد بالتدريج: 7ح
حاولوا . .يفھمو كيف.. باسلوب ھيك
.. بس بيّن وعرفت.. يخبّوا في الأول
ما بتقدر .. الموضوع طويل وشائك
  .تخبّيه
بنادي غلى حدا ييجي يشوفلي : 8ح
بقول مش .. يعني اقل اشي.. الأبرة
.. نادي الدكتور.. ثانيخلّي حدا .. فاضي
يعني بحس انھم محّملينّي جميلة انھم 
  .مقعدينّي عندھم
 
 yranilpicsiditluM
 ytilibaliava maet
 
 
 
 eht yllaicepse ,namuh yrevE :2C
 did I tuB .gnilesnuoc rof sdeen ,tneitap
 eht ni siht ekil ydobyna dnif ton
  .latipsoh
كله ھون، ما العلاج  يكون لازم: 1ح
، لازم يكتبلي تحويلة بصير يوديني بّرة
  .لطبيب بنفس المستشفى
.. خاصة المريض.. كل انسان : 2ح
ما لقيت حدا  بس.. بحتاج لحدا يرشده
  .ھيك
دعم )بس ما فيش .. لو في منيح: 4ح
 (.نفسي اجتماعي
 ..لا.. اخصائيين نفسي اجتماعي :5ح
  .زي ھيك ما شفتش
 
 ni gnirahS
 gnikam noisiced
 ssecorp
ھاي ثامن ابرة .. لكم مّرة بدي اجي: 8ح 
طب احكولي .. كم مّرة بدي اجي.. باخذ
 .الرقم
  noitacude htlaeH
 
 
 
  .مش عارف ..بدي كمان معلومات: 2ح
بعد .. و سوولي ھالكيسبقروني : 6ح
.. انا داري شو ھاظ.. الكيس نبز النزيف
  .الحمد Ϳ
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ح7 :ضرملا عم لماعتلا ..يداع .. يز
يشمب ةرتاكدلا اولوقي ام .. شيدنع ام انا
ءايشلاا ياھ يف ةربخ. . نوكي بحب سب
حضاو يشا لك .. يشا لك فرعا يدب
يضرم و يتلاح نع.  
C7: Dealing with the disease is ok for 
me; I do what doctors are saying, I 
have no experience in such things. But 
I like everything to be clear for me; I 
want to know everything about my 
case and my disease.  
 
Medication, 
diagnostics & 
supplies 
availability  
C7: When the medication is not 
available, we buy it by cash, and 
moreover, these tests are very 
expensive, a thousand and a thousand 
and eight… it should be available; 
sometimes we were obliged to do them 
outside.  
ح7 :دوجوم نوكب ام اّمل ءاودلا ..
يدقن هانيرش .. ياھ تاصوحفلا نيدعب
ريثك ةيلاغ .. و فلا و لقيش فلا
ةينامث ..اھورفوي مزلا. . ّانك تارم
ةّرب اھلمعن.  
ح9 :عجولا لّمحتأ تنك.  
 
Cosmetic 
prosthetics  
availability 
 ح1 :انباسح ىلع اھيرتشنم انحا.  
ح7 : شم ةيليمجتلا تادعملاةرفوتم.  
 
Economical support  Availability of 
transportation 
 ح1 : ام صابلا يف علطن انك امل سب
بلغتن.  
ح4 :راوشم ..اعبط حيرا نوكب برقا. 
ح8 :بعت ّيلع راوشملا وھم.  
 
Good housing 
and house 
sanitation 
 ح1 :هيف دعقا صاخ لحم يف ام .. لا
اوھ لا سمش .  
ح4 :ةشود يلع رثات تناك دلاولاا .. ام
ةيصوصخ يف.  
 
Financial 
support 
C8: The way from Nablus is very far, I 
need at least a hundred shekels just for 
transportation, not counting any food 
or drink.  
ح6 :ايسفن سب ومعدب بيارقلا ..
لأ يراصم.  
ح8 :ريثك ديعب سلبان راوشم .. ةئم يدب
كيھ لقيش ..برش لاو لكأ نودب.  
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 & lautiripS troppus laicosohcysP
 lanoitome
 troppus
 
 
انا بعتقد انه اھم شيء انك تحاول : 5ح
انه .. اول اشي.. تھدي نفسية المريض
يعني تعطيه .. ما يخاف من ھذا المرض
و انه .. ﷲاول اشي انو الاعمار بيد 
بدك .. الألم رحمة من رب العالمين
ثاني شيء بده .. يعني شجعه.. تتحمل
  .ياخذ علاجه
 كله على.. بفكرش في المستقبل: 8ح
  .التساھيل على.. ﷲ
يجيبولي .. يشوفوني ببكي: 8ح
بس تقولي كيف .. اخصائية اجتماعية
الراحة .. اھم اشي للمريض. .حالك
في اي  ولا بحس براحة.. النفسية
  .مستشفى
  
 puorg troppuS
  ytilibaliava
 wonk I mohw stneitap recnac llA :3C
 namow siht ylno tub ,deid dah
 dna em ot deklat dah ehS .devivrus
 stirips ym devorpmi ehs ,em depleh
 dna esaesid eht dah ehs ,elarom dna
 !evila llits si ehs
بس ھاي .. ماتوااللي بعرفھم : 3ح
.. حكت معي ساعدتني.. المرأة طابت
كان معھا المرض و .. رفعتلي معنوياتي
  !بعدھا عايشة
 
 metsys retnec eraC
 tnemeganam
 gnitiaW retteB
 emit
  tnemeganam
 
 
 
 tneitaptuo eht ni redro eht si tI :8C
 ma I ;redro on si ereht ,nwod scinilc
 eht ni osla ,mp6 llit ma01 morf yllausu
 ma I thguoht yeht ;latipsoh rehto
 ym htiw yrgna ma I esuaceb gniyrc
 ereh ma I ,tub …ylimaf ym ro dnabsuh
 eht rof mp1 llit gnitiawa ,ma7 ecnis
عدد الأطباء و .. في ضغط كبير: 1ح
و عدد الأيام .. الممرضين مش كافي
 .كمان
فش .. بس النظام تحت في العيادات: 8ح
و في . .باجي من العشرة للستّة.. نظام
بفكروني ببكي .. المستشفى الثاني
بس .. زعلانة من من جوزي او اھلي
للوحدة تتطلع .. انا باجي من السبعة
ما .. وانا بستنّى.. نتيجة الفحص
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result of the blood test… I ask them, 
but they say: do you think you are the 
only one at the hospital… indeed, I am 
the first one here, even before they 
start work in the morning… when I do 
the blood test outside in a lab, it is five 
minutes, but they do not accept it. 
   
Palliative care 
services   
C1: Any patient would be in need for 
such thing, I wish, it would be of great 
help. Sometimes, I am not in the mode 
to step outside the house.  
ح1 : يشأ كيھل ةجاحب ضيرم يأ
)ةيلزنملا و ةيفيطلتلا ةياعرلا ..( اي
 يف ،دعاسب ريثك ،تير نوكب ام تاقوا
رادلا نم علطا سفن يلا.  
ح7 :لأ .. يسفن دعاست تاسسؤم شف ام
يشا وا يعامتجا وا .. يف نوكي تير اي
كيھ يز يشا ..يف ام.  
ح9 :زكرم كيھ رفوتي Ϳاشنا) .. ةياعر
ةيفيطلت (زاتمم ..دعاسب.  
ح10 :ةمعاد تاسسؤم ..شتيقل ام ﷲو.  
 
Facility and 
capacity  
 
 
 
 
C8: They took me to Ramallah… they 
did not have a free bed for me. I wish 
there is a near treatment center… I 
wish indeed.  
ح7 :مھنوعب نوكي ﷲ مھ .. ةبسن
ريثك ريثك ىضرملا ..اّوفكي بودي .. يف
ريبك ددع.  
ح8 :ﷲ مار ىلع ينولّمح .. شمھدنعم
يضاف ريرس. .ول تيراي  يف
بيرق جلاعزكرم ..تير اي.  
ح9 :ﷲ مار يف رفوم يواميكلا ول ..
انيلع اولھسب .. ىلع يجين ام ناشع
ديعب حرطم. .لھس شم. . انيلع اونّوھب
دھج و بعت.  
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 ytinummoC 8
 rof snoitpecrep
 recnac dna recnac
  stneitap
 htiw sgnileef ytiP
  tneitap recnac
 si em ot kool elpoep yaw ehT :1C 
 yhtapmys dna ytip evah yeht ;lufniap
 ,dab oot si sihT .tneitap roop taht htiw
 ruO .ygolohcysp eht stceffa ti
 yeht ,ti tpecca ton seod ytinummoc
 dna uoy laeh doG yam yas yllausu
 tel yeht …sdik ruoy rof uoy evreserp
  .efil ruoy fo dne eht si ti leef uoy
بتصير .. نظرة الناس مؤلمة جدا: 1ح
انه .. عندھم نظرة عطف و شفقة
ذا كثير مسكين يا حرام، ھ( المريض)
بالنسبة .. بأثر على النفسية.. سيء
بقولو ﷲ يشفيكي و . .لمجتمعنا ما بتقبل
بحسسوك انه نھاية .. يخليكي لاولادك
  . العمر
  . اللي حوليا بكونوا شفقانين علي ّ: 2ح
  .شفقة.. بشوفھم بنظروا اله: 3ح
  .نظرة الناس بنظرولك نظرة شفقة: 5ح
امن لو كل واحد ييجي يطلّع فيك : 7ح
طبعا ھاد بأثر سلبا .. يعطيك نظرة شفقة
انا بحبش نظرة الشفقة .. على الواحد
  .ھاي
 
 fo noitazitamgitS
 recnac
 ot detnaw wal-ni-rehtom yM :1C 
 yeht …wal-ni-rethguad reh egnahc
 reh ekil esoht taht reh llet t’nod :yas
 ot elpoep tnaw t’nod I .deid ydaerla
 siht ,esaesid yratidereh si ti yas
  .srethguad ym detceffa
. .صار بدھا تغيّر كنتھا( حماتي: )1ح
ما . .ھا ماتوما تحكو الھا انه اللي زيّ 
 .يقولو عامل وراثي، ھذا أثر على بناتي
بكرة بتنصاب .. اذا انصبت انا: 3ح
بتجوزنش .. ھذا بأثر.. بنتي و اختي
  .مثلا
أھلي و أھل .. سألوا الدكتور: 8ح
ما .. قال لھم.. بعدي؟.. قالوا له.. جوزي
  .توكل وتشرب معاكوا.. بعدي
.. الكل بقول.. الناس كثير بخافوا: 8ح
حتى .. معاھا ھذاك المرض.. مسكينة
  .الأسم ما بحكوه
 
 suoires / lataF
  esaesid
 elpoep ,esaesid gniyfirret si tI :4C 
 era yeht …suoregnad sa ti eviecrep
 recnac eht tuoba gniksa yllausu
بتطلعوا للمرض الناس .. الو رھبة: 4ح
.. مات.. بسألوا كيف فلان.. انه خطير
 .لھلحين طيب
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 eh sI ?eid eh diD ?eh si woh …tneitap
  ?evila llits
نظرة الناس بنظرولك نظرة : 5ح
.. انو ھذا الانسان بقّضي بايام.. شفقة
  .بس ھيك بوّدع
بس .. في ناس بخافوا من المرض: 7ح
  .ھو بعديش
ﷲ .. ﷲ يساعدك.. الناس بقولوا: 8ح
  .بحس حالي انّي بدي أموت.. يشفيكي
بس الموت . .بعض الناس بتخاف: 01ح
  .بايد ربنا
 
 sa ti redisnoC
  tnemhsinup
 yeht ,elpoep lufhtiaf ton era yehT :7C 
 dna laedro si siht taht sreveileb ton era
 siht taht yas yeht …doG morf tset
 .recnac tog eh os sekatsim did nosrep
يامنوش .. ھدول ناس مش مؤمنين: 7ح
بقولك ھاد عمل غلط و صار .. بالأبتلاء
  .معه ھيك
  
 dna ytiradiloS
  pleh ot gnilleW
  
 …lla ta pleh t’nod yeht …elpoeP :6C
  .lla ta gnihton
 
 
 ,em htiw dnik saw ydobyrevE :9C
 ,em ot doog saw ,stirips ym gnitroppus
 sknaht …evitarepooc dna noissapmoc
  .doG
  .في ناس بساعدوا و في ناس لا: 2ح
ولا بساعدوا .. ولا حاجة.. الناس: 6ح
  .ولا اشي
ساعدني .. وفّر دعم.. اه.. المجتمع: 7ح
  .اه.. 
.. أنا الكل كان متلاطف معاي: 9ح
حنون و  ..منيح معاي.. يرفع معنوياتي
  .الحمد Ϳ ..متعاون
 
 )3( xennA
 stneitap recnaC nainitselaP fo efiL fo ytilauQ
    ecivres eraC evitaillaP fo ecnesba eht nI 
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    (اﻟﺳﺎﺑق 51 ﺳؤاﻝ ﻓﻲ) ؟اﻟﻣؤﺳﺳﺎت ﺗﻠك ﻣن ﺗﻠﻘﻳﺗﻬﺎ اﻟﺗﻲ اﻟﺧدﻣﺎت ﻧوﻋﻳﺔ ﻫﻲ ﻣﺎ (81
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EORTC QLQ-C30 (version 3)  
 
We are interested in some things about you and your health. Please answer all of the questions yourself by circling the 
number that best applies to you. There are no "right" or "wrong" answers. The information that you provide will 
remain strictly confidential. 
 
Please fill in your initials: bbbb 
Your birthdate (Day, Month, Year): cececdde 
Today's date (Day, Month, Year):  31 cececdde 
__________________________________________________________________________________________ 
  Not at A Quite Very 
  All Little a Bit Much 
1. Do you have any trouble doing strenuous activities,  
 like carrying a heavy shopping bag or a suitcase? 1 2 3 4 
 
2. Do you have any trouble taking a long walk? 1 2 3 4 
 
3. Do you have any trouble taking a short walk outside of the house? 1 2 3 4 
 
4. Do you need to stay in bed or a chair during the day? 1 2 3 4  
 
5. Do you need help with eating, dressing, washing  
 yourself or using the toilet? 1 2 3 4 
 
 
During the past week:  Not at A Quite Very 
  All Little a Bit Much 
 
6. Were you limited in doing either your work or other daily activities? 1 2 3 4 
 
7. Were you limited in pursuing your hobbies or other 
 leisure time activities? 1 2 3 4 
 
8. Were you short of breath? 1 2 3 4 
 
9. Have you had pain? 1 2 3 4 
 
10. Did you need to rest? 1 2 3 4 
 
11. Have you had trouble sleeping? 1 2 3 4 
 
12. Have you felt weak? 1 2 3 4 
 
13. Have you lacked appetite? 1 2 3 4 
 
14. Have you felt nauseated? 1 2 3 4 
 
15. Have you vomited? 1 2 3 4 
 
16. Have you been constipated? 1 2 3 4 
 
 Please go on to the next page 
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During the past week:  Not at A Quite Very 
  All Little a Bit Much 
 
17. Have you had diarrhea? 1 2 3 4 
 
18. Were you tired? 1 2 3 4 
 
19. Did pain interfere with your daily activities? 1 2 3 4 
 
20. Have you had difficulty in concentrating on things, 
 like reading a newspaper or watching television? 1 2 3 4 
 
21. Did you feel tense? 1 2 3 4 
 
22. Did you worry? 1 2 3 4 
 
23. Did you feel irritable? 1 2 3 4 
 
24. Did you feel depressed? 1 2 3 4 
 
25. Have you had difficulty remembering things? 1 2 3 4 
 
26. Has your physical condition or medical treatment 
 interfered with your family life? 1 2 3 4 
 
27. Has your physical condition or medical treatment 
 interfered with your social activities? 1 2 3 4 
 
28. Has your physical condition or medical treatment 
 caused you financial difficulties? 1 2 3 4 
 
 
For the following questions please circle the number between 1 and 7 that  
best applies to you 
 
29. How would you rate your overall health during the past week? 
 
  1 2 3 4 5 6 7 
 
 Very poor      Excellent 
 
 
30. How would you rate your overall quality of life during the past week? 
 
  1 2 3 4 5 6 7 
 
 Very poor      Excellent 
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  2102                   اﻟﻣﻘﺎﺑﻼت اﻟﻣﺗﻌﻣﻘﺔ: اﻟدراﺳﺔ اﻟﻧوﻋﻳﺔأﺳﺗﺑﻳﺎن 
  اﳌﻮﺿﻮﻋﺎت ﻗﻴﺪ اﻟﻄﺮح  اﻟﺴﺆال اﻟﺮﺋﻴﺴﻲ
ﻣﺎ  ﻛﻴﻒ أﺛﺮ اﳌﺮض ﻋﻠﻰ ﺣﻴﺎﺗﻚ اﻟﻴﻮﻣﻴﺔ؟ (1
  ﻫﻲ ﺗﻔﺎﻋﻼت اﳌﺮض ﻣﻊ ﺣﻴﺎﺗﻚ اﻟﻴﻮﻣﻴﺔ؟
 اﳊﻴﺎﺗﻴﺔ اﻟﻴﻮﻣﻴﺔ  اﻟﻈﺮوف اﳌﻌﻴﺸﻴﺔ -
 ﻋﺪد اﻓﺮاد اﻷﺳﺮة -
 اﳋﺼﻮﺻﻴﺔ ﰲ اﻟﺒﻴﺖ -
 ﲪﺎم ﺧﺎص/ ﻏﺮﻓﺔ ﺧﺎﺻﺔ/ اﳋﺪﻣﺎت و اﻻﻣﻜﺎﻧﻴﺎت ﰲ اﻟﺒﻴﺖﺗﻮﻓﺮ  -
 اﳊﻴﺎة اﳉﻨﺴﻴﺔ/ اﳊﻴﺎة اﻷﺳﺮﻳﺔ اﻟﻌﺎﺋﻠﻴﺔاﻟﺘﺄﺛﲑ ﻋﻠﻰ  -
 ﻢ اﻟﺼﺤﻲ ﻧﺼﺎﺋﺢ او ﻣﻌﻠﻮﻣﺎت ﺣﻮل اﻣﻜﺎﻧﻴﺔ ﳑﺎرﺳﺔ اﳉﻨﺲ؟ﻫﻞ ﻗﺪم اﻟﻄﺎﻗ o
 رﻋﺎﻳﺔ اﻷﻃﻔﺎل/ اﺳﺮﻳﺔ و ﻣﻌﻴﺸﻴﺔﺗﺮﺗﻴﺒﺎت  -
 اﳊﻴﺎة و اﳌﻮت/ اﻟﺘﺨﻄﻴﻂ ﻟﻠﻤﺴﺘﻘﺒﻞ -
  اﳌﻌﻨﻮﻳﺎت/ اﻟﻨﻔﺴﻴﺔاﻟﺘﺄﺛﲑ ﻋﻠﻰ  -
 اﻷﻋﺮاض اﳉﺎﻧﺒﻴﺔ/ اﻟﺘﻌﺎﻣﻞ ﻣﻊ اﻷﱂ -   ﻛﻴﻒ ﺗﺘﻌﺎﻣﻞ ﻣﻊ اﳌﺮض؟ (2
 ﻋﻮاﻣﻞ اﻟﻘﻮة / اﻟﻌﻮاﻣﻞ اﳌﺴﺎﻋﺪة/ اﳌﺮض و ﺗﻔﻬﻢ ﺗﻘﺒﻞ -
 اﻻﺳﱰاﺗﻴﺠﻴﺎت/ وﺳﺎﺋﻞ اﻟﺘﺄﻗﻠﻢ ﻣﻊ اﳌﺮض o
 اﻟﺼﻼة/ اﻟﺮوﺣﺎﻧﻴﺎت/ اﻟﺪﻳﻦ o
 اﳌﻮﺳﻴﻘﻰ/ اﻟﺘﺄﻣﻞ/ اﻟﻴﻮﻏﺎ/ اﻟﺘﻤﺎرﻳﻦ اﻟﺮﻳﺎﺿﻴﺔ o
 اﻟﺸﻌﻮذة / اﻟﻄﺐ اﻟﻌﺮﰊ/ وﺳﺎﺋﻞ اﺧﺮى o
 اﻷﱂ/ اﻟﻘﻴﻢ و اﳌﻔﺎﻫﻴﻢ اﳌﺘﻌﻠﻘﺔ ﺑﺎﳌﺮض o
 ﻳﻌﺮﻓﻪ اﻷﺧﺮون / ﻣﺎ ﺗﺮﻳﺪ ان ﺗﻌﺮﻓﻪ ﻋﻦ اﳌﺮض o
  ﺧﱪة ﺳﺎﺑﻘﺔ ﺷﺨﺼﻴﺔ او ﻋﺎﺋﻠﻴﺔ/ اﳝﺎن/ روﺣﺎﻧﻴﺎت/ ﻣﺎ ﻳﺴﺎﻋﺪك ﻋﻠﻰ اﲣﺎذ اﻟﻘﺮار o
/ ﺘﻤﺎﻋﻲاﻟﺪور اﻷﺟ/ اﻟﻌﺎﺋﻠﺔ/ اﳉﻨﺲ/ ﻋﻮاﻣﻞ اﺟﺘﻤﺎﻋﻴﺔ و ﺛﻘﺎﻓﻴﺔ ﺗﺆﺛﺮ ﰲ اﻟﺘﺠﺮﺑﺔ o
 اﻟﺘﻮﻗﻌﺎت/ اﻟﻀﻐﻂ
  اﻻﻧﺴﺠﺎم ﻣﻊ  اﻷﺷﺨﺎص اﻟﻨﺎﺟﲔ ﻣﻦ اﳌﺮض o
 ﻣﺮاﺣﻠﻪ/ اﻣﻜﺎﻧﻴﺔ اﻟﺸﻔﺎء ﻣﻦ اﳌﺮض o
 اﻟﺘﻮﻗﻌﺎت/ اﻷﻣﺎل/ اﻷﻫﺪاف -
 ﺑﺎﻟﻔﻘﺪان/ ﺑﺎﳌﻮت/ اﳌﺘﻌﻠﻘﺔ ﺑﺎﳌﺮضاﻷﻫﺘﻤﺎﻣﺎت / اﳌﺨﺎوف o
 اﻟﻨﺎﺟﻴﲔ/ اﻷﺻﺪﻗﺎء/ اﻟﻌﺎﺋﻠﺔ/ اﳊﺎﺟﺔ ﻟﻠﺪﻋﻢ -
   ؟ﻣﺎ ﻫﻮ ﺳﺒﺐ اﻷﺻﺎﺑﺔ ﺑﺎﳌﺮض -
اﻟﱰﺗﻴﺒﺎت اﻟﱵ ﻋﻠﻴﻚ اﻟﻘﻴﺎم đﺎ ﻣﺎ ﻫﻲ  (3
  ﻟﻠﺤﺼﻮل ﻋﻠﻰ اﻟﺮﻋﺎﻳﺔ اﻟﺼﺤﻴﺔ؟
 ﺗﺼﺮﻳﺢ ﻟﻠﻤﺮاﻓﻖ/ رﻓﺾ أﻣﲏ أﺳﺮاﺋﻴﻠﻲ/ ﺗﺼﺮﻳﺢ/ ﻇﺮوف ﺳﻴﺎﺳﻴﺔ -
 ﻋﻤﻠﻴﺔ ﻃﻮﻳﻠﺔ ﻣﻌﻘﺪة ﻻﺧﺬ اﻟﻌﻼج - ﺗﺄﻣﲔ/ ﲢﻮﻳﻠﺔ/ اﻟﻮزارة/ اﻷﺟﺮاءات اﻻدارﻳﺔ ﰲ اﳌﺴﺘﺸﻔﻰ -
 اﻷﻣﻜﺎﻧﻴﺎت اﳌﺎﻟﻴﺔ/ اﻟﱰﺗﻴﺒﺎت اﳌﺎدﻳﺔ -
 اﳌﻮاﺻﻼت/ اﻣﻜﺎﻧﻴﺔ اﻟﻮﺻﻮل ﻟﻠﺨﺪﻣﺔ/ وﺟﻮد ﻋﻮاﺋﻖ ﺟﻐﺮاﻓﻴﺔ -
   ﺗﻮﻓﺮ ﻣﺮاﻓﻖ ﻟﻠﻤﺮﻳﺾ. وﺟﻮد ﻣﺆﺳﺴﺎت داﻋﻤﺔ -
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 اﻟﻔﺤﻮﺻﺎت/ اﻟﺪواء /وﻓﺮة و ﺟﻮدة اﻟﻌﻼج -  ﻛﻴﻒ ﺗﻘﻴﻢ اﳋﺪﻣﺎت اﻟﺼﺤﻴﺔ اﳌﻘﺪﻣﺔ ﻟﻚ؟ (4
 ﺳﻬﻮﻟﺔ اﳊﺼﻮل ﻋﻠﻰ اﳋﺪﻣﺔ o
 ﻋﻮاﻣﻞ ﻣﺘﻌﻠﻘﺔ ﺑﺎﻟﻄﺎﻗﻢ -
 ﺗﻌﺎﻣﻞ اﻟﻄﺎﻗﻢ اﻟﻄﱯ o
 ﺗﻮﻓﺮ اﻟﺪﻋﻢ اﻟﻨﻔﺴﻲ o
 اﻷﺟﺘﻤﺎﻋﻴﺔاﻟﺮﻋﺎﻳﺔ /ﺗﻮﻓﺮ اﻟﺪﻋﻢ  o
 ﺗﻮﻓﺮ اﻟﺘﺜﻘﻴﻒ اﻟﺼﺤﻲ ﻟﻠﺘﻌﺎﻣﻞ ﻣﻊ اﻷﻋﺮاض اﳉﺎﻧﺒﻴﺔ -
 / اﻟﺮاﺣﺔ ﰲ اﻟﺘﻌﺎﻣﻞ ﻣﻊ اﻟﻨﻈﺎم اﻟﺼﺤﻲﻣﺴﺘﻮى  -
 اﻟﻨﻈﺎم ﻋﻠﻰ اﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﺮض ﻘﺪرةﺑ اﻟﺜﻘﺔ o
 ﺗﻮﻓﺮ اﳊﺎﺟﺎت و اﳌﺘﻄﻠﺒﺎت اﻟﺮوﺣﺎﻧﻴﺔ ﻋﻨﺪ اﻟﻄﻠﺐ -
  ﻳﺘﻢ اﻷﻳﻔﺎء đﺎ؟ﻫﻞ ﻛﺎﻧﺖ ﻟﺪﻳﻚ اﺣﺘﻴﺎﺟﺎت أو ﻣﺘﻄﻠﺒﺎت ﱂ  o
اﻷﺷﻴﺎء اﻟﱵ ﳚﺐ وﺟﻮدﻫﺎ / ﻣﺎ ﻫﻲ اﻷﻣﻮر (5
ﳌﺮﻳﺾ  ﻋﺎﻟﻴﺔﻧﻮﻋﻴﺔ ﺣﻴﺎة  ﺟﻮدة و ﻟﺘﻮﻓﲑ
  اﻟﺴﺮﻃﺎن؟
 اﻟﻨﻔﺴﻴﺔ/اﳋﺪﻣﺎت اﻷﺟﺘﻤﺎﻋﻴﺔ ﺗﻮﻓﺮ  -
 اﻟﻘﺪرة ﻋﻠﻰ اﻟﺘﻌﺎﻣﻞ ﻣﻊ اﻷﱂ و اﻟﺘﺨﻠﺺ ﻣﻨﻪ -
 ﺗﻮﻓﺮ اﻟﺪواء اﻟﻼزم ﰲ ﻣﺘﻨﺎول اﻟﻴﺪ  -
 ﺗﻮﻓﺮ اﳌﻌﺪات اﻟﻼزﻣﺔ ﻟﺮاﺣﺔ اﳌﺮﻳﺾ -
 ﺗﻮﻓﺮ اﻟﻄﻮاﻗﻢ اﻟﻄﺒﻴﺔ اﳌﺘﺨﺼﺼﺔ  -
 اﻟﺘﻠﻄﻴﻔﻴﺔوﺟﻮد اﻟﺮﻋﺎﻳﺔ  -
 ﺑﺎروﻛﺔ/ ﺗﻮﻓﺮ اﳌﻌﺪات اﻟﺘﺠﻤﻴﻠﻴﺔ -
 اﻣﻜﺎﻧﻴﺔ ﺗﻮاﺟﺪ اﻷﻫﻞ ﻣﻊ اﳌﺮﻳﺾ -
 ﻣﺴﺘﺸﻔﻰ ﺧﺎص ﻟﺮﻋﺎﻳﺔ اﳌﺮﻳﺾ –ﺗﻮﻓﺮ ﻣﺮﻛﺰ  -
   ﺗﻮﻓﺮ اﻟﺮﻋﺎﻳﺔ اﳌﻨﺰﻟﻴﺔ -
اﻟﻤﺠﺘﻤﻊ ﺑﺸﻜﻞ ﻋﺎم / ﻛﻴﻒ ﺗﺮى ﻧﻈﺮة اﻟﻨﺎس (6
  ﳌﺮض اﻟﺴﺮﻃﺎن ﰲ ﻓﻠﺴﻄﲔ؟
 ﻋﻦ اﳌﺮﻳﺾ ﳛﺮص اﻓﺮاد اﻟﻌﺎﺋﻠﺔ و اﶈﻴﻄﲔ ﻋﻠﻰ اﺧﻔﺎء ﺧﱪ اﳌﺮض ﻗﺪر اﳌﺴﺘﻄﺎع -
 اﻷﻧﺴﺠﺎم اﻷﺟﺘﻤﺎﻋﻲ/ ﳝﻨﻊ اﻟﺰواج/ ﻋﻴﺐ/ ﻛﻮﺻﻤﺔ اﻟﻌﺎر  ﻳﺮاﻩ اﻟﻨﺎس -
 ﻣﻌﺪي/ ﻳﻌﲏ اﳌﻮت/ ﻣﻨﻪ و ﻣﻦ اﻟﺘﻌﺎﻣﻞ ﻣﻌﻪ ﻮنﳜﺎﻓ -
 و اﺑﺘﻼء او اﻧﻪ رﲪﺔ/ ﻳﺮون اﻧﻪ ﻋﻘﺎب ﻣﻦ اﷲ ﻋﻠﻰ اﳋﻄﺎﻳﺎ -
 ﻣﺴﺎﻋﺪة اﳌﺼﺎب ﺑﺎﳌﺮض( ﻻ ﻳﺘﻘﺒﻠﻮن)ﻳﺘﻘﺒﻠﻮن  -
  ﻟﻠﻤﺮﻳﺾ اﻷﻓﺮاد اﻟﺪﻋﻢ اﻟﻼزم / اﻟﻌﺎﺋﻠﺔ/ ﻳﻮﻓﺮ اﻟﻤﺠﺘﻤﻊ -
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Annex (7): Tool Use Approval  
QLQ-C30 download request from Mohamad Khleif  
FROM: qlqc30@eortc.be  
TO: mkhleif@yahoo.com  
Friday, February 10, 2012 8:43 PM 
Dear Sir/Madam,  
 
Please find below the links where you can download the documents you requested. 
 
Best regards, 
 
Your data: 
 
Title: Mr. 
Firstname: Mohamad 
Lastname: Khleif 
Hospital/Institution: AL-Quds University 
Address: Abo Deis  
County/State: Jerusalem 
Postal Code: 970 
Country: West Bank 
Phone: 972 522495249 
Fax:  
Email: mkhleif@yahoo.com 
Protocol: EORTC QLQ-C30 
 
Documents requested: 
 
QLQ-C30 Core Questionnaire in Arabic  
QLQ-C30 Core Questionnaire in Arabic  
QLQ-C30 Core Questionnaire in English  
QLQ-C30 Scoring Manual 
 
URLs: 
 
http://www.eortc.be/home/qol/files/C30/QLQ-
C30%20Arabic1.1.(UAE,Egypt,the%20Arabian%20peninsula,Middle%20East).pdf 
http://www.eortc.be/home/qol/files/C30/QLQ-C30%20Arabic1.2.(Maghreb-
Algeria,Libya,Morocco,Tunisia).pdf 
http://www.eortc.be/home/qol/files/C30/QLQ-C30%20English.pdf 
http://www.eortc.be/home/qol/files/SCManualQLQ-C30.pdf 
 
 
If the links don't work, you can copy and paste the entire URL (so with .pdf included) 
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into your browser and that should work.If you are having other technical difficulties 
please contact us by email: qlqc30@eortc.be 
RE: use of EORTC QLQ 30 for academic research  
FROM: Rossella Guzzo  
TO: 'moh'd khleif'  
Monday, February 13, 2012 1:39 PM 
Dear Mohamad Khleif, 
Thank you for your request and your interest in our measures. 
 
To obtain a copy of the QLQ-C30 and other validated modules, which are copyrighted 
instruments, please visit our website, 
http://groups.eortc.be/qol/questionnaires_downloads.htm where you will be able to fill in 
a download request. 
Once on the web, click the link of the questionnaire you require. A new screen opens 
where you should fill in your details (You must fill in each area, if you do not have a fax 
number, please put your tel. number into that area), once you have completed them at the 
bottom of this page click on SUBMIT. On the next page select the documents you require 
(questionnaires, languages, full reference values manual, or parts of the manual). At the 
bottom of the page you need to tick the box that you agree to the terms of the User's 
agreement. If you have done that, click on SUBMIT and then your request will be sent 
through. You will automatically receive an email with the download details of the 
documents you requested. Therefore it is essential that you have filled in your proper 
email address. So please check it carefully to avoid any inconvenience. 
Please feel free to contact me again if you should need anything further. 
Kind regards,  
Rossella 
_________________________________________ 
Rossella Guzzo Foliaro 
EORTC, Quality of Life Department Assistant 
Tel: +32 2 77416 78  
Fax:+32 (0) 2 779 4568 
Avenue E. Mounier 83/11 • 1200 Brussels • Belgium 
rossella.guzzo@eortc.be  
http://groups.eortc.be/qol 
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_________________________________________ 
From: moh'd khleif [mailto:mkhleif@yahoo.com]  
Sent: Friday, 10 February, 2012 19:25 
To: Rossella Guzzo 
Subject: use of EORTC QLQ 30 for academic research 
Dear Sir/ Madam; 
I am a master student at AL-Quds University in the faculty of public health. my master 
will be in health policy and management. I am planning to conduct a research on the 
quality of life of cancer patients in Palestine. I have found your tool through my 
reviewing of the literature, and it is already translated to Arabic and used in neighboring 
countries, including Palestine in one of the small researches done in 2010. I am 
contacting you for permission to use your tool in my research questionnaire to measure 
the quality of life of the Palestinian cancer patients.  
I hope to hear from you soon. I am ready to provide any needed information about myself 
or my proposed research. 
Very best regards; 
Mohamad Khleif 
Mohamad H. Khleif RN, BSN, Master candidate 
AL-Quds University 
Jerusalem 
 
  ﻋﻠﻰ اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ﺑﺣث ﻋﻠﻣﻲ ﻧﻣوذج ﻣواﻓﻘﺔ ﻣﺳﺗﻧﻳرة
اﻧت ﻣدﻋو ﻟﻠﻣﺷﺎرﻛﺔ ﻓﻲ ﺑﺣث ﻋﻠﻣﻲ ﻳﻘوم ﺑﻪ اﺣد طﻼب اﻟﻣﺎﺟﺳﺗﻳر ﻓﻲ ﺟﺎﻣﻌﺔ اﻟﻘدس ﻓﻲ ﻛﻠﻳﺔ اﻟﺻﺣﺔ اﻟﻌﺎﻣﺔ 
ﻠﻣرﺿﻰ ﻓﻲ ﻟﻧوﻋﻳﺔ اﻟﺣﻳﺎة ﻧﺣن ﻧﺗطﻠﻊ اﻟﻰ اﻻﻓﺎدة اﻟﻌﻠﻣﻳﺔ ﻣن ﺧﻼﻝ دراﺳﺔ . ﻓﻲ ﺑرﻧﺎﻣﺞ اﻟﺳﻳﺎﺳﺎت و اﻻدارة اﻟﺻﺣﻳﺔ
ﻟﻰ ﻳﻬدف ﻫذا اﻟﺑﺣث ا. و ذﻟك ﻣن ﺧﻼﻝ اﺳﺗﻛﺷﺎف طرق اﻻدارة و اﻟﺗﺣﻛم ﺑﺎﻻﻟم و اﻻﻋراض ﻟدى اﻟﻣرﺿﻰ, ﻓﻠﺳطﻳن
ﺳﻳﺎﺳﻳﺔ و او اﺟﺗﻣﺎﻋﻳﺔ اﻣﺣددات ﺛﻘﺎﻓﻳﺔ  اي ﻛﻣﺎ ﻳﻬدف اﻟﻰ ﺗﺳﻠﻳط اﻟﺿوء ﻋﻠﻰ, ﻟﻣرﺿﻰااﻟﺣﻳﺎة  و ﺟودة ﻧوﻋﻳﺔ دراﺳﺔ
اﻟﻰ ﺑﻳﺎن اﻟﺣﺎﺟﺔ اﻟﻰ ﺗوﻓر ﺑراﻣﺞ اﻟرﻋﺎﻳﺔ  اﻳﺿﺎ ﻳﻬدف اﻟﺑﺣث .ﻋﻘﺎﺋدﻳﺔ ﻓﻛرﻳﺔ ﺧﺎﺻﺔ ﻟدى اﻟﻣرﺿﻰ اﻟﻔﻠﺳطﻳﻧﻳﻳناو 
اﻟﻧﺗﺎﺋﺞ ، و ﻣﻘﺎرﻧﺔ ﺿﻣن اﻟﺧطﺔ اﻟﺻﺣﻳﺔ اﻟﻌﻼﺟﻳﺔ ﻟﻠﻣرﺿﻰ ﻟﻠﻣرضاﻟﺗﻠطﻳﻔﻳﺔ و اﻟﺗﺣﻛم ﺑﺎﻻﻟم و اﻻﻋراض اﻟﻣﺻﺎﺣﺑﺔ 
  . ﻣﺣﻠﻳﺎ و ﻋﺎﻟﻣﻳﺎ
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ﺣﻳث ﺗم اﺧﺗﻳﺎرك ﺑﺷﻛﻝ ﻋﺷواﺋﻲ ﻣن ﺑﻳن اﻟﻣرﺿﻰ اﻻﺧرﻳن  ,اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ﻫذا اﻟﺑﺣث ﻫﻲ اﺧﺗﻳﺎرﻳﺔ ﻣﺣﺿﺔ
ﺿﻣﺎن اﻟﺳرﻳﺔ و ﻣﻊ , اﻧﻪ ﻻ ﺗوﺟد اي ﻣﺧﺎطر ﺟﺳدﻳﺔ او ﻧﻔﺳﻳﺔ ﻣﺗﻌﻠﻘﺔ ﺑﺎﻟﻣﺷﺎرﻛﺔ ﻛﻣﺎ .ﺿﻣن ﻧﻔس اﻟﻣواﺻﻔﺎت
ﻣﻊ اﻟﺗﻌﻬد ﺑﻌدم اﺳﺗﺧدام اي ﻣﻌﻠوﻣﺎت ﺷﺧﺻﻳﺔ او طﺑﻳﺔ ﻟﻐﻳر اﻏراض , اﻟﺗﺎﻣﺔ ﻟﻠﻣﺷﺎرﻛﻳن ﻓﻲ ﻫذﻩ اﻟدراﺳﺔ اﻟﺧﺻوﺻﻳﺔ
ﻓﻲ ﻫذا اﻟﺑﺣث ﺗﻌود  ﻛﻣﺎ ان اﻟﻣﺷﺎرﻛﺔ. و ﺗﺑﻘﻰ ﺳرﻳﺔ ﻣؤﻛدﻳن ﻋﻠﻰ ان اﻻﺳﻣﺎء ﻏﻳر ﻣطﻠوﺑﺔ, ﻲ ﻓﻘطاﻟﺑﺣث اﻟﻌﻠﻣ
و اﻟﺣﺎﺟﺎت اﻟﺟﺳدﻳﺔ و اﻟﻧﻔﺳﻳﺔ  ﻰﻣرﺿاﻟﺑﺎﻟﻔﺎﺋدة ﻋﻠﻳك و ﻋﻠﻰ ﺟﻣﻳﻊ اﻟﻣرﺿﻰ ﻣن ﺧﻼﻝ ﻟﻔت اﻻﻧﺗﺑﺎﻩ اﻟﻰ ﻧوﻋﻳﺔ ﺣﻳﺎة 
ﻧﺎﻓﻊ ﺷﺧﺻﻳﺔ ﻣﺑﺎﺷرة ﻟﻠﻣﺷﺎرﻛﻳن ﻓﻲ ﻣﻊ ﻋدم اﻟﺗﻌﻬد ﺑﺎي ﻣ. و رﻓﻊ ذﻟك اﻟﻰ ﻣﺳﺗوى اﺧذي اﻟﻘرار ﻓﻲ اﻟوطن, ﻟﻬم
  . اﻟﺑﺣث
اذا ﻗررت اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ﻫذﻩ اﻟدراﺳﺔ ﺳوف ﻳﻘوم ﺷﺧص ﻣﻬﻧﻲ ﺑﻣﻘﺎﺑﻠﺗك و اﻋطﺎﺋك اﺳﺗﺑﻳﺎن ﻟﻣﻠﺋﻪ ﻓﻲ ﻣدة ﻻ 
و ﻧؤﻛد ﻋﻠﻰ اﻧﻪ ﻳﺑﻘﻰ ﻟك ﻛﺎﻣﻝ اﻟﺣق ﻓﻲ اﻟﻣﺷﺎرﻛﺔ ﻓﻲ اﻟدراﺳﺔ او رﻓﺿﻬﺎ او اﻻﻧﺳﺣﺎب ﻣﻧﻬﺎ ﻓﻲ , ﺗﺗﺟﺎوز اﻟرﺑﻊ ﺳﺎﻋﺔ
د ان ﻟﺟﻧﺔ ﺧﺎﺻﺔ ﻓﻲ اﻟﺟﺎﻣﻌﺔ ﻗﺎﻣت ﺑﻣراﺟﻌﺔ ﻫذا اﻟﺑﺣث اﻟﻌﻠﻣﻲ واﻋطﺎء اﻟﻣواﻓﻘﺔ ﻋﻠﻳﻪ ﺿﻣن ﻛﻣﺎ ﻧؤﻛ. اي وﻗت ﺗﺷﺎء
  . اﻟﻣﻌﺎﻳﻳر اﻟﻌﻠﻣﻳﺔ و اﻟﺑﺣﺛﻳﺔ اﻟوطﻧﻳﺔ و اﻟﻌﺎﻟﻣﻳﺔ اﻟﻣﻌﻣوﻝ ﺑﻬﺎ ﻓﻲ اﻟﺟﺎﻣﻌﺔ
ﻳﻣﻛن  او ﻻﺣق ﺣﺎﻟﻲو ﻓﻲ ﺣﺎﻝ وﺟود اي اﺳﺗﻔﺳﺎر , ﺳوف ﻳﺗم اﻋطﺎؤك ﻧﺳﺧﺔ ﻣن ﻫذا اﻟﻧﻣوذج ﻟﺗﺑﻘﻰ ﻣﻌك
  :اﻟﺗﺎﻟﻲ ﻋﻠﻰ اﻟﻌﻧواناﻻﺗﺻﺎﻝ ﻣﻊ اﻟﺷﺧص اﻟﻘﺎﺋم ﻋﻠﻰ اﻟﺑﺣث ﻓﻲ اي وﻗت 
  ﻣﺣﻣد ﺧﻠﻳف: اﻻﺳم
  .ﺑرﻧﺎﻣﺞ اﻟﺳﻳﺎﺳﺎت و اﻷدارة اﻟﺻﺣﻳﺔ \طﺎﻟب ﻣﺎﺟﺳﺗﻳر ﻓﻲ ﻛﻠﻳﺔ اﻟﺻﺣﺔ اﻟﻌﺎﻣﺔ ﻓﻲ ﺟﺎﻣﻌﺔ اﻟﻘدس : اﻟﻣﻬﻧﺔ
 moc.oohay@fielhkm : ﺑرﻳد اﻟﻛﺗروﻧﻲ     1184957950: ﻫﺎﺗف
و ﻣﺗﺿﻣﻧﺎ اﻗرارك ﺑﻘراءة  و ﺗوﻗﻳﻌك ﻓﻳﻣﺎ ﻳﻠﻲ ﻳﻌﻧﻲ ﻫذﻩ اﻟﻣواﻓﻘﺔ, اﻧت ﻓﻲ طور اﻟﻣواﻓﻘﺔ ﻋﻠﻰ اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ﻫذا اﻟﺑﺣث
  .ﻣﺎ ﺗﻘدم ﻓﻲ ﻫذا اﻟﻧﻣوذج
  ____________________ : اﻟﺗوﻗﻳﻊ      ____ __________________________: اﻟﻣﺷﺎرك
  _______________: اﻟﺗﺎرﻳﺦ       
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Annex 11: Expert reviewers of the study tool 
The study tool had been reviewed by the following experts:  
• Dr. Mohamad Bushnaq, MD, Palliative Care specialist in Jordan. Previously was 
the head of oncology and palliative care department at King Hussein Cancer 
Center (KHCC).  
• Dr. Foad Sabatein, MD, Oncologist at Beit Jala Hospital in Palestine. Previously 
was the head of the oncology department at Augusta Victoria Hospital in 
Jerusalem.  
• Dr. Motasem Hamdan, PhD, researcher and Dean of Public Health faculty at AL-
Quds University in Palestine.  
• Mrs. Amal Dweib Khleif, palliative care nurse specialist in Palestine. Founder and 
chair of AL-Sadeel Society for Palliative Care for Cancer and Chronic Diseases. 
Previously was the head nurse of the oncology unit at Augusta Victoria Hospital 
in Jerusalem.  
• Mrs. Niveen Abdel Hadi, social worker in the field of cancer care, works with 
Palestine Children’s Relief Fund (PCRF) in Palestine.  
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